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ABSTRACT
SOCIAL DETERMINANTS OF CARDIOMETABOLIC DISEASE CONTROL:
AN ECOSOCIAL APPROACH
SEPTEMBER 2018
CRISTINA HUEBNER TORRES, B.A. MOUNT HOLYOKE COLLEGE
M.A., NEW YORK UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Elizabeth Bertone-Johnson

Cardiovascular disease (CVD) is the leading cause of death in the United States. Diabetes
mellitus, hypertension, and dyslipidemia are three primary risk factors for CVD. Each is
disproportionately distributed in the population by race/ethnicity. Social determinants of health
(SDoH) research indicate that social and environmental factors upstream of individual behaviors
can impede an individual’s chronic disease control. Guided by Michael Marmot’s SDoH
theoretical framework and by an ecosocial approach, this study used data from a cross-sectional
mixed methods study conducted in Western Massachusetts at a federally qualified health center
from 2014 to 2018 (RxHL) to examine the association between SDoH—food insecurity and
social stressors—and cardiometabolic disease control. Based on the theoretical framework, selfreported and pill count medication adherence were assessed as a possible mediator of the
exposure/outcome relationship.
In Chapter 1, we situated social determinants of health and cardiometabolic disease
control within a social epidemiologic approach using Michael Marmot’s social determinants of
health and an ecosocial theoretical framework to address the concept of embodiment.
In Chapter 2, we examined food insecurity, medication adherence, and cardiometabolic
disease control and examined mediation by self-reported medication adherence. We had
unexpected null findings for food insecurity and diabetes control and hypertension control. Food
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insecurity was independently associated with higher lipid levels. Self-reported medication
adherence partially mediated the association between food insecurity and dyslipidemia as
measured by Non-HDL-C.
In Chapter 3, we examined social stressors, medication adherence, and cardiometabolic
chronic disease control. Unexpectedly, there was no association observed between social stressors
and glycemic control among those with diabetes or SBP control among those with hypertension.
Adjusted multivariable analyses indicated social stressors were independently associated with
higher lipid levels as measured by LDL-C. Self-reported medication adherence partially mediated
the association between social stressors and LDL-C.
In Chapter 4, we examined racial/ethnic differences in social determinants, medication
adherence and cardiometabolic disease control. Using linear and proportional odds models,
predicted continuous outcomes and predicted prevalence, and pairwise comparisons, we found
race/ethnicity was independently associated with each outcome variable compared to nonHispanic whites controlling for covariates. Pairwise comparisons highlighted additional
significant differences between groups.
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CHAPTER 1
INTRODUCTION AND BACKGROUND:
A SOCIAL EPIDEMIOLOGY APPROACH
1.1. Introduction
Cardiovascular disease is the leading cause of death in the United States (CDC, 2016).
Four commonly co-occurring conditions are risk factors for CVD and include type 2 diabetes,
hypertension (high blood pressure), dyslipidemia (abnormal cholesterol), and obesity (AHA,
2016). Based on National Health and Nutritional Examination Survey data (2010), forty-five
percent of U.S. adults were found to have either diabetes, hypertension, or hyperlipidemia, 13%
had two of the chronic conditions, and 3% had all three (Fryar et al., 2010). Each of these
diseases is disproportionately distributed in the population by race and ethnicity such that
racial/ethnic minorities have higher rates of having one or more of these diseases compared to
whites (CDC, 2016; Fryar et al., 2010).

1.1.2. Diabetes Mellitus
Diabetes mellitus is categorized into four distinct types: Type 1 diabetes, Type 2 diabetes,
Gestational diabetes mellitus, diabetes due to other causes (ADA, 2016; CDC, 2014). The vast
majority (90-95%) of all cases of diabetes is categorized as Type 2 diabetes (ADA, 2016). Type 2
diabetes (T2D) occurs in “individuals who have insulin resistance and usually relative (rather
than absolute) insulin deficiency” (ADA, 2016, p. S16). Unlike Type 1 diabetes, autoimmune
destruction of !-cells is not the cause of Type 2 diabetes (ADA, 2016). Among those with Type 2
diabetes being overweight or obese or having fat concentrated in the abdominal region is common
and overweight/obesity can lead to insulin (ADA, 2016). Weight loss and medication can
improve insulin resistance (ADA, 2016). Type 2 diabetes is more common in “those with
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hypertension or dyslipidemia and in certain racial/ethnic subgroups (African American, American
Indian, Hispanic/Latino, and Asian American)” (ADA, 2016, p.S17). There are several blood
tests used independently to diagnose diabetes. Among them is the Hemoglobin A1c test which
measures average blood glucose (blood sugar) levels over the prior 8 to 12 weeks. An A1c >6.5%
(48 mmol/mol) is diagnosed as diabetes and, without medically confirmed hyperglycemia, repeat
testing is recommended (ADA, 2016). In addition, those with increased risk for developing
diabetes—defined by an A1c> 5.7% and <6.5%--are categorized as having prediabetes (ADA,
2016).
As of 2014, 29.1 million (9.3%) of the U.S. population had either diagnosed diabetes
(21.9 million) or undiagnosed pre-diabetes (8.1 million) (CDC, 2014; ADA, 2016, ). 2,3 Of those,
only 4.3% (1.25 million) are adults and children with Type 1 diabetes. According to a study
using National Health and Nutrition Examination Survey data from 1999-2008, 16% of adults
with diabetes had uncontrolled blood glucose levels (HbA1c>9%) (Berkowitz et al., 2013).
Adults living with diabetes have a 70% increased risk of hypertension and a 2- to 4-fold increased
likelihood of having heart disease, stroke or other heart conditions compared to those without
diabetes (CDC, 2016; DHHS, 2007). Type 2 diabetes (T2D) is the seventh leading cause of death
in the U.S. and is disproportionately distributed in the population by race and ethnicity.

6,7

Nearly

twice as many Blacks (13.2%) and Hispanics (12.8%) compared to whites (7.6%) aged 20 or
older were diagnosed with diabetes as of 2014 in the U.S. (CDC, 2015; ADA, 2014). Among
Hispanics (12.8%), Puerto Ricans (14.8%) account for the largest group with diabetes (ADA,
2016). Each year, 1.4 million individuals in the U.S. are diagnosed with diabetes (ADA, 2014).
Age-adjusted all-cause mortality data from 2003 to 2006 indicate that those with diabetes have a
1.5 times higher chance of death compared to those without the disease (CDC, 2014). 2 Because
diabetes is the leading cause of microvascular complications including blindness and non-
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traumatic lower-limb amputations 2, prevention and management of diabetes is a major public
health concern.
The cost of diagnosed diabetes in the U.S. in 2012 was $245 billion--$176 billion of
which was related to actual medical costs and $69 billion related to decreased productivity among
those with diagnosed diabetes (ADA, 2016). Age- and sex-adjusted medical costs indicate that
expenditures are 2.3 times higher among those with diabetes compared to those without (ADA,
2016). In addition to the serious and costly complications associated with diabetes, diabetes is a
serious risk factor for cardiovascular disease (CVD) and, among those with diabetes, CVD is the
leading cause of early death (CDC, 2016). In 2011, 7.6 million adults aged 35 or older diagnosed
with diabetes self-reported having had a heart attack or stroke (CDC, 2013).
Recommendations to reduce and/or manage diabetes include regular blood glucose selfmonitoring, following a recommended diet for optimal blood glucose control, increasing physical
activity, adhering to regular medical appointments and medications, and annual foot and eye
exams.

1.1.3 Hypertension
Hypertension (high blood pressure) is defined as having systolic blood pressure—the pressure in
the blood vessels when the heart beats—of 140 mmHg or higher and/or diastolic blood
pressure—the pressure in the blood vessels between beats—of 90 mmHg or higher.
Approximately 70 million (29%)—or 1 in 3—adults in the U.S. have hypertension. Among those
with hypertension, just over half (52%) have their high blood pressure in control. This is more
than twice that of diabetes. Reported prevalence rates, however, are likely underestimates since
approximately 20% of adults with hypertension are unaware of their diagnosis (CDC, 2016).
Among those with hypertension, there is four-fold increased risk of death from stroke and a three-
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fold increased risk of death from heart attack (CDC, 2016). Hypertension is associated with $46
billion in health care costs each year. Recommendations to reduce and/or manage hypertension
include eating a reduced sodium diet, adhering to prescribed medications and medical
appointments, getting adequate physical activity and stopping smoking.

1.1.4. Dyslipidemia
Dyslipidemia, defined as “elevated total or low-density lipoprotein (LDL) cholesterol levels, or
low levels of high-density lipoprotein (HDL) cholesterol” and has been identified as a primary
risk factor for CHD (Fodor, 2011, p.1207). One manifestation of dyslipidemia is
hyperlipidemia—high cholesterol—and is defined by having low density lipoprotein level (LDL)
>130 mg/dL. However, among them less a third (29.5%) have their hyperlipidemia in control.
Among those with hyperlipidemia, there is a 2-fold increased risk of CVD compared to those
without hyperlipidemia (CDC, 2015). The highest rates of hyperlipidemia are among Blacks and
Hispanics. For each of these chronic conditions, disease management aims to control disease
progression through prescribed medication, heart-healthy diets, increased physical activity,
tobacco treatment, and minimizing alcohol consumption.

1.1.5. Obesity
Over a third of U.S. adults are obese (CDC, 2016; Ogden et al., 2014) and obesity is a risk factor
for diabetes, heart disease, stroke and other chronic diseases (CDC, 2016). Obesity, like the other
chronic diseases it is associated with, is disproportionately distributed among non-Hispanic
blacks (47.8%) and Hispanics (42.5%), followed by non-Hispanic whites (32.6%) and nonHispanic Asians (10.8%) (CDC, 2016; Ogden et al., 2014). Many federal and state policies and
initiatives have been instituted to address obesity rates in the U.S., though, rates appear to have
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held steady since 2003-2004 and 2009-2010 as measured by the National Health and Nutrition
Examination Survey (NHANES) (Ogden et al., 2014).

1.1.6. Comorbidity/Multimorbidity
Comorbidity is defined as “a specific combination of diseases or additional diseases beyond the
index disease under study” (van den Akker et al., 1998, p.367). In contrast, multimorbidity is
defined as “the co-occurrence of multiple chronic or acute diseases and medical conditions within
one person” and often described as two or more chronic conditions at the same time (Koroukian
et al., 2015, p.1; Goodman et al., 2013; Valderas et al, 2009; van den Akker, 1998).

1.1.7. Cardiometabolic Risk
Cardiometabolic risk is defined by the American Diabetes Association and the American
College of Cardiology Foundation as “the lifetime risk for cardiovascular disease” and is
measured by the presence of at least 3 out of five factors: 1) central obesity; 2) insulin resistance;
3) high blood glucose levels; 4) low HDL (good cholesterol); and 5) hypertension. Individuals
living with diabetes are more likely to have many of these factors (Brunzell et al., 2008; CDC,
2016). The National Diabetes Education Program’s campaign to manage risk factors for CVD and
diabetes focuses on modifiable risk factors referred to as the “ABCs”: A: Hemoglobin A1c (blood
glucose) less than 7%; B: blood pressure less than 130/80 mmHg; C: Cholesterol (LDL less than
100 mg/dl); and s: Stop Smoking (NDEP, 2016).
Cardiometabolic risk as defined above is multi-level and can be categorized into micro(biologic/cellular), individual- (behavioral), macro-level (social/environmental) factors.
According to the American Diabetes Association (ADA) and the American Heart Association
(AHA), managing diabetes, hypertension, and dyslipidemia requires a lifestyle of a heart-healthy
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diet, regular moderate physical activity, reduced alcohol consumption, adherence to medications
and medical appointments, and on-going self-management education. Each cardiometabolic
disease has specific recommendations within these broad categories. For diabetes management,
daily blood glucose monitoring, daily self-exam of feet, and attending diabetes self-management
classes are recommended (ADA, 2016; CDC, 2013). In addition to daily self-management,
recommended preventive care practices to avoid disease progression include: annual dilated eye
exam, annual foot exam, annual doctor’s visit, two or more hemoglobin A1c tests per year, and
annual influenza vaccine (CDC, 2013). For hypertension, maintaining a diet low in sodium,
regular blood pressure monitoring, and quitting smoking are recommended (AHA, 2016). And,
for cholesterol, maintain a diet low in saturated and trans fats is recommended. (AHA, 2016).
It has been well established in the literature that behavior modification of individual-level
factors (e.g., exercise, diet, alcohol use, tobacco use) can greatly reduce cardiometabolic risk and
onset of cardiometabolic diseases such as T2D, hypertension and hyperlipidemia. As such, nearly
five decades of public health and clinical research from the 1950s to early 2000s to address the
prevention and management of chronic disease has been largely focused on individual-level
behaviors and risk factors often referred to as modifiable risk factors or behaviors (AHA, 2016).
A modifiable behavior implies that the individual is in control and has the capacity to
make the change and places the onus of achieving improved health outcomes on the individual.
However, from a social epidemiologic perspective, it is imperative to examine whether the
modifiable risk factors are in fact modifiable and, if so, for whom and in what regions are they
truly modifiable at the individual level? Social, environmental and economic factors frequently
constrain individuals and groups from making behavior changes and/or predispose them to
increased exposure to associated risk factors. For instance, urban dwelling, low income
individuals have decreased access to safe, walkable spaces, increased rates of food insecurity, and
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are exposed to increased sources of stress related to disease management and obtaining basic
needs. Therefore, eating healthier and moving more may not be a matter of choice but rather may
be unattainable and smoking, for example, may not be reduced as a result of the increased stress
associated with living with insufficient resources. Observational studies have found that, as a
result, interventions and policy changes that promote behavior change have been less effective in
the long-term than expected (Berkman, 2009). Additionally, cultural health beliefs—the meaning
that individuals from different cultural backgrounds make about their health and illness and what
is believed to cause or remedy disease—vary and therefore subsequent behaviors may not align
with medical treatment plans (Shaw et al., 2012; Orzech et al., 2013; Shaw et al., 2009). This can
further complicate the notion of modifiable behaviors.
According to the American Diabetes Association and the American Heart Association,
the non-modifiable cardiometabolic risk factors include age, race/ethnicity, gender, and
family/genetic history (AHA, 2016). Chronic exposure to poverty over the lifetime (and, often
times, transgenerationally), the built and social environments, and the effects of racial
discrimination can all impede the degree to which an individual is able to modify behavior in
order to prevent or manage cardiometabolic disease. Interventions and policies aimed at
eliminating systems-level barriers and inequities can make individual-level behavior changes a
more achievable goal—particularly for those who are disproportionately burdened by
cardiometabolic disease.

1.2. Social Epidemiology of Cardiometabolic Disease Control
1.2.1. Social Epidemiology
Social epidemiology—the social determinants and distribution of disease in human populations—
emerged in response to the shift from infectious disease to noncommunicable chronic diseases as
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the lead cause of morbidity and mortality in most regions of the world post WWII era (Berkman
et al., 2014). It evolved to better understand the etiology, distribution and determinants of
diseases not adequately explained by the more traditional epidemiologic triangle of host, agent,
and environment used in infectious disease research (Cassel, 1964). Social epidemiologists drew
from the social and behavioral sciences including medical sociology to develop theoretical
frameworks that can address the interface between the biological, psychosocial and ecological
factors. These frameworks are used to guide epidemiologic investigations that can address social
factors as part of the etiology of disease and can link social/environmental exposures with health
outcomes (Susser & Stein, 2009; Berkman & Kawachi, 2014). When examining the relationship
between social determinants of health and health outcomes, theoretical frameworks and research
methods that address the multiple-level factors involved (e.g., social/environment, individual,
biological) are needed.
Much of the public health and clinical research in adult chronic disease prevention and
management over the past five decades has focused on individual-level risk factors and
behavioral modifications. As described above, the cardiometabolic disease burden in the U.S. is
disproportionately distributed among communities of color. Among low income, ethnically
diverse, urban-dwelling individuals living with chronic disease—namely diabetes and/or
cardiovascular disease—making recommended behavioral modifications are often constrained by
issues associated with poverty such as lack of access to healthy, affordable foods for improved
dietary intake or safe and walkable spaces for increased physical activity. Low health literacy
(Shaw et al., 2012), cultural and linguistic barriers (Shaw et al., 2009), and other social
determinants of health pose significant challenges to self-care. These factors complicate patients’
ability to make behavioral changes. Yet, to date, much of the research addressing prevention and
management of chronic disease is focused on behavior change at the individual level. Therefore, a
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social epidemiologic approach is necessary as it prioritizes “an understanding of the complex
social and economic dynamics driving what seems to be, but is not, individual choice” (Berkman,
Kawachi & Glymour, 2014, p. 9).
Geoffrey Rose, a foremost epidemiologist, identified that “a large number of people at a
small risk may give rise to more cases of disease than the small number who are at high risk”
(Rose, 2001, p. 431). Rose introduced the idea that, while the medical and public health fields
often aim to identify and protect those at high risk, the focus should instead be a population
approach which aims “to discover and control the causes of incidence” (Rose, 2001, p.427).
Rose’s work gets at why certain individuals and populations are affected by disease while others
are not or are to a lesser degree—a key concept in health disparities and social determinants of
health research that aim to address the “causes of the causes” (Marmot, 2006, p.2) or those factors
that are upstream of individual-level risk factors like lifestyle and behavior (Berkman et al.,
2014).

1.2.2. Social Determinants of Health
The World Health Organization defines the social determinants of health as “the
conditions in which people are born, grow, work, live, and age, and the wider set of forces and
systems shaping the conditions of daily life. These forces and systems include economic policies
and systems, development agendas, social norms, social policies and political systems” (WHO,
2016). Several federal institutions and initiatives have defined the social determinants of health
and identified primary domains of focus to eliminate health disparities, improve health outcomes,
and reduce health care costs. Specifically, Healthy People 2020 (ODPHP, 2016), the American
Heart Association’s Scientific Report on the social determinants of risk and outcomes for CVD
(AHA, 2015), the National Academy of Medicine’s (formerly the IOM) report “Capturing Social
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and Behavioral Domains in the Electronic Medical Record—Phase 2 (IOM, 2014), and the
National Association of Community Health Center’s Protocol for responding to and assessing
patients’ assets, risks and experiences (PRAPARE) (NACHC, 2016) tool each identifies and
defines the primary social determinants of health domains/variables to be addressed through
various health policy, initiatives, research, and clinical and public health programs (Appendix 1).
As demonstrated in Appendix 1, the domains and corresponding subcategories are largely
comparable across the various institutions and initiatives helping to focus the scope of SDoH
research, policy, and intervention.
Drawing from these definitions, the domains of the SDoH, and from the work of Michael
Marmot, epidemiologist and a leader of research on health inequities, the term “social
determinants of health” is used in this paper to represent four primary constructs (Figure 1). First,
it refers to the well-established fact that “health follows a social gradient: the higher the social
position, the better the health” (Marmot & Wilkinson, 2006, p.2) and that this phenomenon exists
even among those not living in poverty but rather at every point on the social spectrum (Marmot
et al., 2006). Second, it refers to the social conditions in which people live and work and
identifies these factors as the cause of the social gradient of health. It is these social conditions
that are thought to influence behaviors that are then more proximally associated with biologic
markers of disease. Therefore, the focus of SDoH is to identify “the causes of the causes”
(Marmot et al., 2006, p.2). Very specifically, medicine and public health have tended to approach
disease prevention and management from an individual-level perspective addressing the
behaviors associated with markers of health or illness (e.g., high density, low nutrient diets and
obesity; smoking). SDoH looks upstream of individual behaviors to identify the social, economic
and environmental circumstances in which people are at increased risk to consume high density,
low nutrient foods, to be physically inactive, and to experiences increased stress associated with
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having insufficient access to material resources throughout life (Barnard et al., 2015). These
circumstances have been associated with increased engagement in behaviors, such as overeating
and smoking—coping methods known to increase risk and poor health outcomes. Third, it refers
the impact of chronic stress on biologic processes that can result in disease and early death
(Marmot et al., 2006). National and global policies are upstream of social and environmental
factors and thus critical sources where change can have broad and lasting impacts—both positive
and negative depending on the policy (Marmot et al., 2006). Therefore, to address SDoH at the
policy level is one way to effect change in the rates and distribution of disease where decades of
emphasis on individual and behavioral factors in public health and medicine have not.
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Figure 1. Social determinants of health (Marmot et al., 2006, p. 9)
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1.3. Physiology of Social Determinants and Cardiometabolic Disease Control
Three broad areas have been hypothesized as links between social conditions and health
outcomes: 1) social/built environments; 2) health behaviors; and 3) stress and cognitive/affective
processes (Kubzansky et al., 2014, p.512). The possible physiologic mechanisms include: 1)
Autonomic function; 2) HPA axis; 3) Immune function; 4) Inflammatory processes; and 5)
Apoptotic regulation (Kubzansky et al., 2014, p. 513). As illustrated in Marmot’s model of social
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determinants of health (Figure 1), the more proximal/downstream factors like behavior,
psychological and biologic processes that are associated with disease are modeled as possible
mediators in the relationship between the social environment and health or illness (Marmot et al.,
2006). “These downstream factors are the proximal causes of disease which tend to be the main
focus of medical attention” (p. 9). From a social epidemiologic approach, the term “ecosocial” is
used to encompass the possible mechanisms that explain the effect of upstream systems-level or
neighborhood-level exposures, such as factors associated with systems- or neighborhood-level
poverty, on health outcomes.18,19 There are several mechanisms that may explain the association
between social determinants and cardiometabolic disease control and multimorbidity.3,10-12 For
each of the subsequent papers, a detailed description of the specific mechanisms for each
exposure (food insecurity, health literacy and social stress) and outcome (cardiometabolic disease
control and multimorbidity) will be described. The following is a brief and overarching summary.
While there is extensive and compelling evidence of the psychological, behavioral, and
biological pathways associated with the risk and management of cardiometabolic chronic
diseases, there is a paucity of research that examines these psychological, behavioral, and
biological factors as potential mediators in the relationship between social determinants of health
and cardiometabolic chronic disease management (Havranek et al., 2015). To date, much of this
research addresses the effect of social/environmental factors at the neighborhood-level on health
behaviors (Kawachi & Berkman, 2003). Neighborhoods that have characteristics associated with
deprivation have been associated with higher prevalence of cardiometabolic risk factors, higher
rates of diabetes and other cardiometabolic diseases, and lower rates of chronic disease control
(Laraia et al., 2012; Diez Roux & Mair, 2010; Seligman, Laraia & Kushel, 2010). For instance,
“the impact of walkability [of a neighborhood] on walking behavior” and the impact of access to
healthy foods on eating behaviors and levels of obesity (Diez Roux, 2016, p. 430) are two
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examples of how neighborhood factors can impact individuals’ health behaviors and may impede
adoption or maintenance of recommended behavior changes to prevent or manage chronic
disease. Educational level, “the most used indicator of socioeconomic position in the United
States” has been associated with health literacy levels (Havranek et al., 2015, p. 875).
Neighborhoods with higher rates of low educational attainment (< high school) have been found
to also have higher rates of low health literacy (Havranek et al., 2015). Low health literacy has
been associated with higher rates of CVD and poorer cardiometabolic chronic disease
management (Havranek et al., 2015). Neighborhoods characterized by higher rates of social and
environmental stressors associated with violence and crime and lower SEP have been found to
have increased rates of depression and depression symptoms (Havranek et al., 2015), which are in
turn associated with increased rates and risk of cardiometabolic chronic diseases and poor
management. Conversely, the higher social support or social cohesion associated with ethnic
density in a neighborhood may lead to decreased rates of depression or depression symptomology
and improved behaviors, even in the presence of neighborhood barriers (Becares et al., 2014).
Based on a recent and summative review conducted by the American Heart Association,
there are three primary biologic pathways that link SDoH to cardiovascular health. The pathways
include: 1) socioeconomic disadvantage leads to increased burden of risk factors; 2) on-going
social and environmental stressors lead to cumulative stress on the biologic systems or allostatic
load; and 3) lifecourse exposure to low SEP (e.g., in utero and during critical windows of
development) can have long term effects on risk for CVD in adulthood (Havranek et al., 2015).
The possible biologic mechanisms by which social/environmental neighborhood-level factors
including low SEP are related to health include “increased stimulation of stress hormones,
inflammation, endothelial dysfunction, thrombosis, vascular hyperactivity, and metabolic
disturbances” (Havranek et al., 2015, p. 884).
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1.4. Theoretical Frameworks
Nancy Krieger poses the critical question whether all epidemiology is in fact social epidemiology.
(Krieger 2001). There is substantial debate about this given the social context in which we exist
(Kaplan, 2004; Oakes, 2013). To this aim, Krieger (2001) questions whether there is any
biological process or physiologic experience that occurs in the absence of a social environment
and vice versa. To be clear, this argument by no means minimizes the importance of identifying
and understanding the behavioral and biologic mechanisms underlying disease. Rather, it
encourages an expanded vantage point so that the biologic processes, often identified as the
“cause” of disease, are within context upstream of individual biology and related to the social
position of individuals in their environments. While the controversy as to whether in fact all
epidemiology is “social” remains, three primary theoretical frameworks have emerged from
social epidemiology to contextualize the psychological, social and environmental factors
associated with risk and distribution of chronic disease. These theoretical frameworks can be used
to inform the development of interventions and policy that address systems-level factors in
concert with individual-level ones. A more extensive review of all three (1. psychosocial, 2.
ecosocial, and 3. political ecology of health) can be found in the Minor Exam paper. For the
purposes of this study, we will be using the ecosocial framework guided by the subconstruct,
embodiment (Krieger, 2001; 2005), in combination with Marmot’s model of the social
determinants of health to guide the research questions and methods. 4
The theoretical frameworks that have emerged in social epidemiology have both
developed in response to evidence from landmark studies such as the Whitehall study of British
civil servants (Marmot, Shipley & Rose, 1984) and based on the need to examine factors not well
understood by the traditional epidemiologic triangle. These theoretical frameworks address the
social gradient of health (Marmot & Wilkinson, 2006; Marmot et al., 1984),

15

upstream/downstream or distal/proximal factors (Link & Phelan, 1995; 2004; 2010), and social
determinants of health (Marmot et al., 2006). They provide a framework with which to examine
disproportionate burden of disease among vulnerable populations and the associated health
disparities and inequities (Marmot & Wilkinson, 2006; Marmot et al., 1984). The effect of these
factors at different points in life or across generations (Kuh & Ben-Shlomo, 2004) has become a
primary focus of social epidemiologic theoretical frameworks (Berkman et al., 2014) particularly
as they relate to chronic disease epidemiology.

1.4.1. Ecosocial Theoretical Framework
Identification of the upstream determinants of health is not, on its own, sufficient to determine
how the individual/biological-level factors and the exogenous social factors are linked to cause
disease or to improve health. Krieger suggests a blended, multilevel theoretical framework which
considers both or multiple levels simultaneously.
The ecosocial theoretical framework has evolved in response to the realization that that
social epidemiology must consider causal relationships from a “multidimensional and dynamic”
perspective (Krieger, 2001). According to Krieger, the ecosocial framework is multilevel in its
approach, taking time, history, the political ecology and economy into account but also
considering the level, pathway and power of each contributing factor over the lifecourse (Krieger,
2008). Ecosocial theory is dynamic in that it is constantly evolving and building on prior efforts
to address the multidimensional reality of the social distribution and determinants of disease in a
population as they shift over time (Krieger, 1994; Susser, 1994; Susser, 1973; Krieger 2001;
Krieger, 2008; Gary-Webb, 2013). In comparison to other “eco-focused” models that have
evolved over time, Krieger’s ecosocial model “fully embraces a social production of disease
perspective while aiming to bring in a comparably rich biological and ecological analysis”
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(Krieger, 2001, p.672). She identifies ecosocial constructs within the ecosocial model that, when
taken together, can be used to develop multilevel pathways to examine the effects of “racial
discrimination and their biological embodiment across the life course” (p. 673).

1.4.2. Ecosocial Construct: Embodiment
Embodiment—one of the constructs of ecosocial theory (Krieger, 2001; 2008)——is defined as
“how we literally incorporate, biologically, the material and social world in which we live, from
conception to death” and thus it is understood that an individual’s biological process cannot be
accurately examined without including the social, historical and environmental factors in which
she lived (Krieger, 2001, p.668). The construct of embodiment is not unique to social
epidemiology. Theoretical constructs of embodiment exist across a range of disciplines including
anthropology, psychology, feminist, gender and queer studies and somatic studies (Fuchs, 2012;
Koch, Caldwell & Fuchs, 2013). Each addresses, in some capacity, the biological incorporation of
the social, cultural, psychological, and/or political environment. Given the corporeal capacity to
incorporate interactions with the world and with people at the cellular level, it only makes sense
that, in order to change individual-level experiences of health or disease, the social and
environmental conditions in which the individual exists must be addressed as well. A primary
focus of embodiment is the effect of systems-level sources of oppression (e.g., institutional
racism and discrimination) on bodies (Krieger, 2004). For example, inequitable distribution of
and access to necessary material resources such as fresh, healthy food, safe and affordable
housing, quality education, and safe, walkable neighborhoods over a lifetime or over the course
of multiple generations may lead to actual biological changes (Krieger, 2000; 2004). It is
important to consider how best to capture or measure the “stories” that bodies tell (Krieger,
2005).
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1.4.3. Mixed-Method Approach
Mixed-method studies that rely on both epidemiologic quantitative methods and qualitative
methods from the social sciences, in particular medical anthropology, can provide context and
meaning to quantitative findings (Trostle & Sommerfield, 1996). The dataset being used for the
current study comes from the NIH-funded cross-sectional Medication Adherence Health Literacy
and Cultural Health Beliefs Study (RxHL) and includes a rich qualitative databank. While those
data will not be included in this study, they are used in publications from the overall study
elsewhere.

1.5. Conclusion
Moving forward, additional research is needed to continue to understand the relationship between
social and environmental factors and their effect on individual behaivor and biology so that we
can develop more effective policy and interventions to eliminate health disparities. Engaging the
theoretical frameworks and methods of social epidemiology can facilitate research on the social
determinants of health and can contribute critical information to the field regarding how biologic
processes are situated within a larger context of social, political, historical and environmental
circumstances. Toward achieving these aims, chapters two through four will be guided by the
ecosocial theoretical framework outlined in Figure 2. Each will address the social determinants of
cardiometabolic disease control. They are:
1) Food insecurity and cardiometabolic disease control and possible mediation by
medication adherence;
2) Social stressors and cardiometabolic disease control and possible mediation by
medication adherence;
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3) Racial/ethnic differences in social determinants of health, medication adherence, and
cardiometabolic disease control.

Figure 2. Study Model: Social Determinants of Cardiometabolic Disease Control
Upstream
Social/Environmental

Downstream
SDoH

Mediators/Modifiers

Outcomes

Poverty/SES
Household Income
Household Size
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Educational Level
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(Racism/Discrimination)

Paper 1:
Food Insecurity

Paper 2:
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Stress Response
Allostatic Load

Paper 3:
Racial/Ethnic & Cultural Differences

Medication Adherence
Uncontrolled Disease
Depression, BMI,
Social Support
(Possible Moderators)

Note: Additional a priori covariates included: Age, gender, education, income, partnership status, employment, insurance coverage,
comorbidities/multimorbidity, tobacco and alcohol use, BMI, social support, and insulin (for DM models).

Food insecurity was explored as a social determinants of health, as identified by Healthy People
2020 SDoH domains. Social stressors were examined as a measure of stress associated with
social determinants from all five Healthy People 2020 SDoH domains. Each of these SDoH
exposures were measured at the individual level in the RxHL study but represent systems-level,
social/environmental conditions.
The goal for conducting social epidemiologic reseasrch is, in large part, to inform policy
development since policy is at the outermost ring of an ecologic map—even more upstream than
the social determinants. It is crucial in defining resource distribution to environments and thus the
social conditions of the environments in which people live and work and ultimately how health
and illness are distributed throughout the population.
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CHAPTER 2
FOOD INSECURITY, MEDICATION ADHERENCE AND
CARDIOMETABOLIC DISEASE CONTROL: AN ECOSOCIAL APPROACH
2.1. Introduction: Cardiometabolic Disease Control
As discussed in the Introduction Chapter, cardiovascular disease (CVD) is the leading cause of
death in the United States (CDC, 2016). Three cardiometabolic diseases—diabetes mellitus, high
blood pressure (hypertension) and high blood cholesterol (hyperlipidemia) –have been identified
as modifiable risk factors for CVD (AHA, 2016). Effective management of each of these
cardiometabolic diseases is fundamental to preventing morbidity and mortality associated with
disease progression and to reduce the risk of CVD events (e.g., heart attack and stoke). For
instance, glycemic control is one of the primary methods of diabetes management and poor
glycemic control is associated with higher risk of microvascular (e.g., retinopathy, neuropathy)
and macrovascular complications (e.g., cardiovascular events) (Giugliano et al., 2018; CDC,
2016). As of 2014, 20.5% of adults with diabetes in the U.S. have poor glycemic control
(glycosylated hemoglobin (HbA1c) >9%) and prevalence is higher among low income ethnic
minorities (HP2020, 2016). Hispanics with diagnosed diabetes had the highest prevalence of poor
glycemic control (30.2%)—twice the prevalence of non-Hispanic whites (14.6%)—followed by
non-Hispanic Blacks (25.5%) and non-Hispanic Asians (17.3%) (HP2020, 2016). As of 2014, just
over half (54%) of adults with hypertension in the U.S. had their blood pressure under control
(systolic blood pressure (SBP)<140 mmHg and diastolic blood pressure (DBP) <90 mmHg)
(Merai et al., 2016; CDC, 2018). Similar to diabetes management, prevalence of blood pressure
control is also lower among racial/ethnic minorities (HP2020, 2016). Compared to non-Hispanic
Whites (54.8%), African American (43.1%), Asian (40.1%), and Hispanic/Latino (45%) all had
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lower prevalence of blood pressure control (HP2020, 2016). Little is known about racial/ethnic
differences in dyslipidemia control (Tayie et al., 2009).
Medication adherence is one of the primary recommendations to achieve cardiometabolic
disease control, along with adherence to diet and physical activity guidelines, reduction or
cessation of tobacco and alcohol use, and adherence to medical appointments (ADA, 2018; CDC,
2018). Medication adherence is low (Osterberg et al., 2005)—approximately 50%--among those
with chronic diseases in developed countries (Sabaté, 2003; Oung et al., 2017). As described in
the introduction chapter, according to Marmot’s social determinants of health model (Marmot,
2006), medication adherence is a behavior and is hypothesized to act as a mediator between more
upstream social determinants—such as food insecurity—and disease outcomes.

2.1.2. Food Insecurity
Food insecurity is identified as one of the Healthy People 2020 social determinants of health
(SDoH) under the domain of economic stability (HP2020, 2016), and has been examined as a risk
factor for chronic disease and poor disease management, especially among low-income ethnic
minority populations (Seligman et al., 2012). Food insecurity is defined as having “limited or
uncertain availability of nutritionally adequate and safe foods or limited or uncertain ability to
acquire acceptable foods in socially acceptable ways” (Anderson, 1990, p. 1576; USDA, 2015).
Food insecurity, particularly in the U.S. among low income individuals, is an episodic and cyclic
phenomenon such that individuals and households experience adequate access to food (though
often food that is calorie dense, nutrient poor) for most of the month followed by food scarcity
toward the end of the month (Seligman et al., 2010; Seligman et al., 2011).
Food insecurity is broken into categories: low food security and very low food security
(Castillo et al., 2012). Low food security is “characterized by irregular access to food, binge
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eating when food is available, overconsumption of energy-dense foods, obesity, and even type 2
diabetes” (p.245). Low food security characterized in this manner is common in low income
urban environments in industrialized, high income countries like the U.S. (Castillo et al., 2012).
Very low food security is characterized by lack of access to food and starvation—a very different
outcome from low food security—and is more commonly found in developing nations (Castillo et
al., 2012). Food insecurity in the U.S. is often measured by the United States Department of
Agriculture’s U.S. Household Food Security Survey Module (Appendix 2). Research using this
scale sometimes combines the low food security and very low food security groups to represent
food insecurity (Coleman-Jensen et al 2015; Nord et al., 2004; USDA 2012; Appendix 2 and 3).
First reported in 1995 by the USDA, food insecurity was prevalent at that time in
approximately 11.9% of households (Carlson et al, 1999). As of 2016, 12.3% (15.6 million
households) of households in the United States were food insecure (USDA, 2017). 7.4% had low
food security and 4.9% had very low food security (USDA, 2017). In 2014, Black non-Hispanic
households had nearly twice the national prevalence of food insecurity (26.1%) followed by
Hispanics (22.4%). Households with incomes less than 185% of the federal poverty level
($24,008 for a family of 4 in 2014) had the greatest food insecurity (33.7%). The prevalence of
food insecurity in 2004 in Massachusetts was 7.1% (USDA, 2004). As of 2014, it was estimated
that 9.6% of households (375,695 households) in Massachusetts were food insecure, a 35%
increase over the past decade (USDA, 2014).
With food insecurity so common in the U.S.—particularly among ethnically diverse and
low-income groups—there is a need to better understand its effect on the management of one or
more cardiometabolic diseases such as diabetes mellitus, hypertension, and hyperlipidemia. Food
insecurity has been examined as a risk factor for cardiometabolic diseases and for poor chronic
disease management especially among low income populations (Laraia, 2013; Seligman et al.,
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2010; Seligman et al., 2007; Castillo et al., 2012; Seligman et al., 2009). Living in a food desert—
defined by the USDA and Healthy Food Financing Initiative (HFFI) as “a low-income census
tract where a substantial number or share of residents has low access to a supermarket or large
grocery store” (USDA, 2011)—is associated with high rates of food insecurity (Tolzman et al.,
2014; Seligman et al., 2010). Energy dense, low nutrient foods are those high in saturated fats and
sugars, often highly processed, and with long shelf life that are cheaper and easily accessible but
offer little nutrients. They include sodas or other sugar sweetened beverages, fast/fried foods,
cakes, cookies, chips, and other “empty calories”. Diets high in energy dense foods are common
in food deserts because they are cheaper, last longer, and more readily accessible than nutrient
dense foods, and have been associated with weight gain and the development or progression of
chronic diseases (Laraia, 2013).

2.1.2. Ecosocial/Physiologic Mechanisms
There are several ecosocial and physiologic mechanisms that may link food insecurity and risk of
poor cardiometabolic disease control as defined in Outcome Assessment section (Seligman et al.,
2010b; Seligman et al., 2012). The term “ecosocial” is used to describe mechanisms that explain
the link between social conditions and health outcomes (Krieger, 2001a; Krieger, 2001b; Krieger,
2011; Krieger, 2012). The mechanisms described are considered from the perspective of
embodiment (discussed in Chapter 1) and how social and environmental “exposures ‘outside the
body’ get under the skin to influence physical health and disease” (Kubzansky, Seeman &
Glymour, 2014, p.513; Krieger, 2001b).
Three broad areas have been proposed as links between social conditions and health
outcomes: 1) social/built environments; 2) health behaviors; and 3) stress and cognitive/affective
processes (Kubzansky et al., 2014, p.512; Introduction Figure 1). Each of these broad categories
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is upstream of relevant physiologic processes though research to examine the actual causal
pathways is limited due to the complexity of the possible mechanisms involved (Krieger, 2008;
Braveman et al 2011). The physiologic processes then impact cardiometabolic regulation and
tissue which then impacts health outcomes.
This proposed eco/physiologic mechanism is consistent with Marmot’s model of social
determinants of health (Introduction, Figure 2)which also posits SDoH as upstream of health
behaviors and psychological processes which are upstream of the biologic processes (Marmot &
Wilkinson, 2006). It is also in sync with the American Heart Association’s proposed biologic
pathways that link SDoH to cardiovascular health discussed in the Introduction Chapter
(Havranek et al., 2015). In each case, the proposed mechanisms situate the individual and their
behavior within the social and environmental context. Much of the clinical and medical literature
focuses specifically on the relationship between individual-level, modifiable health behaviors and
health outcomes. With regard to cardiometabolic disease prevention and management, the five
focal behaviors most frequently addressed are diet, exercise, tobacco use, alcohol use, and
medication adherence. As described in Paper 1 based on the social determinants of health
theoretical framework (Marmot & Wilkinson, 2006) and based on the scope of the current study
and available data, we focus on medication adherence as the primary individual-level behavior of
interest and examine its role as a possible mediator of the association between food insecurity and
cardiometabolic disease control while addressing the other behaviors as possible covariates.
Based on several studies of food insecurity and diabetes risk and management, it has been
suggested that food insecurity is associated with both hyper- and hypoglycemia (Seligman et al.,
2010, 2012):

24

Hypoglycemia may occur when meals are skipped or caloric intake is reduced1 in
response to inadequate food supplies. Hyperglycemia may result from the inability to
afford diabetes-appropriate foods, overconsumption during food adequacy (a behavior
often observed among adults exposed to episodic food scarcity), reduced medication
adherence, or lack of medication intensification by clinicians because of frequent
hypoglycemic episodes or unpredictable dietary intake (Seligman et al., 2010 b, p.1231).
Several possible pathways have been proposed in the diabetes literature that may explain the
proposed associations. The mechanisms include: 1) barriers to diets prescribed for chronic disease
management, 2) frequent fluctuations in daily caloric intake; 3) competing costs (e.g., medicine,
transportation); 4) increased disease-related emotional stress; and 5) as proposed in the literature
with regard to diabetes, provider-initiated relaxed glycemic targets (Seligman et al., 2010b;
Seligman et al., 2012). We posit that at least two of these possible mechanisms—barriers to
prescribed diets for disease management and competing costs—may extend to the other two
cardiometabolic diseases, hypertension and dyslipidemia, given that they are both diet-sensitive
diseases and both rely on self-management treatment plans that often include a medication
regimen, dietary and other recommendations.
In terms of the first possible mechanism, (i.e., barriers to diets prescribed for diabetes
management) diets prescribed for diabetes are generally characterized by food practices
associated with health promotion such as high intake of fresh produce and low intake of high-fat
meats and processed foods (Salas-Salvado et al., 2011). Food insecure individuals, however, are
characterized by their limited access to quality food items and lack of well-balanced meals. Food
insecure individuals tend to have high consumption of energy-dense, nutrient-poor foods because

1

It is clinically noted that this would be the case if the individual was taking insulin or
sulfonylurea medications.
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they are cheaper and more accessible, (Seligman et al., 2010b; Seligman et al., 2012) however
such foods have been found to impede glycemic control (Seligman et al., 2010b). By extension,
energy dense, nutrient poor foods are also high in sodium and saturated fats and could therefore
also impede blood pressure control among those with hypertension and lipid control among those
with dyslipidemia. Therefore, it is plausible that food insecurity may increase risk for poor
disease control because food insecure individuals may be unable to follow a disease-specific
recommended diet.
Second, frequent fluctuation in daily caloric intake (Seligman et al., 2010b) is common
among food insecure individuals given their intermittent access to adequate foods and, at times,
the need to skip meals (Seligman et al., 2010b; Seligman et al., 2012). Fluctuating caloric intake
can lead to widely varied blood glucose levels and can complicate adherence to a regularly
scheduled medication regimen (Seligman et al., 2010b). Under these circumstances, food
insecurity may increase risk for poor glycemic control through frequent fluctuations in daily
caloric intake and related medication nonadherence.
The cost of food may be in direct competition with the cost of other chronic diseaserelated necessities including medication and transportation to medical appointments or the
pharmacy (Seligman et al., 2010b). This third possible mechanism proposes that competing costs
can compromise self-management and therefore increase risk for poor disease control.
Increased disease-related emotional distress (Seligman et al., 2012) associated with not
having regular access to adequate foods and the increased effort associated with trying to adhere
to a diabetes-specific diet in the presence of being food insecure can complicate disease
management (Seligman et al., 2010b; Seligman et al., 2012). Therefore, increased emotional
distress may increase the risk for poor control.

26

Lastly, food insecure individuals with diabetes are at increased risk for experiencing
clinically significant episodes of hypoglycemia (due to frequent fluctuations in daily caloric
intake) (Seligman et al., 2010b; Seligman et al., 2012) and, as a result, providers may relax the
overall glycemic target in order to decrease the likelihood of hypoglycemic events. Increasing the
target HbA1C (e.g., from <7.0% to 8.0%) may ultimately result in poorer glycemic control.
In summary, there are multiple interrelated eco/physiologic mechanisms that support the
hypothesis of a positive association between food insecurity and poor cardiometabolic disease
control.

2.1.3. Epidemiologic Evidence
The majority of studies that have examined the association of food insecurity and chronic disease
have been cross-sectional and focused specifically on diabetes risk and/or diabetes management
(Ippolito et al., 2016; Seligman et al., 2015, 2014, 2012, 2011, 2010b, 2007; Mayer et al., 2015;
Heerman et al., 2016; Silverman et al.; 2015; Berkowitz et al., 2015, 2013; Sattler et al., 2014;
Vivian et al., 2014; Kollannoor-Samuel et al., 2012, 2011; Knight et al., 2016, Smalls et al, 2015;
Dipnall et al., 2015; Seligman et al., 2014; Billimek et al., 2012; Vijayaraghavan et al., 2011).
Few have examined this association among patients with multiple chronic diseases (Seligman et
al., 2010a; Wang et al., 2015). In this section, we provide a review of existing literature
examining food insecurity and each of the cardiometabolic diseases. We consider covariates and
possible mediators and moderators. At the end of each sub-section, we synthesize findings,
summarize past results, and identify gaps to orient the current study.
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2.1.3.1. Diabetes Control
Food insecurity has been found to be significantly associated with higher risk of diabetes
(Seligman 2007; Seligman 2010) and independently associated with poor diabetes control as
measured by hemoglobin A1c (Mayer et al., 2015; Heerman et al., 2016; Wang et al., 2015;
Berkowitz et al., 2015, 2013; Seligman, 2012; Seligman, 2010).
Significant associations between food insecurity and diabetes risk have been
demonstrated (Seligman et al., 2007). Multiple cross-sectional studies conducted by Seligman and
colleagues have also identified significant associations between food insecurity and diabetes selfmanagement factors including hypoglycemia or glycemic control, medication and glucose
monitoring adherence, and self-efficacy (Seligman et al., 2010; 2011). Seligman et al. (2011)
conducted a cross-sectional survey and chart review with 711 patients with T2D from community
health centers in San Francisco and Chicago to examine food insecurity and severe
hypoglycemia. Food insecurity was assessed using the 6-item USDA Household Food Security
Survey Module and hypoglycemic episodes were assessed by asking “In the past year, how many
times have you had a severe low blood sugar reaction, such as passing out or needing to help to
treat the reaction?” (Seligman et al., 2011, p.1204). Overall, 46% of the participants reported
being food insecure and 28% reported at least one severe hypoglycemic episode. Compared to
food secure participants, food insecure participants had nearly a 3-fold higher odds of having 4 or
more severe episodes of hypoglycemia (AOR 2.95, 95% CI 1.48, 5.91). Inability to purchase food
due to cost (43.2%) among the food insecure was significantly associated with the higher
frequency of hypoglycemic episodes compared to among the food secure participants (6.8%)
(p<0.001).
In a later study, Seligman et al. (2012) conducted a cross-sectional study among the 711
patients (of 782 eligible, 91% response rate) diagnosed with diabetes who were participants in the
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Immigration, Culture and Healthcare Study from 2008 to 2009. The adjusted mean HbA1c was
8.6% among food insecure patients compared to 8.1% in food secure patients (p=.06). Rates of
poor glycemic control were higher among food insecure participants as compared to food secure
patients (adjusted OR 1.46 95% CI 1.07-2.04). The association between food insecurity and poor
glycemic control was attenuated when three possible mechanisms (following a diabetic diet, selfefficacy, and emotional distress) were included in the adjusted model. A randomized control trial
by the same investigators has begun to explore the effect of providing diabetes-appropriate foods
at food banks to improve glycemic control (Seligman et al., 2015).
Another series of studies conducted by Berkowitz and colleagues has investigated the
association of food insecurity and chronic disease control. A cross-sectional analysis of NHANES
data from 1999-2008 with 2,557 adults with type 1 or type 2 diabetes was conducted to examine
food insecurity and metabolic control (Berkowitz, 2013). Poor metabolic control was assessed as
HbA1c>9.0%, or LDL>100 mg/DL, or SBP>140 mmHg. Overall, 12% of the sample was food
insecure, however, among those with poor glycemic control, 22% were food insecure. A total of
16% had poor glycemic control. There was a 53% higher odds of poor glycemic control (AOR
1.53, 95% CI 1.07, 2.19) and an 86% higher odds of poor cholesterol control (AOR 1.86, 95% CI
1.01, 3.44) among the food insecure compared to the food secure (Berkowitz et al., 2013). No
statistically significant association was found between food insecurity and blood pressure control.
One of the few prospective cohort studies—the Boston Puerto Rican Health Study—
included Puerto Rican adults with diabetes to assess food-insecurity, dietary patterns and
longitudinal glycemic control (Berkowitz et al., 2014a). Food insecurity was assessed using the
10-adult item USDA Household Food Security Survey Module and dietary patterns were
measured using the Healthy Eating Index-2005 (HEI). Higher HEI scores indicate higher intake
of healthy foods like fruits and vegetables and a lower intake of solid fats, alcoholic beverages
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and added sugars (SoFAAS) (Berkowitz et al., 2014a). Glycemic control was measured using
HbA1c at baseline and follow-up visits 2 years later. There was a statistically nonsignificant
positive association between food insecurity and poor diet quality (p=0.07). Overall, 26% of the
sample reported being food insecure while, among those with lower diet quality, food insecurity
was 29.6%. For every one-point increase in total HEI score (! = −0.014, 95% -. −
.022, −0.005), vegetables (! = −0.101, 95% -. − .184, −0.019), and calories from SoFAAS
(calories from solid fats (! = −0.035, 95% -. − .056, −0.014), alcoholic beverages and added
sugars) there was a statistically significant decrease in HbA1c. Therefore, food insecurity was
associated with lower diet quality which was found to be statistically and clinically significantly
associated with poorer HbA1c control (Berkowitz et al., 2014a). Suggestions for future research
were to consider diet quality and access to vegetables among food insecure populations
(Berkowitz et al., 2014a).
Three very recent cross-sectional studies have mixed findings regarding food insecurity
and glycemic control. The first was a cross-sectional telephone survey with 407 low income
adults with T2D (Mayer et al., 2015). Overall, 40.5% of the sample reported being food insecure
and food insecurity was significantly associated with poor glycemic control such that compared
to the food secure, those who were food insecure had more than a 2-fold higher odds of poor
glycemic control (OR 2.23, 95% CI 1.22, 4.10). The second study, also cross-sectional, analyzed
data from a health literacy randomized control trail among 401 adults with T2D (Heerman et al.,
2016). Nearly three quarters of the sample (73%) reported food insecurity. Again, this study
found food insecurity to be significantly associated with poor glycemic control (adjusted ! =
0.12, 95% -. .01, .23) such that for every one-unit increase in food insecurity, there was a
statistically significant 0.12 increase in HbA1c (Heerman et al., 2016). The third study found no
association between food insecurity and diabetes control as measured by hemoglobin A1c
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(Ippolito et al., 2016). However, compared to the food secure group, among the very low food
secure group diabetes self-management outcomes were worse as measured by self-efficacy,
diabetes distress, medication non-adherence, number of hypoglycemic episodes, depression
symptoms, and other management “trade-offs” (Ippolito et al., 2016, p. 2).
In summary, the majority of epidemiologic studies of food insecurity and disease control
have been cross-sectional and have focused on diabetes. The prevalence of food insecurity ranged
from 12% (Berkowitz et al., 2014a) to 73% (Heerman et al., 2016) and one study found twice the
food insecurity prevalence among those with poor glycemic control compared to those with
adequate glycemic control (Berkowitz et al., 2014a). All but one study (Ippolito et al., 2016)
found a statistically significant association between food insecurity and glycemic control. Among
those who were food insecure, higher odds of poor glycemic control ranged from 53%
(Berkowitz, 2013) to 2-fold (Mayer, 2015) compared to those who were food secure. And, severe
episodes of hypoglycemia were found to be 3-fold higher among the food insecure (Seligman,
2011) compared to the food secure. Several studies have had nationally representative samples
from the NHANES (Seligman et al., 2007; Berkowitz et al., 2013) while others have examined
the association among community health center patients (Seligman, 2011), food pantry clients
(Ippolito et al, 2016; Seligman et al., 2015) and ethnic/immigrant-specific cohorts (Seligman et
al., 2012; Berkowitz, 2014a). Among these studies, possible mechanisms by which food
insecurity may decrease glycemic control were explored (Seligman et al., 2012). These studies
provide important evidence of an association between food insecurity and disease control among
those with diabetes and therefore serve as foundation from which to further examine this
association and possible mechanisms among individuals with diabetes and other diet-sensitive,
cardiometabolic diseases like hypertension and dyslipidemia.
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2.1.3.2. Hypertension Control
Self-reported hypertension has been identified as higher among the food insecure (Irving et al.,
2014). Few studies have examined the association between food insecurity and hypertension
control (Grillo et al. 2015; Wang et al., 2015; Seligman, 2010;). A randomized controlled trial to
compare a home blood pressure telemonitoring (HBPTM) program with the same plus nurse case
management (HBPTM+NCM) was conducted with 28 English and Spanish speaking individuals
with type 2 diabetes and uncontrolled hypertension in New York City (Grillo et al., 2015). They
measured food insecurity using the 6-item USDA Household Food Insecurity Survey Module and
tracked systolic blood pressure (SBP) at baseline and 6 months. They identified 57.1% food
insecurity in the overall sample and greater food insecurity among Hispanic participants
compared to Black participants (P=.04). Overall, there was a statistically non-significant 2.7
mmHg reduction in SBP in both groups. Among the food secure group, the decrease in SBP over
six months was statistically and clinically significant (b=-0.77, t=-4.35, P<.001). However,
among the food insecure group, the interventions had no significant effect (b=0.25, t=1.52,
P=.14). The overall drop in SBP among the food secure group was 9.2 mmHg while for the food
insecure group SBP increased by 3.1 mmHg over the same time period. The investigators suggest
that standard behavioral interventions for chronic disease management are insufficient when
working with populations experiencing food insecurity (Grillo et al., 2015).
In summary, data to examine the association between food insecurity and hypertension
control are limited. To date, they have included a cross-sectional study using national sample
(Irving et al., 2014) and an intervention to test home-based blood pressure telemonitoring (Grillo
et al., 2015). The prevalence of food insecurity ranged from 17.3% (Irving et al., 2014) to 57.1%
(Grilo et al., 2015) and the rate was nearly double among Hispanics and African Americans
compared to non-Hispanic whites (Irving et al., 2014). The cross-sectional study found a
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statistically significant association between food insecurity and hypertension control (Irving et al.,
2014) while the intervention found that, among individuals who are food insecure, behavioral
interventions alone are inadequate to address blood pressure control (Grillo et al., 2015).

2.1.3.3. Dyslipidemia Control
A cross-sectional study to examine food insecurity and dyslipidemia (Tayie et al, 2009) used
NHANES data from 1999-2002 with 5,549 adults. They measured food insecurity using the 10item USDA Household Food Security Survey Module and dyslipidemia based on serum lipids
data including serum triglycerides, total cholesterol, high-density lipoprotein cholesterol and lowdensity lipoprotein cholesterol. The prevalence of food insecurity (defined here as with and
without hunger) was 11% overall. While there was no association detected between food
insecurity and dyslipidemia in men, among women, marginal food security was significantly
associated with dyslipidemia indicators, specifically LDL-C and triglyceride/HDL-C ratio (Tayie
et al., 2009). This study identified an association between food insecurity and dyslipidemia
control as well as possible differences in the association by gender. Additional studies to examine
the association between food insecurity and dyslipidemia as well as possible effect modifiers are
needed.

2.1.4. Common Covariates
Most studies examining food insecurity and at least one of the cardiometabolic diseases of
interest have adjusted for factors known to be associated with food insecurity or chronic disease
control. These include age, gender, race/ethnicity, language, educational level, income or %FPL,
employment status, marital status, and insurance coverage. Some studies included other possible
confounders such as smoking status, body mass index, duration of disease(s), comorbidity or
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number of other medical condition, insulin use (in studies of diabetes), medication adherence,
social support, and depression. Based on these, the following section provides a more detailed
review of potential mediators and effect modifiers to be examined in the proposed study.

2.1.4.1. Chronic Disease Self-Management Behaviors: Medication Adherence
Medication adherence is one of several primary chronic disease self-management behaviors
(ADA, 2016; AHA, 2016). Medication non-adherence and cost-related medication underuse are
addressed in several studies of food insecurity and cardiometabolic disease risk or
management/control (Ippolito et al., 2016; Seligman et al., 2015; Heerman et al., 2016; Silverman
et al., 2015; Grillo et al., 2015; Sattler et al., 2014; Seligman et al., 2010; Knight et al., 2016;
Smalls et al., 2015; Berkowitz et al., 2014b; Billimek et al., 2012; Vijayaraghavan et al., 2011;
Herman et al., 2015; Alfulani et al., 2015). Several studies were specifically focused on
medication adherence and its association with food insecurity among individuals with chronic
disease outcomes. All were cross-sectional studies and several used data from the National Health
Interview Survey (Knight et al., 2016; Herman et al., 2015; Berkowitz et al., 2014b;).
These studies have identified among individuals with chronic disease, those who are food
insecure are 30% to 6 times as likely to have cost-related nonadherence (CRN) or “medication
scrimping” compared to the food secure (Patel et al., 2016; Knight et al., 2016; Berkowitz et al.,
2014b; Billimek et al., 2012). One study that examined food insecurity as a SDoH determined
that providing cost-reducing strategies can help to reduce CRN. Increased screening for both
medical and social/environmental stressors as well as self-management education for patients to
promote patient-provider communication about cost-reducing treatments are recommended (Patel
et al., 2016). However, none to our knowledge, specifically examined medication adherence as a
potential mediator of food insecurity and chronic disease control.
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2.1.4.2. Psychosocial Factors: Depression
Depression has been associated with increased risk of chronic disease and has been found to be a
common comorbidity of chronic disease (Walker et al., 2016; Chapman et al., 2005). A literature
review of the link between chronic disease and depressive disorders found depression to both
“precipitate” and be “exacerbated” by chronic disease (Chapman et al., 2005). The U.S.
Preventive Services Task Force recommends depression screening to the general adult population
in settings where diagnosis and resulting treatment can be adequately provided (U.S. PSTF,
2016). Because cardiometabolic disease management is complex, those with limited resources
and who face increased barriers to self-management are at increased risk for comorbid depression
and chronic disease (Chapman et al., 2005; Osborn et al., 2014).
Several studies have specifically examined the association between food insecurity,
depression and chronic disease outcomes. A cross-sectional analysis of baseline data from a
randomized control trial—Peer support for achieving Independence in Diabetes (Peer-AID)—
examined food insecurity, depression, diabetes distress and medication adherence among 287 low
income patients with uncontrolled type 2 diabetes (T2D) (Silverman et al., 2015). Compared to
the food secure participants, those who were food insecure had 50% higher odds of elevated
HbA1c after adjusting for possible confounders. Depression and diabetes distress were both
tested as possible mediators between food insecurity and glycemic control using Sobel-Goodman
mediation tests. The association was mediated by depression (8.3% of total effect) and by
diabetes distress (18.7% of total effect) (Silverman et al., 2015). Because there was no
statistically significant association found between medication adherence and glycemic control,
medication adherence was not tested as a possible mediator (Silverman et al., 2015).
In another study, investigators examined the association of food insecurity and depression
among Latinos with type 2 diabetes and assessed social support as a possible mediator. Using the
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DIALBEST randomized controlled trial—an intervention to assess use of community health
workers to facilitate diabetes self-care—investigators conducted a cross-sectional analysis of
baseline data. Participants were 211 Latinos with uncontrolled Type 2 Diabetes (HbA1c >7%) in
Hartford, Connecticut. Social support was tested as a mediator to determine if it buffered the
effects of food insecurity on depression symptoms. They found a lower risk of depression among
those with higher levels of social support across the range of food insecurity levels (KollannoorSamuel et al., 2011) and therefore social support acted as a buffer (p.986). These studies
demonstrate the need to consider the role of social support and depression when examining food
insecurity and cardiometabolic disease management or control. Depression has been found to
mediate the association between food insecurity and glycemic control (Silverman et al., 2015)
and social support to modify these effects acting as a buffer against the negative effects of food
insecurity on depression symptoms (Kollannoor-Samuel et al., 2011). Future research should
evaluate depression and social support as possible mediators and/or effect modifiers to better
inform the development of meaningful and targeted interventions.

2.1.5. Summary
Despite the high prevalence of both food insecurity and multimorbidity of chronic disease among
low income, ethnic minority individuals, particularly those residing in urban environments,
epidemiologic research to investigate the association between food insecurity and
cardiometabolic diseases had been predominantly focused diabetes, generally-speaking. Fewer
studies have addressed cardiometabolic disease control particularly among those with
hypertension and/or dyslipidemia. Both hypertension and dyslipidemia are diet-sensitive diseases
and treatments include self-management recommendations, including dietary and medication.
Few studies include both U.S.-born and foreign-born racially/ethnically diverse populations. And,
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to our knowledge, none so far have examined medication adherence as a possible mediator of the
relationship between food insecurity and cardiometabolic disease control.
To address this gap in the literature, we used an ecosocial approach from a crosssectional study to examine the relationship between food insecurity, medication adherence and
cardiometabolic disease control. This study included low-income, adult patients from five
racial/ethnic groups (African American, Latino, Vietnamese, Russian-speaking, and white) with a
clinical diagnosis of diabetes, hypertension, and/or hyperlipidemia and co-morbid depression who
were enrolled in a larger study of health literacy, cultural beliefs, and medication adherence
(RxHL). Given the paucity of research examining food insecurity and cardiometabolic disease
control, this study will contribute to existing literature and expand our understanding of the role
of SDoH in chronic disease control among diverse groups.

2.1.6. Hypotheses and Specific Aims
Preliminary findings from the current study have identified statistically significant
associations between measures of food insecurity and inadequate medication adherence—both by
self-report and assessed by pill count. This study expanded those analyses to assess food
insecurity, medication adherence (as a possible mediator) and cardiometabolic disease control. To
achieve this, an ecosocial approach was used.

Specific Aims
1: To examine the relationship between food insecurity and cardiometabolic disease control. We
hypothesized that patients with higher levels of food insecurity would have:
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1a) poorer cardiometabolic disease control as measured by their respective clinical
marker of disease control (Diabetes: HbA1c; Hypertension: SBP; Dyslipidemia: nonHDL-C and LDL-C);
2. To examine whether medication adherence mediates the association between food insecurity,
cardiometabolic disease control. Based on Marmot’s model of SDoH, we hypothesized food
insecurity would be:
2a) negatively associated with medication adherence (higher food insecurity would be
associated with lower medication adherence);
And, that lower medication adherence would be:
2b) positively associated with poorer cardiometabolic disease control.
3. To evaluate whether the association between food insecurity and cardiometabolic disease
control varies by: a) depression status (not depressed vs. depressed); b) BMI status (not obese vs.
obese). Based on Marmot’s model of SDoH, we hypothesized that the association between food
insecurity and cardiometabolic disease control would:
3a) be higher among those with depression or higher levels of depressive symptoms; and
3b) be higher among those with BMI>30 (obese)

2.2. Methods
2.2.1. Study Design and Population
This study assessed the association between food insecurity, medication adherence and
cardiometabolic disease control using cross-sectional data from the Medication Adherence,
Health Literacy and Cultural Health Beliefs mixed-methods study (RxHL) study. They study was
conducted at Caring Health Center in Springfield, Massachusetts from January 2014 to December
2018 (Figure 3).

38

Caring Health Center (CHC), a section 330 federally qualified health center, serves
approximately 20,000 patients per year. CHC serves primarily low-income, ethnically diverse
populations. As the only refugee health assessment site in Western Massachusetts, CHC provides
translation services in over 30 languages. Over 52% of patients at CHC require translation
services and over 90% are Medicaid insured.
The RxHL study used a convenience sample generated by provider referral and by review
of CHC’s EPIC/OCHIN electronic medical record to identify potential participants. Patients were
invited to participate in the study if they had a medical diagnosis of at least one of four chronic
diseases (diabetes, hypertension, dyslipidemia and/or depression) and were 1) taking at least one
daily oral medication to manage their chronic disease; 2) 18 years or older; and 3) self-identified
as non-Hispanic U.S.-born white, non-Hispanic U.S.-born African American, Latino, Russianspeaking or Vietnamese2. Trained, bilingual/bicultural interviewers administered surveys
containing demographic, exposure and outcome measures at baseline, conducted a pill count of
all daily oral medications at baseline and 3-months follow-up, and collected the most recent
clinical data from the patients’ medical record at baseline. For the purposes of the current study,
participants diagnosed with at least one of the three qualifying cardiometabolic disease—diabetes,
hypertension, and/or hyperlipidemia—were included as well as those with or without comorbid
depression. Those diagnosed with depression only were excluded from the analyses. In addition,

2

Because the larger RxHL study is in large part examining the effect of cultural health beliefs
and practices on medication adherence and disease management, an effort was made to decrease
the heterogeneity of culture represented by each racial/ethnic group. Therefore, the RxHL study
defines white as U.S. born. In this way, white is distinguished from Russian-speaking based on
the difference in culture and language. Similarly, African American was also defined as U.S.
born. Therefore, this group does not individuals who self-identify as Black African or Black
Caribbean. Again, this was done in an effort to limit the heterogeneity of culture and language
among the self-identified African American group. Based on the location of the study, Latinos are
primarily Puerto Rican. The research team is aware that these study groups do not reflect the
usual Census-derived racial/ethnic categories.
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participants with missing food insecurity and/or disease control outcome data (A1c, SBP, LDL-C,
Non-HDL-C) were also excluded.

2.2.2. Exposure Assessment
Food insecurity was measured at baseline using the 6-item U.S. Department of Agriculture’s
Household Food Security Module (Appendix 1). The 6-item survey is a short version of the 18item survey and only pertains to households with adults. The scoring of the survey categorizes
individuals/households into three groups: food secure, low food security, and very low food
security. As is common in the literature, we then group low food security and very low food
security into one to represent food insecurity (USDA, 2012).
For Spanish, we used the USDA’s Spanish translation of the 6-item scale (USDA, 2013)
and modified it from its primarily Latin American Spanish to meet the language needs of Puerto
Rican speakers using a professional Spanish translator. For Russian and Vietnamese, we had the
scale professionally translated. Final revisions of the professional translation in each language
were provided by the team’s bilingual/bicultural interviewer, respectively.
Trained, bilingual interviewers administer surveys in the participant’s preferred language
(English, Spanish, Russian or Vietnamese). The module includes six questions about the food
eaten in the individual’s household in the last 12 months and specifically addresses whether the
individual was able to afford the quantity of food needed (Appendix 3). The first three items on
the scale are used as a screen of food insecurity. Participants are asked to rate the first two
statements regarding running out of food and eating balanced meals on a three-point Likert scale
ranging from “often true” to “never true”. The third item is a yes/no question and assesses
whether meals are cut or skipped due to a lack of money for food. Those who responded “never
true” to the first two items and “no” to the third will be assigned a zero score and will be
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designated as food secure. The remaining questions (4-6) determine the degree of food insecurity.
The fourth item determines the frequency of skipped meals due to lack of funds for food and
respondents are asked to use a 3-point Likert scale ranging from “almost every month” to “only 1
or 2 months”. In the fifth and sixth questions, the participant is asked to respond yes/no about
their eating practices based on a lack of money. Food secure individuals obtained a score of 0 or 1
(includes those identified with marginal food security raw score 1 when using the 18-item scale
(USDA, 2012)). Food insecure individuals obtained a score of 2 to 6 (Appendix 3).

2.2.2.1. Validity of exposure assessment
The 6-item U.S. Household Food Security Survey Module has been demonstrated to be a
valid and reliable measure of food insecurity in diverse populations (Bickel, Nord, Price,
Hamilton and Cook, 2000; Gulliford et al., 2004). In one study that tested the reliability and
validity of the 6-item survey in a Caribbean community, internal consistency measured by
Cronbach’s alpha was 0.84 and Pearson correlation by ethnic group ranged from 0.52 to 0.79
(Gulliford et al., 2004). Intraclass correlation coefficients by household size were high for all
items and for the classification of food insecurity (ICC ranged from .68 [95% CI 0.61, 0.75]
to .78 [95% CI 0.73, 0.83) (Gulliford et al., 2004). Food insecurity as measured by the 6-item
U.S. Household Food Security Survey Module has been associated with poor chronic disease
outcomes in previous studies (Seligman et al., 2010b; Seligman et al., 2012).

2.2.3. Outcome Assessment
The outcomes of interest are cardiometabolic disease control in patients with diabetes,
hypertension and/or dyslipidemia. Cardiometabolic disease control was assessed as a clinical
measure of disease control using HbA1c, SBP, and non-HDL/LDL. At the baseline survey, the
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most recent value was collected from the patient’s electronic medical record by a trained medical
record abstractor.
For those with a medical diagnosis of diabetes HbA1c value was used. The HbA1c test
measures average blood glucose (blood sugar) levels over the prior 8 to 12 weeks. An HbA1c
>6.5% (48 mmol/mol) is diagnosed as diabetes and, without medically confirmed hyperglycemia,
repeat testing is recommended (ADA, 2016). Based on the American Diabetes Association
(ADA) recommended guidelines for diabetes management, HbA1c levels <7% will be
categorized as controlled and >7% will be categorized as uncontrolled.
For those with a medical diagnosis of hypertension, SBP was used. Based on the
American Heart Association (AHA) guidelines for hypertension management, SBP<140 mmHg
was categorized as controlled and SBP>140 mmHg was categorized as uncontrolled (NHBEP,
2004; Pickering et al., 2005).
For those with a medical diagnosis of dyslipidemia, we used two measures of control:
non-high-density lipoprotein cholesterol (non-HDL-C)<130 mg/dL and low-density lipoprotein
cholesterol (LDL-C)<100 mg/dL. We selected these two measures of dyslipidemia control in
alignment with the 2014 National Lipid Association Guidelines which retained the cholesterol
goals. . Additionally, though the 2013 ACC/ACH guidelines focus on statin intensity per
atherosclerotic cardiovascular disease risk, the treatment goal identifies levels for both Non-HDLC and LDL-C. Non-HDL-C is a useful measure because, unlike LDL-C, it accounts for all
lipoproteins that are atherogenic (Virani, 2011).

2.2.3.1. Validity of outcome assessment
HbA1c is a measure of the average level of blood glucose attached to hemoglobin in the
red blood cell over the past three months (NIDDK, 2018; NGSP 2018; Penttilä et al., 2016).
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Since its introduction into diabetes management in 1976, the HbA1c test has been recognized as
the gold standard approach to assess glycemic control (Higgins, 2012). Quality reports indicate
substantial improvements in HbA1c quality over the past three decades regarding reliability and
validity whether using the % or mmol/mol units (Penttilä et al., 2016). HbA1c is frequently used
as the primary measure of diabetes control in epidemiologic research (Ippolito et al., 2016; Mayer
et al, 2015; Heerman et al., 2016; Silverman et al., 2015; Seligman et al 2012, 2015; Berkowitz et
al., 2013; 2014, 2015; Smalls et al, 2015).
According to the AHA’s 2005 Scientific Statement of recommendations for hypertension
measurement in human populations, systolic and diastolic blood pressure measurement is the gold
standard to detect and monitor hypertension (AHA, 2005). Hypertension is defined by a systolic
blood pressure (SBP) >140 mm Hg, diastolic blood pressure (DBP) > 90 mm Hg, and/or current
use of antihypertensive medication (AHA, 2005). SBP is frequently used as the primary measure
of hypertension control in epidemiologic studies (Grillo et al., 2015; Berkowitz et al., 2013). It is
known that blood pressure measurement can vary depending on the method and setting (AHA,
2005).
In 2014, the National Lipid Association (NLA) established an expert panel to review both
the similarities and differences between the two existing guidelines3 to establish a set of patient-

3

According to the NCEP ATP III guidelines released in May 2001, LDL was identified as a
primary cause of CHD and, as a result, LDL-lowering therapies were identified as a primary
target for treatment of dyslipidemia (NCEP, 2001). The ATP III was based on a robust review of
clinical trial data as well as other epidemiologic studies and showed that lowering LDL was
associated with overall decreased risk of morbidity and mortality from CHD (NCEP, 2001). In
2013, the American College of Cardiology (ACC) and the AHA released a new guideline on the
treatment of blood cholesterol (Stone et al, 2013). These guidelines differed from the ATP III in
that the guidelines drew upon findings only from randomized control trials and focused primarily
on lifestyle promotion and statin use (Stone et al, 2013). Efforts to compare the two guidelines—
ATP III and ACC/AHA—have raised concerns that the ACC/AHA guidelines were based on
older RCT studies and perhaps not generalizable to the current U.S. population and that the
lifestyle recommendations were not supported by RCT evidence (Grundy, 2013).
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centered recommendations (Jacobson et al., 2014). Based on their expert assessment of the
existing guidelines by ATP III and ACC/AHA (2013), the NLA has identified non-HDL-C<130
mg/dL and LDL-C<100 mg/dL and as the primary and secondary cutoffs, respectively, for
cholesterol control. In addition, this is in alignment with the research site’s general practice. Total
cholesterol concentration >240 mg/dL is less often considered because total cholesterol can be
elevated if HDL is high (per the calculation formula) (Jacobson et al., 2014).

2.2.4. Covariate Assessment
Sociodemographic and clinical variables known to be associated with food insecurity and
cardiometabolic disease control were included. Variables obtained through self-report during the
survey interviews included age (continuous), gender (male/female), race/ethnicity (white, African
American, Vietnamese, Russian-speaking, Latino), educational level (< than high school, high
school/GED, some college/college), monthly household income (continuous) and monthly
household income equivalence (continuous)4, language spoken at home (English, Spanish,
Vietnamese, Russian), employment status (not employed, part/full time employed), health literacy

Both the ATP III (2001) and the ACC/AHA (Stone et al., 2013) guidelines continue to be
used to guide clinical detection, evaluation and treatment of dyslipidemia (Grundy, 2013).
Therefore, per provider or per practice, decision making about the detection and treatment of
dyslipidemia or hyperlipidemia can vary. This is true at the research site where some providers
follow ACC/AHA guidelines and, for example, prescribe a statin to anyone between the ages of
40-70 with an hbA1c >7.5%, while others adhere to a more ATP III informed approach and base
their diagnosis and treatment on the complete cholesterol panel including close review of LDL
levels.
4

In the absence of a household size variable in the RxHL dataset, for this study we used monthly
household income and living situation/partnership status to create an equivalence income
measure. We followed the square root equivalence scale (OECD, 2018; Atkinson et al., 1995;
Kawachi et al., 1997) approach. Household income equivalence was calculated as the monthly
income from all sources divided by the square root of 2 for those participants who reported living
with a partner.
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level (low health literacy, high health literacy) and depressive symptoms level (continuous;
dichotomous: no depression symptoms, depression symptoms). Sociocultural factors included
primary language spoken at home, partner status (living single/not partnered, living with
partnered/family), and social support (continuous). Clinical data including diagnosis of diabetes
(0/1), hypertension (0/1), dyslipidemia (0/1) and depression (0/1), oral medications (0/1)), insulin
use (0/1), tobacco (no, yes/current) and alcohol use (no, yes/current), body mass index (BMI)
(continuous; dichotomous: not obese <30 kg/m2, obese >30 kg/m2, and health insurance status
(yes, no, don’t know) were collected from the electronic medical record (EMR). Prior studies
demonstrating a positive association between food insecurity and poor cardiometabolic disease
control have included these covariates in their analyses (Seligman et al., 2010a; 2012).
Several variables were assessed as possible mediators or moderators of the association
between food insecurity and cardiometabolic disease control. Based on Marmot’s SDoH model,
the factors examined as possible mediators or effect modifiers in this study are conceptualized as
downstream of the social determinant (food insecurity) but upstream of the biologic mechanisms
and disease control. They include the medication adherence (8-item Morisky Medication
Adherence Scale-self-reported: adequate vs. low; pill count >80% vs. <80) as a possible mediator
and depression (not depressed vs. depressed) and BMI (<30 not obese vs. >30 obese) as possible
effect modifiers.

2.2.4.1. Medication Adherence
Medication adherence was examined as a possible mediator of food insecurity and
chronic disease outcomes (Specific Aim 2). Of the four approaches typically used to measure
medication adherence (self-report, electronic monitoring, pill count, and pharmacy fill rates
(Morisky, et al. 2008, 11)), the RxHL study used self-report and manual pill count. Self-reported
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medication adherence is assessed using the Morisky 8-Item Medication Adherence Scale at
baseline and at 3-months follow-up. Responses from the 8-items create a score ranging from 0-8.
Response categories are yes/no for each item and a 5-point Likert response for the last item. The
original scale score is categorized into three groups: high adherence (0), medium adherence (1-2),
and low adherence (3-8). The RxHL study reversed the order such that a higher score (7.01-8.00)
reflects high adherence, a medium score (5.01-7.00) reflects adequate adherence and lower score
(0-5) reflects low adherence. We then dichotomized the groups into adequate/high adherence (1)
(scores ranging 5.01-8.0) and low adherence (0 ) (scores ranging 0-5) (Morisky et al, 2008; Kelly
et al., 2016).
Pill counts are one of the objective measures used to calculate medication adherence
(Lam et al., 2015; Farmer et al., 1999). Medication adherence using pill count is based on the
number of prescribed pills taken between two points (e.g., two clinical visits) and is calculating
using the formula (Lam et al., 2015; Farmer et al., 1999): % Adherence by Pill Count=
(number of dosage units dispensed - number of dosage units remained)
X 100
(prescribed number of dosage unit per day x number of days between two visits)

For the larger RxHL study, pill counts are conducted at baseline and at 3-months follow-up.
Percentage adherence rates collected at baseline and at 3-month follow-up of at least 80% are
used to define an acceptable level of medication adherence for the conditions targeted in this
study (Osterberg et al., 2005; Lee et al., 2006; Gerin et al., 2007; Ho et al., 2009; James et al.
2014; Martin et al., 2011; Noble et al., 2016; Ritchey et al., 2016). We calculated both overall and
disease-specific mean adherence rates based only on viable pill counts. Viable pill counts
included: 1) a baseline and 3-month follow-up pill count for the specified medication; 2) no
changes in dose, instructions or type of medication between the two time points for the specified
medication; and 3) a medication prescribed for daily oral use (medications prescribed “as needed”
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were not viable). Of the total 361 participants in the sample for this study, there were 45 missing
viable pill counts and therefore pill count analyses are based on n=316. We also created
dichotomized overall and disease-specific pill count medication adherence: <80% underadherent; >80% adherent. All participants in the study were taking at least one daily oral
medication to manage their disease(s). There was not, however, an equivalent objective measure
of adherence for participants taking insulin (n=44).

2.2.4.2. Depression
To assess depression in patients, the Patient Health Questionnaire (PHQ)-2 and 9 are used. The
PHQ-2 is administered first as an initial screen for depression (Kroenke et al., 2003). The
questions ask whether “Over the past 2 weeks, how often have you been bothered by any of the
following problems: 1) Little interest or pleasure in doing things; 2) Feeling down, depressed or
hopeless” (Kroenke et al., 2003). The 4-point response option ranges from “Not at all” to “Nearly
Every Day”. If the patient responds positively to both questions on the PHQ-2, the PHQ-9
administered (Kroenke, K., Spitzer, R. L., Williams, J. B., 2001, 2003). The PHQ-9 contains nine
questions and the same 4-item response option. The first two questions are the same as the PHQ-2
and are followed by seven additional questions that get at issues of sleep, energy level, appetite,
feeling badly about oneself, centration, movement and speech patterns, and suidcide ideation
(Kroenke et al., 2001, 2003). PHQ-9 scores of 5, 10, 15, and 20 represents mild, moderate,
moderately severe and severe depression (Kroenke et al., 2001, 2003). We dichotomized the
depression score: <5 no depression, >5 depression. In addition, a medical diagnosis of depression
using ICD-9 and/or ICD-10 codes was collected from the electronic medical record. If either
PHQ-9>=5 OR ICD code indicated depression, the subject was coded as depressed.
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2.2.4.3. Obesity (BMI>30)
To assess BMI, height and weight as documented in the electronic medical record were abstracted
by the trained interviewer following the baseline survey administration. Height and weight are
measured using standard clinical procedure and entered into the EMR. BMI is automatically
generated by the EMR once height and weight values are entered and updates based on the latest
values entered. The continuous BMI value from the medical record was then dichotomized into
not obese (<30 kg/m2) and obese (>30 kg/m2).
Obesity is defined for adults ages 20 and older as having a body mass index (BMI,
measured as weight in kilograms divided by height in meters squared) of > 30. The CDC
identifies healthy eating and active living as the key recommendations to reduce the rates of
overweight/obesity. There are initiatives aimed at achieving these guidelines that range from
national to local-level (CDC, 2016). The first clinical guidelines for the identification, evaluation
and treatment of overweight and obesity were first established in 1998 (NHLBI, 2000). In 2013, a
new guideline for managing overweight and obesity in adults was released (NHLBI, 2013).
Recommendations continue to focus on lifestyle and behavioral changes to increase physical
activity and changes in dietary intake (NHLBI, 2013).
2.2.5. Statistical Analysis
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas).
Two-sided P values of less than 0.05 were considered to be statistically significant.
We calculated percent distribution disease control (HbA1c, SBP, non-HDL, and LDL).
We calculated the number and percent or mean and standard deviation of categorical and
continuous variables, respectively, to include food insecurity and the proposed covariates.
Based on the literature, covariates known to be associated with food insecurity and
cardiometabolic disease control were identified a priori. Categorical covariates were cross-
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tabulated with both the exposure and the outcome variables using chi-square tests or Fisher’s
exact tests, as appropriate. Corresponding p-values were reported. For continuous covariates,
mean and standard deviations were presented for both the exposure and outcome variables.
Separate unadjusted logistic regression models were built to examine the cross-sectional
relationship between food insecurity and cardiometabolic disease control (diabetes control:
HbA1c <7.0%; hypertension control: SBP<140 mmHg; dyslipidemia control: non-HDL-C <130
gm/dL; LDL-C <100 mg/dL). Separate unadjusted linear regression models were also built to
examine the cross-sectional relationship between food insecurity and the cardiometabolic disease
outcomes as continuous measures (diabetes: HbA1c; hypertension: SBP; dyslipidemia: non-HDLC and LDL-C).
We built linear regression models to examine the association between food insecurity and
each continuous cardiometabolic control outcome and adjusted for possible confounders. We
built two adjusted models for each exposure-outcome relationship. First, we built a saturated
model (Model A) and adjusted for variables identified a priori in the literature as associated with
the exposure and outcome (age, gender, race/ethnicity, education, income, employment, health
insurance, comorbidities/number of diseases, and depression, BMI, social support, tobacco use).
We also included variables with a crude association with the exposure or outcome based on a pvalue of <.25 (alcohol use, homelessness, cost barriers to care and medications, transportation
barriers to care and pharmacy, and social stress). Second, we then built a parsimonious or trim
model (Model B). We began with the saturated model and removed one covariate at a time. In the
final parsimonious model, we adjusted for those covariates that, when included in the model 1)
resulted in more than 10% change in estimate or resulted in a F-Partial Test p-value of <.05.
Covariates that were established as important for inclusion in the literature but did not meet these
two criteria were retained in the model.
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We followed the same model procedure using individual logistic regression models to
examine the association between food insecurity and uncontrolled cardiometabolic disease. In
these models, the parsimonious model adjusted only for those covariates whose inclusion in the
model resulted in more than 10% change to the log odds or where the Likelihood Ratio Test had a
p-value of <.05.

2.2.5.1. Mediation
Based on the social determinants of health theoretical framework (Marmot et al., 2006) discussed
in Chapter 1, we conducted mediation analyses to assess whether medication adherence, a key
component of chronic disease management, mediated the association between the upstream social
determinant of food insecurity and the downstream physiology of cardiometabolic disease
control. We followed the 4-step procedure as described by Baron and Kenny (1986) to assess
self-reported medication adherence and pill count medication adherence and then compared the
results of the two methods. The 4-step procedure includes examining whether there is an
independent association between: 1) the exposure and the outcome; 2) the exposure and the
mediator; 3) the mediator and the outcome (Baron et al., 1986). In step 4, the multivariable model
includes all three variables. Complete mediation is identified if in step 4 there is no longer an
independent association between the exposure and the outcome (Baron et al., 1986). Partial
mediation is identified if in step 4 the association is attenuated (Baron et al., 1986). We assessed
the potential for mediation by medication adherence ( self-report and pill count) for each of the
exposure-outcome associations.
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2.2.5.2. Effect Modification
Possible effect modification by BMI was assessed by stratifying the linear and logistic regression
models of food insecurity and cardiometabolic disease control by BMI (not obese < 30 kg/m2 vs.
obese >30 kg/m2). If the odds ratios or beta coefficients of each stratum differ from one another
and from the overall odds ratio, we conducted a Mantel-Haenszel test of homogeneity to assess
whether the stratum-specific odds ratios and beta coefficients were significantly different from
one another. If they were found to be significant, we included a multiplicative interaction term
(food insecurity X BMI status) in our final models. We used likelihood ratio tests or F-partial
tests to determine if the interaction term was statistically significant in the logistic or linear
regression model, respectively. We presented stratum-specific odds ratios to describe the
association between food insecurity and cardiometabolic disease control per BMI group. We
followed the same procedure to assess depression (not depressed vs. depressed) as a possible
effect modifier in the association of food insecurity and cardiometabolic disease control.

2.2.5.3. Human Subject Protection
The Institutional Review Board of the University of Arizona and the University of Massachusetts,
Amherst, approved the RxHL Study. Signed informed consent forms were obtained from all
study participants indicating that they were 18 years or older and understood their participation
was voluntary, that they could refuse to answer any question or withdraw their participation from
the study at any time, and that their medical care at Caring Health Center would not be impacted
by their decision of whether or not to participate.
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2.2.5.4. Permission to Access Data
We were given permission by the principal investigator of the RxHL Study (Susan J. Shaw) to
access the data for the purpose of conducting the current study. We will have access to all of the
study data including the baseline survey data, pill count data, and medical record data.

2.3. Results
Participant characteristics for the study sample of 361 community health center patients are
shown in Table 1a. This is a sub-sample from the larger RxHL study sample as of November 22,
2016 (n= 422) and includes all participants with a diagnosis of at least diabetes, hypertension
and/or dyslipidemia. RxHL participants with only a diagnosis of depression (n=44) were
excluded from this study.
The study sample mean age was 58.8 (standard deviation [SD] 11.6) and participant age
ranged from 21-86. The majority were female (57.9%). Participants were from five self-reported
mutually exclusive cultural/ethnic groups including Vietnamese (26.9%), African American
(23.6%), Latino (21.1%), Russian-speaking (17.5%), and white (11.1%). The majority (57.9%)
speak a language other than English at home including Spanish (14.4%), Vietnamese (26.6%) and
Russian (16.9%). More than two thirds (69.9%) of the participants had a high school degree/GED
or less education (38. 8% < HS education; 31.3% HS/GED) and over a third had low health
literacy (37.1%). The mean (SD) monthly household income was $1,165 ($745). The equivalence
scale household monthly income was $1,001 (SD=$565) and accounts for those living with a
partner or family member by dividing the total reported income by square root of two (OECD,
2018). Nearly two thirds of the sample reported living single (61.8%) and 8% report being
homeless. Over half of the study sample was obese (52.9%) and an additional 25.8% were
overweight. Over two thirds (69.3%) of the sample received Supplemental Nutrition Assistance
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Program (SNAP) and report a mean (SD) monthly SNAP assistance of $126.76 (122.33). Nearly
half of the sample reported using tobacco (43.2%) and 20.2% report using alcohol. While nearly
all participants report having health insurance coverage (96.4%), health care access barriers were
also common: gaps in coverage (10.6%), cost of care (8.3%), cost of medications (25.2%),
transportation to care (19.9%), and transportation to pharmacy (13.6%) were reported health care
access barriers.
Since eligibility of the larger RxHL study required all participants have one of four
chronic diseases (diabetes, hypertension, dyslipidemia, and/or depression), everyone in the study
had one or more chronic diseases. In this sample, prevalence of hypertension (85.6%) was highest
followed by dyslipidemia (66.2%) and diabetes (47.4%) (Table 1a.). Thirty percent had only one
of the cardiometabolic diseases, 41% had two and 29% had all three. Over a quarter (26.6%) had
a comorbid medical diagnosis of depression. Across the three cardiometabolic diseases,
dyslipidemia was the least controlled followed by diabetes and hypertension.
Among those with diabetes, mean (SD) A1c was 8.3% (9.9) and 46.2% had uncontrolled
A1c (>7.0%).
Participants with dyslipidemia (n=239) had a mean (SD) non-HDL-C of 136.7 (41.3) and
a mean (SD) LDL-C of 105.1 (41.1). Nearly half of participants had uncontrolled dyslipidemia
with 47.7% having uncontrolled LDL-C (>100 mg/dL) and 49.4% having uncontrolled non-HDLC (>130 mg/dL) (Table 1a).
Those with hypertension (n=309) had a mean (SD) SBP of 130.9 (16.4) and 29.1% had
uncontrolled hypertension (SBP>140 mmHg) (Table 1a).
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2.3.1. Food Insecurity
Just over one third of participants reported food insecurity (36.3%) with 22.7% reporting
low food security and 13.6% very low food security. Among those with only one disease (n=108;
29.9%), food insecurity was highest in those with dyslipidemia (52%) compared to those with
either hypertension (36%) or diabetes (36%). Food insecurity differed significantly by
race/ethnicity (p<.001) (Table 2). Among the food insecure, the majority were Latino (66%) and
African American (42%) followed by white (35%), Vietnamese (23%), and Russian-speaking
(14.3%) (row %). Similarly, among the food insecure, more were English- (51.2%) and Spanishspeakers (26%) compared to the food secure among whom most were English (37%), Vietnamese
(32.2%) and Russian-speakers (23%) (p<001). Compared to food secure patients, food insecure
participants were younger (mean age 54.5 versus 61.3, p<.001), had lower social support
(p<0.001), and were more likely to use tobacco (p<.001). They had higher rates of transportation
barriers to care and medication (<.001) and cost barriers to medication (<.001). The food insecure
participants had higher social stress (p<.001) and higher prevalence of depression as measured by
both medical diagnosis (p=.003) and by the PHQ-9 depression symptom screener (p<.001).

2.3.2. Diabetes Control
Participants with uncontrolled diabetes (A1c>7.0%) were more likely to be insulin users (p<.001)
and obese (p=.02) (Table 3). Mean A1c was significantly higher among insulin users (8.9%)
compared to those not using insulin (7.1%) (p<.001) (not shown).
There was no association between food insecurity and uncontrolled diabetes in
unadjusted (OR = 1.02; 95%CI = 0.53, 1.96) or in adjusted analyses (Model A OR = 1.29; 95%
CI = 0.56, 2.97; Model B OR = 1.27; 95% CI = 0.58, 2.77) (Table 4a).
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In simple and multiple linear regression models of continuous HbA1c level, there were
no differences observed between those reporting food insecurity with those reporting being food
secure (unadjusted MD = 0.56%; 95% CI = -0.03, 1.16; Model A adjusted MD = 0.44%; 95% CI
-0.25, 1.13; Model B: Beta = 0.27%; 95% CI = -0.41, 0.95) (Table 5a).

2.3.3. Hypertension Control
In logistic regression models of uncontrolled hypertension, there was no association between food
insecurity and uncontrolled hypertension in unadjusted (OR = 1.04; 95% CI = 0.62, 1.73) or
adjusted analyses (Model A OR = 1.09; 95% CI = 0.57, 2.12; Model B: (OR = 0.89; 95% CI =
0.51, 1.53) (Table 4b).
In simple and multiple linear regression models of SBP, food insecurity was not
associated with SBP in unadjusted (MD = -2.42 mmHg; 95% CI = -6.27, 1.43) or adjusted
(Model A MD = 0.24 mmHg, 95% CI = -4.17, 4.65; Model B MD = -1.22 mmHg, 95% CI -5.19,
2.76) analyses (Table 5b).

2.3.4. Dyslipidemia Control
Uncontrolled dyslipidemia differed significantly by cultural/ethnic group (p=.03) and was highest
among Vietnamese participants (28.8%) and lowest among white participants (11.9%) and was
similar among African Americans (20.3%), Russian-speakers (20.3%), and Latinos (18.6%).
Participants with uncontrolled dyslipidemia reported more gaps in health insurance (p=.001), cost
barriers to care (p<.001) and medication (p=.04) compared to those with controlled dyslipidemia
(Table 3).
Participants with uncontrolled dyslipidemia (non-HDL>130) reported higher rates of
food insecurity (p=.02). Among those reporting food insecurity, mean non-HDL-C (149.1) was
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significantly higher than among those reporting food security (130.3) (p=.001). Similarly, mean
LDL-C was significantly higher (115.2) among the food insecure compared to the food secure
(102.3) (p=.02). (Table 3).
In unadjusted logistic regression, we observed a significant association between food
insecurity and dyslipidemia control as measured by non-HDL-C, , with significantly higher odds
of uncontrolled dyslipidemia among the food insecure compared to those reporting food security
(OR = 2.26; 95% CI = 1.27, 4.02); as well as with dyslipidemia control as measured by LDL-C
(OR = 1.78; 95% CI = 1.10, 3.13) (Table 4c-d). After adjustment for the a priori potential
confounders, we observed a significant positive association between food insecurity and
dyslipidemia control as measured by non-HDL-C (OR = 2.56; 95% CI = 1.18, 5.55). After similar
adjustment, the association between food insecurity and LDL-C control became null and we
observed wider confidence intervals (OR = 1.91; 95% CI = 0.88, 4.10).
In the final parsimonious model using non-HDL-C, we observed a slightly attenuated
significant association. Participants reporting food insecurity had a 2.3-fold higher odds of
uncontrolled dyslipidemia than food secure (95% CI = 1.29, 4.29). Confounding did not explain
much, if any, of the observed bivariate relationship. In the final parsimonious model using LDLC, the wider confidence intervals for LDL-C indicate the possibility of no association (OR = 1.96;
95% CI = 0.98, 3.97).
There was an independent positive association between food insecurity and non-HDL-C
evaluated continuously; those reporting food insecurity had 18.73 mg/dL higher non-HDL-C
(95% CI = 7.49, 29.97) than those reporting being food secure, and this association remained
after adjusting for all priori potential confounders (MD = 15.45 mg/dL; 95% CI = 3.25, 27.66)
(Table 5c). In final parsimonious model, participants reporting food insecurity had non-HDL-C
levels 13.3 mg/dL higher than those reporting food security (95% CI = 1.72, 24.92). While food

56

insecurity was associated with continuous LDL-C levels in unadjusted analyses (MD = 12.89
mg/dL; 95% CI = 2.08, 23.69), after adjustment the confidence intervals were wider and suggest
the association may be null (MD = 10.18 mg/dL; 95% CI = -1.43, 21.78). The same was true for
the final parsimonious model (MD = 9.02 mg/dL; 95% CI = -2.22, 20.26) (Table 5d).

2.3.5. Medication Adherence
Participant characteristics of medication adherence are shown in Table 1b. Among the entire
study sample (N=361), self-reported adequate medication adherence using the 8-item Morisky
Medication Adherence Scale was 70.4% compared to 55.4% adequate adherence (>80%) as
measured by pill count among participants with viable pill count data (n=316; viable medications
include medications prescribed for conditions other than diabetes, hypertension and dyslipidemia)
(Table 1b). Disease-specific self-reported adequate medication adherence ranged from 69.6%
among those with diabetes to 73.6% among those with dyslipidemia and was lowest among those
with co-morbid depression (51%). Disease-specific pill count adherence ranged from 68.1%
among those with hypertension to 71.9% among those with dyslipidemia. The highest pill count
adherence was among those with co-morbid depression (92.9%).
The majority of participants took one (23.7%), two (24.7%), or three (20.9%)
medications. Fewer (17.7%) were identified with polypharmacy (4+ medications). Food insecure
participants had lower self-reported medication adherence compared to the food secure (p<.001).
A similar association was not found for food insecurity and pill count adherence.
Distribution of medication adherence by disease outcomes are shown in Table 3.
Participants with uncontrolled dyslipidemia (non-HDL-C>130, LDL-C>100) self-reported higher
prevalence of low medication adherence (p=.002) compared to those with controlled
dyslipidemia. Participants with uncontrolled hypertension (SBP>140) were more likely to have
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<80% adherence to hypertension medications (p=.003) with a mean (SD) medication adherence
to hypertension medications of 70% (63.3) compared to 80% (22.4) among those with controlled
hypertension. There were no significant associations between self-reported or pill count
adherence and diabetes control. Mean pill count adherence by self-reported medication adherence
is presented in Table 6. Those who self-reported adequate adherence had a mean pill count
adherence of 75%(21.4) (p=0.004), under the 80% benchmark to indicate adequate adherence by
pill count.
2.3.6. Mediation Analyses: Evaluation of Mediation of Food Insecurity Association with
Dyslipidemia Control by Medication Adherence
Primary analyses for diabetes control and hypertension control were null. Therefore, mediation
analysis was performed to further investigate the observed association between food insecurity
and dyslipidemia control (non-HDL-C: MD = 18.73 mg/dL; 95% CI = 7.5, 30.0; LDL-C: MD =
12.9 mg/dL; 95% CI = 2.1, 23.7). The unmediated model—Step 1 (Baron & Kenny, 1986)—is
illustrated in Figure 7.
We found that food insecurity was independently associated with self-reported
medication adherence (Step 2; Figure 8-9) such that food insecure individuals had a 1.12 unit
(95% CI-1.48, -0.77) lower self-reported medication adherence score compared to food secure
individuals. Lastly, we determined there was an independent association between self-reported
medication adherence and dyslipidemia control as measured by non-HDL-C (unadjusted MD = 4.15; 95% CI = -7.5, -0.81) (Figure 8) and by LDL-C (unadjusted MD -17.6, 95% CI=-29.27, 5.95) (Step 3; Figure 9). There was not, however, a similar independent association between pill
count adherence and dyslipidemia control.
Therefore, the final mediation analysis examined the association between food insecurity,
self-reported medication adherence, and dyslipidemia control using both non-HDL-C and LDL-C.
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The independent association between food insecurity and dyslipidemia control as measured by
non-HDL-C was attenuated when self-reported medication adherence was included in the model
(MD15.55 mg/dL, 95% CI4.30, 26.80) and only slightly further attenuated after adjusting for the
a priori covariates (MD 15.18 mg/dL, 95% CI = 2.86, 27.5) indicating that self-reported
medication adherence partially mediated the association and that there was minimal additional
confounding (Figure 8). The independent association between food insecurity and dyslipidemia
control using LDL-C became null after adding self-reported medication adherence to the model
indicating that self-reported medication adherence completely mediated the association
(MD=10.23 mg/dL, 95% CI -0.63, 21.09). The association was only slightly further attenuated
after adjusting for a priori covariates (MD 10.16 mg/dL, 95% CI=-1.58, 21.91) similarly
indicating minimal confounding (Figure 9).

2.3.7. Evaluation of Potential Effect Modification
We assessed whether the association between food insecurity and each of the cardiometabolic
outcomes was modified by BMI (not obese, obese) or depression (not depressed vs. depressed)
(Tables 7-10). After identifying differing stratum-specific estimates from linear regression and
logistic regression models for food insecurity and dyslipidemia control among obese compared to
non-obese, we tested a food insecurity X BMI interaction term and found no evidence of effect
modification of the food insecurity-dyslipidemia control relationships by BMI (LDL-C: p=0.31;
non-HDL-C: p=0.52). The same was true for depression and, after testing a food insecurity X
depression interaction term, we found no evidence of effect modification of the food insecuritydyslipidemia control relationship (LDL-C: p=0.71; non-HDL-C: p=0.84).
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2.4. Discussion
While several literature reviews have considered the social context of food insecurity and chronic
disease (Castillo et al., 2012; Popovic-Lipovac et al., 2015; Barnard et al., 2015), social
epidemiologic studies of this association are lacking. Given the multilevel nature of food
insecurity—at the neighborhood level it is often associated with residing in a food desert; and at
the household and individual-levels it can be associated with SES and self-management
behaviors—consideration of food insecurity as an upstream SDoH from a social epidemiologic
lens is an opportunity to better understand chronic disease control among community health
center patients. In this analysis, we aimed to examine the association between food insecurity and
uncontrolled cardiometabolic disease using Marmot’s social determinants of health theoretical
framework. We found a significant positive association of food insecurity with risk of
uncontrolled dyslipidemia, particularly as measured by non-HDL-C. Those patients reporting
food insecurity had approximately a 2-fold higher odds of uncontrolled dyslipidemia compared to
the food secure. We did not find significant associations between food insecurity and diabetes
control or hypertension control. These analyses contribute to the literature on food insecurity and
dyslipidemia control and contrast with the one prior study that reported null findings (Seligman et
al., 2010).
We also identified self-reported dyslipidemia medication adherence as a partial mediator
of the association between food insecurity and uncontrolled dyslipidemia. This finding has
important potential applied implications and can help to target dyslipidemia control interventions
among food insecure populations in clinical settings—a strategy, to the best of our knowledge,
not otherwise reported in the literature.
As with prior research, we found similarly elevated mean HbA1c among the food
insecure compared to the food secure (Seligman et al., 2012). However, our findings differed
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unexpectedly from the majority of previous cross-sectional studies in which a significant positive
association between food insecurity and poor glycemic control was detected (Seligman et al.,
2010; Seligman et al., 2012; Berkowitz et al., 2013; Mayer et al., 2015; Wang et al., 2015;
Heerman et al., 2016). Our findings were similar to one prior study that found no association
between food insecurity and diabetes control but found a significant association between very low
food security and diabetes self-management factors—specifically medication adherence and
depression (Ippolito et al., 2016). Most research has reported food insecurity as a categorical or
dichotomous variable as did we in this study. Given this analysis had the smallest sample size
(n=162), using food insecurity as a continuous variable in the multivariable regression modeling
is warranted. Additionally, next steps aim to conduct similar analyses with a similar but larger
sample size.
Our null findings of the association between food insecurity and uncontrolled
hypertension adds to the few existing studies with mixed findings including null (Seligman et al.,
2010) and a positive significant association (Wang et al., 2015). Given that the sample size for
this analysis was the largest of the disease-specific models (n=309) and that an independent
association was detected among those with dyslipidemia which has fewer participants (n=224),
the null finding warrants additional consideration beyond sample size and lack of power to detect
effects.
Our study found similarly high prevalence of food insecurity ranging as prior studies
which ranged from 40-75% (Seligman et al., 2007; Mayer et al., 2015; Heerman et al., 2016). In
this study, prevalence of food insecurity among Latino participants was 66% and African
American participants was 42%, 1.5 to three times the national rate of 22% among minority
populations as of 2015 (Coleman-Jensen et al., 2016).
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Unexpectedly, individuals reporting food insecurity had higher levels of education
compared to the food secure. We found that food insecurity differed significantly by cultural
group with the greatest rates among Latinos and African Americans and the lowest rates among
Vietnamese and Russian-speaking. To contextualize these differences, preliminary qualitative
data analyses (not reported here) indicate that Vietnamese participants are older and have
larger/stronger social/cultural networks that help to secure access to important resources
including food, food stamps, travel to local food pantries, and home health aids. The Vietnamese
also have the lowest educational levels. Latinos, in contrast, are younger, report higher levels of
stress associated with running out of food each month and sacrificing meals when food is scarce
to ensure their children eat. They do not report similar social networks for resource sharing as
reported by the Vietnamese which corresponds with their lower rates of receiving SNAP benefits.
We observed an overall self-reported medication adherence rate of 70.4% and pill count
medication adherence rate of 55.4%. There is currently no gold stand approach to medication
adherence, however, multimeasure approaches such as ours are recommended (Lam et al., 2015).
Both the rates and their difference (15%) observed are in accordance with prior research on selfreported and pill count adherence (Lee et al., 2007; Osterberg et al., 2005; Garber et al, 2004;
Grymonpre et al., 1998; ) in which self-reported adherence is found to be an overestimate
compared to pill count adherence. To our knowledge, however, no prior study has examined
disease-specific medication adherence by self-report or by pill count and the role of medication
adherence in the association between food insecurity and dyslipidemia control.

2.4.1. Strengths and Limitations
There are several important strengths to this study. This study includes a diverse sample of
community health center patients from five racial/ethnic groups including both U.S. and foreign-
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born immigrant and refugee groups less frequently including in SDoH and health disparities
research. It allowed for consideration of cardiometabolic disease control among a federally
qualified health center patient population where multimorbidity cardiometabolic diseases and
SDoH-related barriers are prevalent. This study was able to assess disease-specific medication
adherence by both self-report and pill count. Finally, it offered an opportunity to examine an
important theoretical framework of social determinants of health focused on food insecurity
among a patient population for whom addressing social and environmental barriers to care is
necessary.
There were also several limitations. As with the majority of the existing literature on the
association of food insecurity and cardiometabolic disease control, this was a cross-sectional
study and therefore precluded any determination of temporality in the relationships observed. We
were unable to assess whether higher food insecurity led to poor cardiometabolic disease control,
or whether poor cardiometabolic disease control led to higher food insecurity. In addition, food
insecurity is a cyclic and time varying phenomenon; therefore, given the cross-sectional design
we have a single measure of food insecurity.
Small sample size was another limitation. We observed wide confidence intervals and
were underpowered to detect smaller effects.
Measurement error related to self-reported variables and EMR data was another possible
limitation. While the USDA Household Food Security Survey Module is the primary measure of
food insecurity in the U.S., as a self-reported measure, there is some potential for nondifferential
misclassification of exposure.
Culturally-rooted differences identified in the larger RxHL mixed-methods study, may
have impacted either actual difference in self-reported food insecurity or perceptions of selfreported food insecurity. For instance, Vietnamese participants reported multiple means of access
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to alternative food resources primarily through well-established social networks linking
individuals and families with community-based resources and navigational supports. In contrast,
Latinos did not report similar support networks and instead frequently reported running out of
food before the end of the month and sacrificing food to ensure children had sufficient food. In
contrast to both Vietnamese and Latino participants, Russian-speaking participants described the
U.S. food environment as abundant compared to the conditions they previously lived through in
former, native countries where lack of access to any food sources was common. Each of these
differing cultural perceptions could impact participant responses to each of the screening and
frequency questions included in the food security survey and could lead to an over- or underestimate among groups. The data were collected by bilingual, bicultural interviewers who were
trained to administer the survey in a standardized, non-judgmental and culturally appropriate
manner to all study participants. For this reason, we expect to have minimized the likelihood of
nondifferential misclassification of exposure.
Cardiometabolic disease control was measured based on having a medical diagnosis of
one of three diseases as documented in the electronic medical record and on the most recent
laboratory values recorded in the electronic medical record. Trained medical chart abstracters
obtained diagnosis, HbA1c, SBP, non-HDL-C and LDL-C data from participants’ medical
records at baseline after administering the survey where food insecurity is assessed.
Nondifferential misclassification of disease control for diabetes, dyslipidemia, and hypertension
is possible. HbA1c and lipid levels are based on point of care blood draws and SBP is determined
by doing a blood pressure reading. Each of these clinical measures are all time varying measures
and thus would depend on reproducibility of blood levels/blood pressure reading. It is also
possible that lab variability could result in nondifferential misclassification of HbA1c, non-HDLC or LDL-C. Measurement error associated either with human error or error associated with the
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actual blood pressure cuff and instrument could result in nondifferential misclassification of SBP.
In addition, regarding diabetes control, while HbA1c is generally accepted as the gold standard,
some literature suggests that HbA1c is not a perfect measurement of glycemic control, in part
because of possible hemoglobin variants and the fact that it measures control over a broader time
period (2-3 months). However, clinical measurement of HbA1c, SBP, non-HDL-C and LDL are a
part of routine diabetes, hypertension, and dyslipidemia management within the primary care
environment and clinical staff are trained to collect/measure each. These measures are similar to
ones used in other studies and, given our results and unexpected findings regarding diabetes and
hypertension, it is possible that this nondifferential misclassification of outcome may help to
explain the differences from what others have found.
It is also possible those with uncontrolled disease, may have different self-reporting of
food insecurity, either due to differential over or under reporting or generally poorer recall
(imprecision).

2.4.2. Confounding
Confounding can be an issue, where factors related to food insecurity and disease control could
lead to biased estimates of the association of interest. We measured and controlled for a fairly
large number of variables including age, gender, race/ethnicity, educational level, health literacy,
income or income equivalence, employment status, partner status, language spoken at home, body
mass index, comorbid conditions/number of diseases (e.g., diabetes, hypertension, dyslipidemia
and depression), smoking use, alcohol use, insulin (among those with diabetes), health insurance
status, cost and transportation barriers to care and medications, BMI, social support, and social
stress. However, their inclusion in the models with small sample size resulted in wide confidence
intervals. Residual confounding due to both unmeasured confounders and measurement error in
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those confounders included in models is always a potential limitation. Though limited by sample
size, based on the crude and adjusted analyses, we observed minimal change in estimate. It is
possible that several important unmeasured confounders including exercise, duration of disease,
length of time in U.S., and household size could have resulted in residual confounding.
One confounder that did result in a change in estimate was insulin. Insulin is an effective
medication used in diabetes management particularly among those with uncontrolled HbA1c
and/or for whom diet, exercise, and oral medications are insufficient to adequately control HbA1c
levels. Though all of the diabetes disease control models were null (unadjusted and adjusted),
inclusion of insulin in the model resulted in an overall change in the size and direction of the odds
ratio indicating it may be an important potential confounder of the association between food
insecurity and diabetes control. To assess this more closely, we conducted two sensitivity
analyses. First, we examined the association between food insecurity and diabetes control and
excluded all insulin users (n=41). Second, because the majority of insulin users were also Latino
(29%), we also examined the association between food insecurity and diabetes control by
excluding Latinos. Both sensitivity analyses were non-significant but similar to each other.
Adjusting for insulin when assessing A1c control among individuals with diabetes is critical.
However, given the non-significant results and the relatively limited power and small sample
size, these results cannot be adequately interpreted. They do indicate a potentially important role
and overlap between insulin users and Latino identity that may be important to explore in future
research and may have contributed to the lack of association observed in this study. Only a few of
the prior studies examining the association between food insecurity and diabetes control
specifically report adjustment for insulin and, among those that did, results were mixed.
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2.5. Significance
The findings of this study contribute to understanding the role of food insecurity in dyslipidemia
control and the role of self-reported medication adherence in that association. Food insecurity is
prevalent in the U.S. and highest among minority populations. This study indicates food
insecurity rates two- to four-times national averages among this study population thereby further
complicating effective management of diet-sensitive chronic diseases. This analysis indicates
that being food insecure increases odds of uncontrolled dyslipidemia 2-fold and that adherence to
dyslipidemia medications partially mediates that association. Therefore, food insecurity screening
is needed to better target dyslipidemia management interventions, including medication
adherence. Additionally, public health programming—like existing national campaigns to address
diabetes and hypertension prevention and management—are needed to increase awareness of
dyslipidemia control and to increase access to healthy, affordable foods among those with
dyslipidemia. Our null findings with diabetes and hypertension are unexpected and warrant
further consideration. Next steps aim to conduct similar research with a larger, similar patient
population to explore this further.
The findings in this study may be generalizable to other patient populations seeking care
from similar urban settings where food insecurity is associated with increased access to low
nutrient, high density foods.
Additional research is needed to assess the association between food insecurity and
cardiometabolic disease control and the possible role of medication adherence among diverse
patient populations. Prospective studies with sufficient sample sizes to adequately examine
differences by racial/ethnic/cultural group and that specifically examine whether food insecurity
increases risk of poor dyslipidemia control would be useful to inform future targeted public health
and community health initiatives. Current public health programs aimed to prevent and manage
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hypertension (e.g., AHA’s Check, Change, Control) and diabetes (CDC’s Diabetes Prevention
Program) are common in community health center settings. Campaigns, educational
programming, and practice/policy interventions have been developed to increase awareness and
adoption of self-management behaviors for diabetes and hypertension while reducing
social/environmental barriers to care, for instance, by introducing community health workers into
primary care teams. It is possible that these public health interventions have been successful in
increasing diabetes and hypertension control and should be expanded to target dyslipidemia.
Development of similar clinical and public health initiatives to address dyslipidemia prevention
and management, particularly in regions serving diverse patient populations with higher rates of
food insecurity, may be warranted.
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Table 1a. Participant Characteristics, n=361
Characteristics
Continuous Variables
Diabetes
A1c (n=162)
Hypertension
SBP (n=309)
Dyslipidemia
Non-HDL-C (224)
LDL-C (n=223)
BMI
Food insecurity score
Health Literacy Score
Social Stress
Age
Monthly household income (all sources)
Monthly household income-Equialence
Scale (Income/sqrt2 if living with
partner/family)
Monthly mean SNAP
Social support overall
Categorical Variables
Diabetes Only
Hypertension Only
Dyslipidemia Only
Depression Only
Diabetes All
Hypertesion All
Dyslipidemia All
Depression All
Pre-diabetes
Numbner of diseases
1 cardiometabolic disease
2 cardiometabolic disease
3 cardiometabolic disease
Disease Control
Diabetes (n=171)
A1c Controlled (<7)
A1c Uncontrolled (>=7)
missing
Hypertension (n=309)
SBP Controlled (<140)
SBP Uncontrolled (>=140)
Dyslipidemia (n=239)
Non-HDL Controlled (<130)
Non-HDL Uncontrolled (>=130)
missing
LDL Controlled (<100)
LDL Uncontrolled (>=100)
missing
Depression Screen_All (PHQ-9)
No Depression
Depression
BMI
<30 (not obese)
>30 (obese)
missing
Insulin (among those with DM n=171)
No
Yes
Tobacco Use
No
Yes
missing
Alcohol Use
No
Yes
missing

Mean

SD

7.5

1.8

130.9

16.4

136.7
106.7
32.1
1.5
13.8
4.6
58.8
1,165.06

41.3
39.2
7.9
2.0
4.9
4.1
11.6
745.4

1,001.08
126.76
4.1

565.4
122.33
1.1

N
11
69
25
0
171
309
239
96
24

%
3.1
19.1
6.9
0.0
47.4
85.6
66.2
26.6
6.7

108
148
105

29.9
41.0
29.1

83
79
9

48.5
46.2
5.3

219
90

70.9
29.1

106
118
15
109
114
16

44.4
49.4
6.2
45.6
47.7
6.7

269
91

74.5
25.2

145
191
25

40.2
52.9
6.9

127
44

74.3
25.7

202
156
3

56.0
43.2
0.8

280
73
8

77.6
20.2
2.2
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Table 1a. Participant Characteristics (continued) n=361
Table 1a. Participant Characteristics (continued) n=361
Categorical Variables
n
Food Insecurity
Food Secure
230
Low Food Security (Categ)
82
Very low food security (Categ)
49
Food Insecure (Dichot)
131
Social Stress_overall
No Stress
56
Stress
305
Health Literacy
Adequate Health Literacy (15+)
227
Low Health Literacy (0-14)
134
Gender
Male
152
Female
209
Ethnicity
White
40
African American
85
Vietnamese
97
Russian-speaking
63
Latino
76
Employment
Not emplyed
303
Part/Full-time employed
57
missing
139 (44)
SNAP
No
111
Yes
250
Educational Level
<High School
140
High School Degree (or GED)
113
Some college+
107
missing
139 (44)
Partner/Household Status
Living single/not partnernered
223
Living with partner/family
138
Homeless
No
331
Yes/Shelter
30
Language Spoken at Home
English
152
Spanish
52
Vietnamese
96
Russian
61

%
63.7
22.7
13.6
36.3
15.5
84.5
62.9
37.1
42.1
57.9
11.1
23.6
26.9
17.5
21.1
83.9
15.8
0.3
30.8
69.3
38.8
31.3
29.6
0.3
61.8
38.2
91.7
8.3
42.1
14.4
26.6
16.9
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Table 1a. Participant Characteristics (continued) n=361
Table 1 Participant Characteristics (continued) n=361
Categorical Measures
n
Health Insurance Coverage
No
7
Yes
348
Don't know
6
Medicare
No
177
Yes
171
Don't know
13
Gap in Health Insurance
No
322
Yes
37
missing
2
Barriers to Care-Cost
No
330
Yes
30
missing
139 (44)
Barriers to Care-Transportation
No
287
Yes
72
missing
2
Barriers to Medication-Cost
No
269
Yes
91
missing
139 (44)
Barriers to Medication-Transportation
No
311
Yes
49
missing
1

%
1.9
96.4
1.7
49.0
47.4
3.6
89.2
10.3
0.5
91.4
8.3
0.3
79.5
19.9
0.6
74.5
25.2
0.3
86.2
13.6
0.3
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Table 1b. Participant characteristics for medication adherence (Morisky self-report and pill count)
and medication use
Characteristics
Morisky Medication Adherence Score (self-report)
Mean % Medication Adherence (pill count)
DM (n=91)
HTN (n=210)
DYS (n=126)
DEP (n=23)
Medication Adherence: Self-Report
Morisky, Overall (n=361)
Adequate Adherence
Low Adherence
Morisky, if Diabetes (n=171)
Adequate Adhernece
Low Adherence
Morisky, if Hypertension (n=309)
Adequate Adhernece
Low Adherence
Morisky, if Dyslipidemia (n=239)
Adequate Adhernece
Low Adherence
Morisky, if Depression (n=96)
Adequate Adhernece
Low Adherence
Medication Adherence: Pill Count
Medication Adherence Overall: Pill Count (n=316)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Medication Adherence, if Diabetes (n=171)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Medication Adherence, if HTN (n=309)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Medication Adherence, if DYS (n=239)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Medication Adherence, if DEP (n=96)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Polypharmacy n=316
<4 meds
4 or more meds
Insulin (among those with Diabetes n=171)
Yes
No

Mean
6
72.6
75.3
77
76.8
79.56

SD
1.7
23.9
25.2
23.9
24.5
28.1

N

%

254
107

70.4
29.6

119
52

69.6
30.4

216
93

69.9
30.1

176
63

73.6
26.4

49
47

51.0
49.0

175
141
45

48.5
39.1
12.5

99
43
29

57.9
25.2
17.0

186
87
36

60.2
28.2
11.7

151
59
29

63.2
24.7
12.1

78
6
12

81.3
6.3
12.5

252
64

79.8
20.3

127
44

74.3
25.7
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Table 2. Disease control and covariates by food security status
Characteristics
Mean(SD)
Age
Diabetes (n=171)
A1c
DM without insulin (n=127)
Mean A1c
DM with insulin (n=44)
Mean A1c
HTN (n=309)
Mean SBP
DYS (n=239)
Mean non-HDL-C
Mean LDL-C
DEP (n=96)
PHQ_score
BMI score
Social Stress Score
Monthly household income (all sources)
Income (Equialence Scale)
Social support overall

Food Security
Food Secure
Food Insecure
n=230 (63.7)
n=131 (36.3)
61.3(0.7)

54.5(1.1)

<0.001

7.3(1.6)

7.9(2.1)

0.06

7.1(1.4)

7.1(1.4)

0.98

8.4(1.98)

9.4(2.3)

0.14

131.7(16.14)

129.3(16.8)

0.22

130.3(40.3)
102.3(35.1)

149.1(40.7)
115.2(45.2)

0.001
0.02

2.4(0.3)
31.8(0.5)
2.97(0.2)
1185.89(45.0)
1014.2 (527.5)
4.4(0.1)

7.3(0.7)
32.7(0.8)
7.4(0.4)
1128.48(74.0)
978.0 (565.4
3.6(0.1)

<0.001
0.33
<.001
0.48
0.56
<.001

56(49.6)
53(46.9)

27(46.6)
26(44.8)

0.37

52(57.1)
35(38.5)

23(63.9)
11(30.6)

0.7

4(18.2)
18(81.8)

4(18.2)
15(68.2)

0.33

143(71.1)
58(28.9)

76(70.4)
32(26.6)

0.89

80(50.3)
68(42.8)
79(49.7)
68(42.8)

26(32.5)
50(62.5)
30(37.5)
46(57.5)

0.02

181(78.7)
49(21.3)

84(64.1)
47(35.9)

0.003

195(84.8)
35(15.2)

74(56.5)
56(42.8)

<0.001

91(39.6)
22(9.6)

36(27.5)
22(16.8)

0.03

95(41.3)
122(53.0)

50(38.2)
69(52.7)

0.43

144(62.6)
83(36.1)

58(44.3)
73(55.7)

0.001

182(79.1)
44(19.1)

98(74.8)
29(22.1)

0.54

n(%)
Diabetes (DM) (n=171)
Controlled (<7)
Uncontrolled (>7)
DM without insulin (n=127)
Controlled (<7)
Uncontrolled (>7)
DM with insulin (n=44)
Controlled (<7)
Uncontrolled (>7)
Hypertension (n=309)
Controlled (<140)
Uncontrolled (>140)
Dyslipidemia (n=239)
Controlled (non-HDL-C<130)
Uncontrolled (non-HDL-C>130)
Controlled (LDL-C<100)
Uncontrolled (LDL-C>100)
Depression (Clinical Diagnosis) (n=96)
No Depression
Depression
Depression Screen (PHQ-9)
No Depression
Depression
Insulin (among those with diabetes)
No insulin
Insulin
BMI
<30 (not obese)
>30 (obese)
Tobacco User
No
Yes/Current
Alcohol Use
No
Yes/Current
*

P-value*

Two sample t-test or Chi square test, as appropriate
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Table 2. Disease control and covariates by food security status (continued)
Characteristics
n(%)
Ethnicity
White
African American
Vietnamese
Russian-speaking
Latino
Gender
Male
Female
Educational Level
<High School
High School Degree (or GED)
Some college+
Missing
Employment
Not employed
Part/full-time employed
SNAP
No SNAP
SNAP
Health Literacy
Adequate Health Litearcy
Low Health Literacy
Partner/Household Status
Living single/not partnernered
Living with partner/family
Homeless
Not homeless
Homeless
Language Spoken at Home
English
Spanish
Vietnamese
Russian
Gap in Health Insurance
No
Yes
Barriers to Care-Cost
No
Yes
Barriers to Care-Transportation
No
Yes
Barriers to Medication-Cost
No
Yes
Barriers to Medication-Transportation
No
Yes
*

Food Security
Food Secure
Food Insecure
n=230 (63.7)
n=131 (36.3)

P-valuea

26 (11.3)
49(21.3)
75(32.6)
54(23.5)
26(11.3)

14(10.7)
36(27.5)
22(16.8)
9(6.9)
50(38.2)

<0.001

99(43.0)
131(57.0)

53(40.5)
78(59.5)

0.63

95(41.3)
78(33.9)
56(24.4)
1(.43)

45(34.4)
35(26.7)
51(38.9)
0(0)

0.03

186(80.9)
43(18.7)

117(89.3)
14(10.7)

0.1

70(30.4)
160(69.6)

41(31.3)
90(68.7)

0.86

138(60.0)
92(40.0)

89(67.9)
42(32.1)

0.13

135(58.7)
95(41.3)

88(67.2)
43(32.8)

0.11

219(95.2)
11(4.8)

112(85.5)
19(14.5)

85(37.0)
18(7.8)
74(32.2)
53(23.0)

67(51.2)
34(26.0)
22(16.8)
8(6.1)

<.001

207(90.0)
22(9.6)

115(87.8)
15(11.5)

0.78

214(93.0)
16(7.0)

116(88.6)
14(10.7)

0.19

202(87.8)
27(11.7)

85(64.9)
45(34.4)

<.001

191(83.0)
39(17.0)

78(59.5)
52(39.7)

<.001

216(93.9)
14(6.1)

95(72.5)
35(26.7)

<.001

Two sample t-test or Chi square test, as appropriate
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0.001

Table 3. Food insecurity and covariates by disease control
Categorical Measures
Food Insecurity
Food Secure
Low Food Security
Very low food security
Food Insecure
Social Stress (TAPS)
Low Stress (0-1 stressors)
Some Stress (2-4 stressors)
Moderate Stress (5-7 stressors)
High Stress (8+ stressors)
Health Literacy
Adequate Health Litearcy
Low Health Literacy
Depression (Medical Diagnosis)
No Depression
Depression
Depression (PHQ-9)
No Depression
Depression
Missing
Medication Adherence: Morisky (self-report)
Adequate Adherence
Low Adherence
Disease-specific Adherence (Pill Count)
DM medications >=80% adhernece
DM medications<80% adherence
missing
HTN medications >=80% adhernece
HTN medications<80% adherence
missing
DYS medications >=80% adhernece
DYS medications<80% adherence
missing
Overall Adherence (Pill Count)
Adequate Adhernece (>=80%)
Low Adherence (<80%)
missing
Polypharmacy
<4 viable medications
4 or more viable medications
missing
Insulin
No insulin
Insulin
missing
*
Chi square or Fisher's Exact test, as appropriate

Diabetes Control (n=171; 9 missing)
Controlled (n=83)
Uncontrol (n=79)
(HbA1c < 7%)
(HbA1c>7%)
N(%)
N(%)

p value*

56 (67.5)
16 (19.3)
11(13.3)
27(32.5)

53(67.1)
16(20.3)
10(12.7)
26(32.9)

0.52

23(27.7)
29(34.9)
15(18.1)
16(19.3)

26(32.9)
23(29.1)
17(21.5)
13(16.5)

53(63.9)
30(36.1)

HTN Control (n=309)
Controlled (n=219)
Uncontrol (n=90)
(SB<140 mmHg)
(SB>140 mmHg)
N(%)
N(%)
143(65.3)
47(21.5)
29(13.2)
76(34.7)

58(64.4)
21(23.3)
11(12.2)
32(35.6)

0.72

59(26.9)
69(31.5)
46(21.0)
45(20.6)

22(24.4)
32(35.6)
14(15.6)
22(24.4)

47(59.5)
32(40.5)

0.79

139(63.5)
80(36.5)

61(73.5)
22(26.5)

63(79.8)
16(20.3)

0.24

62(74.7)
21(25.3)
0(0)

56(70.9)
22(27.9)
1(1.3)

58(69.9)
25(30.1)
51(61.5)
19(22.9)
13(15.66)

p value*

p value*

80(75.5)
15(14.2)
11(10.4)
26(24.5)

68(57.6)
33(28.0)
17(14.4)
50(42.4)

0.6

35(33.0)
41(38.7)
17(16.0)
13(12.3)

30(25.4)
39(33.1)
24(20.3)
25(21.2)

0.12

55(61.1)
35(38.9)

0.7

67(63.2)
39(36.8)

69(58.5)
49(41.5)

0.66

167(76.3)
52(23.7)

67(74.4)
23(25.6)

0.74

83(78.3)
23(21.7)

92(78.0)
26(22.0)

0.98

0.84

164(74.9)
55(25.1)
0(0)

65(72.2)
24(26.7)
1(1.1)

0.28

83(78.3)
22(20.8)
1(.94)

93(78.8)
25(21.2)
0(0)

0.87

55(69.6)
24(30.4)

0.98

157(71.7)
62(28.3)

59(65.6)
31(34.4)

0.29

90(84.9)
16(15.1)

77(65.3)
41(34.7)

0.002

43(54.4)
21(26.6)
15(19.0)

0.87

145(66.2)
52(23.7)
22(10.1)

41(45.6)
35(38.9)
14(15.6)

0.003

67(63.2)
27(25.5)
12(11.3)

75(63.5)
27(22.9)
16(13.6)

0.86

0.37

0.9

DYS Control (n=239; 15 missing)
Controlled (n=106)
Uncontrolled (n=118)
(non-HDL<130)
(non-HDL>130)
N(%)
N(%)

0.89

0.06

0.016

43(51.8)
27(32.5)
13(15.7)

33(41.8)
31(39.2)
15(19.0)

0.55

115(52.5)
82(37.4)
22(10.1)

35(38.9)
41(45.6)
14(15.6)

0.076

58(54.7)
36(34.0)
12(11.3)

56(47.5)
46(39.0)
16(13.6)

0.8

43(51.8)
27(32.5)
13(15.7)

39(49.4)
25(31.7)
15(19.0)

0.57

148(67.6)
49(22.4)
22(10.1)

66(73.3)
10(11.1)
14(15.6)

0.045

58(54.7)
36(34.0)
12(11.3)

86(72.9)
16(13.6)
16(13.6)

0.002

75(90.4)
8(9.6)

46(58.2)
33(41.8)

<0.001

84(38.4)
21(9.6)
114(52.1)

24(26.7)
15(16.7)
51(56.7)

0.06

45(42.5)
21(19.8)
40(37.7)

35(29.7)
10(8.5)
73(61.9)

0.003
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Table 3. Food insecurity and covariates by disease control (continued)
Diabetes Control (n=171; 9 missing)
Controlled (n=83)
Uncontrol (n=79)
(HbA1c < 7%)
(HbA1c>7%)
N(%)
N(%)

Categorical Measures
Gender
Male
Female
Race/ethnicity
white
African American
Vietnamese
Russian-speaking
Latino
Educational Level
<High School
High School Degree (or GED)
Some college+
missing
Partner/Household Status
Living single/not partnernered
Living with partner/family
Homeless
No Shelter
Yes Shelter
Language Spoken at Home
English
Spanish
Vietnamese
Russian
BMI (dichotomous)
<30 (not obese)
>30 (obese)
missing
Tobacco User
No
Yes/Current
Missing
Alcohol Use
No
Yes/Current
missing
Gap in Health Insurance
No
Yes
Don't know
Barriers to Care-Cost
No
Yes
Don't know
Barriers to Care-Transportation
No
Yes
Don't know
Barriers to Medication-Cost
No
Yes
Don't know
Barriers to Medication-Transportation
No
Yes
Don't know
*
Chi square test or Fisher's Exact Test, as appropriate

p value*

HTN Control (n=309)
Controlled (n=219)
Uncontrol (n=90)
(SB<140 mmHg)
(SB>140 mmHg)
N(%)
N(%)

p value*

DYS Control (n=239; 15 missing)
Controlled (n=106))
Uncontrolled (n=118)
(non-HDL<130)
(non-HDL>130)
N(%)
N(%)

p value*

32(38.6)
51(61.5)

34(43.0)
45(57.0)

0.77

90(41.1)
129(58.9)

43(47.8)
47(52.2)

0.28

47(44.3)
59(55.7)

53(44.9)
65(55.1)

0.69

4(4.8)
18(21.7)
30(36.1)
8(9.6)
23(27.7)

8(10.1)
17(21.5)
22(27.9)
14(17.7)
18(22.8)

0.13

31(14.2)
48(21.9)
56(25.6)
39(17.8)
45(20.6)

6 (6.7)
29(32.2)
23(25.6)
18(20.0)
14(15.6)

0.15

13(12.3)
19(17.9)
51(48.1)
9(8.5)
14(13.2)

14(11.9)
24(20.3)
34(28.8)
24(20.3)
22(18.6)

0.03

33(39.8)
22(26.5)
28(33.7)

36(45.6)
25(31.7)
18(22.8)

0.49

81(37.0)
72(32.9)
65(29.7)
1(.46)

34(37.8)
26(28.9)
30(33.3)
0(0)

0.8

50(47.2)
33(31.1)
22(20.8)
1(.9)

50(42.4)
34(28.8)
34(28.8)
0(0)

0.34

50(60.2)
33(39.8)

48(60.8)
31(39.2)

0.96

139(63.5)
80(36.5)

59(65.6)
31(34.4)

0.73

62(58.5)
44(41.5)

67(56.8)
51(43.2)

0.23

79(95.2)
4(4.8)

68(86.1)
11(13.9)

0.12

205(93.6)
14(6.4)

82(91.1)
8(8.9)

0.44

100(94.3)
6(5.7)

111(94.1)
7(5.9)

0.51

30(36.1)
15(18.1)
30(36.1)
8(9.6)

32(40.5)
12(15.2)
22(27.9)
13(16.5)

0.36

95(43.4)
31(14.2)
55(25.1)
38(17.4)

41(45.6)
9(10.0)
23(25.6)
17(18.9)

0.8

37(34.9)
10(9.4)
50(47.2)
9(8.5)

45(38.1)
16(13.6)
34(28.8)
23(19.5)

0.01

35(42.2)
41(49.4)
7(8.4)

22(27.9)
55(69.6)
2(2.5)

0.02

79(36.1)
121(55.3)
19(8.7)

37(41.1)
50(55.6)
3(3.3)

0.22

49(46.2)
50(47.2)
7(6.6)

50(42.4)
59(50.0)
9(7.6)

0.98

43(51.8)
39(47.0)
1(1.2)

49(62.0)
29(36.7)
1(1.3)

0.65

120(54.8)
98(44.8)
1(.46)

54(60)
35(38.9)
1(1.1)

0.54

66(62.3)
40(37.7)
0(0)

71(60.2)
45(38.1)
2(1.7)

0.3

70(84.3)
11(13.3)
2(2.4)

66(83.5)
11(13.9)
2(2.5)

0.99

172(78.5)
43(19.6)
4(1.8)

70(77.8)
19(21.1)
1(1.1)

0.87

80(75.5)
23(21.7)
3(2.8)

100(84.8)
17(14.4)
1(.85)

0.35

73(88.0)
9(10.8)
1(1.2)

69(87.3)
10(12.7)
0(0)

0.67

197(90.0)
20(9.1)
2(.91)

77(85.6)
13(14.4)
0(0)

0.27

100(94.3)
5(4.7)
1(.9)

111(94.1)
7(5.9)
0(0)

0.001

77(92.8)
5(6.0)
1(1.2)

73(92.4)
6(7.6)
0(0)

0.84

199(90.9)
20(9.1)
0(0)

79(87.8)
10(11.1)
1(1.1)

0.25

102(96.2)
4(3.8)
0(0)

111(94.1)
7(5.9)
0(0)

<.001

67(80.7)
15(18.1)
1(1.2)

65(82.3)
14(17.7)
0(0)

0.85

174(79(5)
44(20.1)
1(.5)

73(81.1)
16(17.8)
1(1.1)

0.73

87(82.1)
17(16.0)
2(1.9)

98(83.1)
20(17.0)
0(0)

0.62

62(74.7)
21(25.3)
0(0)

60(76.0)
18(22.8)
1(1.3)

0.8

169(77.2)
49(22.4)
1(.5)

62(69.0)
28(31.1)
0(0)

0.23

86(81.1)
20(18.9)
0(0)

92(78.0)
25(21.2)
1(.85)

0.04

73(88.0)
9(10.8)
1(1.2)

68(86.1)
11(13.9)
0(0)

0.61

193(88.1)
26(11.9)
0(0)

75(83.3)
14(15.6)
1(1.1)

0.2

95(89.6)
10(9.4)
1(.9)

106(89.8)
12(10.2)
0(0)

0.25
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Table 3. Food insecurity and covariates by disease control (continued)
Diabetes Control (n=171; 9 missing)
Controlled (n=83)
Uncontrol (n=79)
(HbA1c < 7%)
(HbA1c>7%)
Continous Measures
Mean (SD)
Mean (SD)
Food Insecurity
1.4(1.9)
1.4(2.0)
Social Stressors
4.3(4.0)
4.0(3.6)
Social Stressors-weighted
8.3(9.3)
7.4(8.1)
PHQ_score
4.2(6.6)
4.1(6.2)
Morisky Medication Adherence Score (self-report)
1.9 (0.68)
1.9 (0.73)
DM medications mean adhernece (pill count)
74.8(28.1)
75.9(23.0)
HTN medication mean adhernece (pill count)
DYS medication mean adherence (pill count)
Age
60.0(9.8)
60.0(10.7)
Monthly household income
1,065(563.9)
1,078(689.3)
Income (Equialence Scale)
921(433.5)
919.5(512.4)
Social support overall
4.2(1.2)
4.2(1.2)
BMI score
32.4(8.7)
34.1(8.1)
*
Two sample t-test

p value*
P
0.85
0.55
0.53
0.94
0.61
0.84

0.99
0.89
0.98
0.95
0.2

HTN Control (n=309)
Controlled (n=219)
Uncontrol (n=90)
(SB<140 mmHg)
(SB>140 mmHg)
Mean (SD)
Mean (SD)
1.5(2.0)
1.3(1.8)
4.51(4.0)
4.5(4.0)
8.8(9.0)
9.3(9.6)
4.06 (6.3)
4.4 (6.8)
1.93 (.70)
1.9 (.77)

p value*
P
0.58
0.89
0.64
0.67
0.73

79.8 (22.4)

70(63.3)

0.007

59.4(11.2)
1217.05(765.03)
1047.67(971.96)
4.2(1.1)
32.5(8.0)

60.0(10.9)
1153.04(809.77)
1001.64(870.58)
4.2(1.2)
32.9(8.1)

0.63
0.51
0.53
0.76
0.74
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DYS Control (n=239; 15 missing)
Controlled (n=106)
Uncontrolled (n=118)
(non-HDL<130)
(non-HDL>130)
Mean (SD)
Mean (SD)
1.1(1.8)
1.7(1.9)
3.7(4.1)
4.4(3.9)
6.8(9.1)
8.8(8.7)
3.1(5.4)
3.8(6.3)
2.1(.63)
1.9(.76)

80.4(20.1)
62.5(10.9)
1135.20(755.95)
971.02(568.34)
4.4(1.1)
31.2(8.0)

74.0(26.9)
60(11.6)
1144.96(725.91)
969.59(550.63)
4.1(1.1)
31.9(8.2)

p value*
P
0.03
0.19
0.11
0.33
0.02

0.14
0.13
0.92
0.98
0.03
0.54

Table 4a: Food insecurity and diabetes control logistic regression models

Table 4b: Food insecurity and hypertension control logistic regression models

Table 4c: Food insecurity and dyslipidemia control (non-HDL-C) logistic regression models

Table 4d: Food insecurity and dyslipidemia control (LDL-C) logistic regression models
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Table 5a: Food insecurity and diabetes control linear regression models
DM Level of Control (n=162)
A1c
Unadjusted (n=162)
Beta

95% CI

Insulin
(n=159)
Beta

95% CI

Model A
(n=156)
Beta

95% CI

Model B
(n=151)
Beta

95% CI

Food Insecure
0.56
-.03, 1.16
.29
-.26, .85
.44
-.25,1.13
.27
-.41, .95
Insulin: Adjusted for Insulin
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number of diseases, depression, BMI,
social support, smoking status, cost of meds, transportation to pharmacy and homelessness
Model B-Parsiomonious: Adjusted for age, education, social support, cost of medicationss, transportation to pharmacy and homelessness

Table 5b: Food insecurity and hypertension control linear regression models
SBP Level of Conrol (n= 309 )
SBP (continuous)
Unadjusted (n=162)
Beta

95% CI

Model A
(n=156)
Beta

95% CI

Model B
(n=151)
Beta

95% CI

Food Insecure
-2.42
-6.27, 1.43
.24
-4.17, 4.65
-1.22
-5.19, 2.76
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of
diseases, depression, BMI, social support and smoking status
Model B-Parsimonious: Adjusted for age, insurance gaps and smoking status

Table 5c: Food insecurity and dyslipidemia control (non-HDL-C) linear regression models
Non-HDL Level of Control (n= 224 )
SBP (continuous)
Unadjusted (n=162)
Beta

95% CI

Model A
(n=156)
Beta

95% CI

Model B
(n=151)
Beta

95% CI

Food Insecure
18.73
7.49, 29.97
15.45
3.25, 27.66
13.32
1.72, 24.92
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of
diseases, depression, BMI, social support and smoking status
Model B- Parsimonious: Adjusted for number of diseases and social support

Table 5d: Food insecurity and dyslipidemia control (LDL-C) linear regression models
LDL Level of Control (n= 224 )
SBP (continuous)
Unadjusted
(n=162)

Model A
(n=156)
Beta

95% CI

Model B
(n=151)
Beta

95% CI

Food Insecure
12.89
2.08, 23.69
10.18
-1.43, 21.78
9.02
-2.22, 20.26
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance, number of
diseases, depression, BMI, social support and smoking status
Model B-Parsimonious: Adjusted for number of diseases and social support and smoking status
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Table 6. Mean pill count adherence by self-reported Morisky medication adherence

Mean Pill Count Adherence
Self-Reported
Adequate
Self-Reported
Adherence
Low Adherence
Overall (n=284)
75.0 (21.4)
65.6 (29.1)
0.004
Diabetes (n=91)
79.2(19.9)
63.6(48.6)
0.01
Hypertension (n=210)
77.6(22.8)
75.0(27.5)
0.51
Dyslipidemia (n=126)
78.3(22.9)
71.1(29.8)
0.18
Co-morbid Depression (n=23)
86.9(18.0)
71.5(35.3)
0.2
T-test of continous pill count % mean adherence by low/adeequate self-reported Morisky adherence
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Tables 7-10: Effect modification analyses
Table 7a: Logistic regression of food insecurity and diabetes control by BMI (<30 vs. >=30)

Table 7b: Logistic regression of food insecurity and hypertension control by BMI (<30 vs. >=30)

Table 7c: Logistic regression of food insecurity and dyslipidemia control (non-HDL-C) by BMI
(<30 vs. >=30)

Table 7d: Logistic regression of food insecurity and dyslipidemia control (LDL-C) by BMI (<30
vs. >=30)
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Table 8a: Linear regression of food insecurity and diabetes control by BMI (<30 vs. >=30)

Table 8b: Linear regression of food insecurity and hypertension control by BMI (<30 vs. >=30)

Table 8c: Linear regression of food insecurity and dyslipidemia control (non-HDL-C) by BMI
(<30 vs. >=30)

Table 8d: Linear regression of food insecurity and dyslipidemia control (LDL-C) by BMI (<30
vs. >=30)
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Table 9a: Logistic regression of food insecurity and diabetes control by depression (not depressed
vs. depressed)

Table 9b: Logistic regression of food insecurity and hypertension control by depression (not
depressed vs. depressed)

Table 9c: Logistic regression of food insecurity and dyslipidemia control (non-HDL-C by
depression (not depressed vs. depressed)
DYS Uncontrolled
non-HDL>=130
Unadjusted
(n=175)

Food Security Status
Food Secure
Food Insecure

No Depression Dx
Adjusted
(n=172)

Depression Dx
Unadjusted (n=49)
Adjusted
(n=49)

OR

95% CI

OR

95% CI

OR

1.00
2.07

Referent
1.07, 4.01

1.00
1.72

Referent
.82, 3.64

1.00
3.12

95% CI

OR

Referent 1.00
.96, 10.15 5.75

95% CI
Referent
.62, 53.09

Table 9d: Logistic regression of food insecurity and dyslipidemia control (LDL-C by depression
(not depressed vs. depressed)
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Table 10a: Linear regression of food insecurity and diabetes control by depression (not depressed
vs. depressed)

Table 10b: Linear regression of food insecurity and hypertension control by depression (not
depressed vs. depressed)

Table 10c: Linear regression of food insecurity and dyslipidemia control (non-HDL-C by
depression (not depressed vs. depressed)

Table 10d: Linear regression of food insecurity and dyslipidemia control (LDL-C by depression
(not depressed vs. depressed)
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Figure 3. Medication Adherence, Health Literacy and Cultural Health Beliefs (RxHL) Study
Activities and Timeline

Screening (N= 771)

Baseline (N=459)

Screening/enrollment via EMR,
patient registries, provider and selfreferral

Self-report Baseline Survey
Medical Chart Abstraction

3-month follow-up (N~383)
•
Pill Count
•

8-item Morisky Medication
Adherence Scale

Pill Count

Qualitative data collection (subset of total RxHL sample)
•
In-depth interviews (n=50)
•
Home/Pharmacy Observations (n=38)
•
Chronic Disease Diaries (n=30)
January

December

2014

2018

Figure 4. Study enrollment for RxHL and the current study, Social Determinants of
Cardiometabolic Disease Control
Screened N=771
Eligible n=705
91% of screened
RxHL
N=411
(as of 1.2017)
Retained n=383
At 3 month f/u
83% of enrolled
54% of eligible

SDoDC

Included (n=361)
Diabetes (n=171, 47%),
Hypertension (n=309, 86%)
Dyslipidemia (n=239, 66%)
(Comorbid depression (n=96, 27%))
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Figure 5. Odds ratios of uncontrolled disease among food insecure versus food secure
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Figure 8. Mediated Model: Food insecurity and Non-HDL-C by medication adherence
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Figure 9. Mediated Model: Food insecurity and LDL-C by medication adherence
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APPENDIX 1
SOCIAL DETERMINANTS OF HEALTH-DEFINITIONS BY HP2020, NAM (IOM), AHA,
AND NACHC
Healthy People 2020:
Social Determinants of Health

National Academy of Medicine (formerly IOM): Capturing
Social and Behavioral Domains in EMR-Phase 2 (2014)

American Heart Association-Scientific Statement: Social
Determinants of Risk and Outcomes for CVD

National Associaiton of Community Health Centers:
Protocol for Responding to and Assessing Patients' Assets, Risks,
and Experiences (PRAPARE)

Economic stability

Sociodemographic Domains

Socioeconomic Position (SEP)

Personal Characteristics

Poverty

Sexual Orientation

Income/income inequality

1. Are you Hispanic or Latino?

Employment

Race and ethnicity

Education (level of education, health literacy)

2. Which race(s) are you?

Food security

Country of origin/U.S. born or non-U.S. born

Occupation (employment, unemployment, job loss)

a. Asian

Housing stability

Education

Race/Ethnicity

b. Pacific Islander

Education

Employment

Racism

c. American Indian/Alaskan Native

High school graduation

Financial resource strain: Food and housing insecurity

Discrimination

d. Native Hawaiian

Enrollment in higher education

Psychological Domains

Health care provider bias/stereotype

e. Black/African American

Language and literacy

Health literacy

Low quality provider-patient communication

f. White

Early childhood education and development

Stress

Social Support

g. Choose not to answer.

Social community context

Negative mood and affect: Depression and anxiety

Social support

3. At any point in the past 2 years, has seasonal or migrant farm work
been your or your family's main source of income?

Social cohesion

Psycholocial Assets: conscientiousness, patient
engagement/activation, optimism, self-efficacy

Social networks

4. Have you been discharged from the armed forces of the US?

Civic participation

Behavioral Domains

Access to medical care

5. What language are you most comfortable speaking?

Perceptions of discrimination and equity

Dietary Patterns

Approachability

a. English

Incarceration/institutionalization

Physical Activity

Acceptability

b. Language other than Englsih.

Health and health care

Tobacco use and exposure

Availability and accomodation

c. Choose not to answer

Access to health care

Alcohol use

Affordability

Family & Home

Access to primary care

Individual-level Social Relationships and Living Conditions Appropriateness
Domains

6. How many family members, including yourslef, do you currently
live with?

Health literacy

Social connections and social isolation

Residential Environment

7. What is your housing situation today?

Neighborhood and built environment

Exposure to violence

Neighborhood socioeconomic disadvantage/deprivation

a. I have houseing

Access to healthy foods,

Neighborhoods and Communities

Neighborhood built/physical environment

Quality of housing

Neighborhood and community compositional characteristics

Neighborhood social environment

b. I do not have housing (staying with others, in a hotel, in a chleter,
living outside on the street, on a beach, in a car, or in a park)
c. I choose not to answer this question

Culture and language

8. Are you worried about loosing your housing?

US DHHS (2013): National Standards for Culturally and
Linguistically Appropriate Services in Health and Health Care

9. What address do you live at? Include street and zipcode)

Requires language services to be provided to those indivudials
with limited English proficiency and/or other communication
needs at no cost to facilitate access to health care servicds

Money & Resources

Crime and violence

Community Health Workers-bring language and cultural needs of 10. What is the highest level of school that you have finished?
patients and provider care teams
a. less than high school degree
b. high school diploma or GED
c. More than high school
d. I choose not to answer this question
11. What is your curent work situation?
a. Unemployed and seeking work
b. Part time or temporary work
c. Full time work
d. Otherwise unemployed but not seekign work (e.g., student, retired,
disabiled, unpaid primary care giver)______________
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APPENDIX 2
U.S. HOUSEHOLD FOOD SECURITY SURVEY MODULE: SIX-ITEM SHORT FORM,
ECONOMIC RESEARCH SERVICE, USDA, SEPTEMBER 2012
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APPENDIX 3
U.S. HOUSEHOLD FOOD SECURITY SURVEY MODULE (6-ITEM) SUMMARY (USDA,
2012)

Question
(Last 12 months)

Function

1. Running out of food

1-3: Screen of food
insecurity

Score &
Categorization

Categorical
Raw score: 0-1
2. Eating balanced meals
• High/marginal food
security
Raw score 2-4:
3. Meals cut/skipped
• Low food security
4. Frequency of skipped 4-6: Degree of food
Raw score 5-6:
meals
insecurity
• Very low food
5-6. Eating practices
security
based on lack of money
Dichotomous
Raw score: 0-1
• High/marginal food
security
Raw score 2-6:
• Food insecure
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CHAPTER 3
SOCIAL STRESSORS, MEDICATION ADHERENCE AND CARDIOMETABOLIC
DISEASE CONTROL: AN ECOSOCIAL APPROACH
INTRODUCTION
3.1. Introduction: Cardiometabolic Disease Control
As previously discussed in the Introduction and Chapter 1, cardiovascular disease (CVD)
is the leading cause of death in the United States (CDC, 2016). Three cardiometabolic diseases—
diabetes mellitus, high blood pressure (hypertension) and high blood cholesterol (hyperlipidemia)
have been identified as modifiable risk factors for CVD (AHA, 2016). Effective management of
each of these cardiometabolic diseases is fundamental to preventing morbidity and mortality
associated with disease progression, to reduce the risk of CVD events (e.g., heart attack and
stoke). Additionally, control of one of these diseases can possibly prevent the onset of one
another.

3.1.2.Social Stressors
3.1.2.1. History of Social Stress Research
Since its introduction into the medical literature by Austrian-Canadian endocrinologist Hans
Selye in 1936, abundant scientific evidence has accrued to support the idea that stress is
associated with higher risk of disease and progression of disease (Selye, 1955; Selye, 1973;
Selye, 1976; Chrousos, 1997; APA, 2016; RWJ, 2016). Selye famously stated in an attempt to
define stress: “Everybody knows what stress is and nobody knows what it is” (Selye, 1973, p.
692). Nearly forty years after its introduction, Selye came to define stress as “the nonspecific
response of the body to any demand made upon it” (Selye, 1973, p.692). The term “nonspecific”
refers to the fact that no matter the stimulus of the stress response, the body is faced with needing
to adapt to the problem and return to normal or homeostasis. Selye’s work affirmed that the
nonspecific nature of the response is central to understanding the phenomenon of stress and its
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effect on the body and disease. During these early stages of scientific examination of stress to
define it and its biological mechanisms, an important distinction was made between stress and
stressors, wherein stress is identified as the response or reaction and stressors are the factors that
trigger stress response (Selye, 1955; 1973). Stressors have a range of origins including, but not
limited to, biological, emotional, physical, or social.
With increasing attention to the social/environmental underpinnings of health disparities
in health care research, social stressors have been identified as factors in a patient’s social and
environmental context that interfere with their ability to comply with complex medical regimens
(Rothberg et. al., 2011). Social stressors, akin to social determinants of health (SDoH), include
factors such as socioeconomic disadvantage, financial strain or poverty, homelessness or unstable
housing, food insecurity, social conflict (e.g., problems with family, friends, and/or significant
others), family responsibilities, discrimination, exposure to violence (e.g., victimization, trauma),
lack of transportation, and others (Rothberg et al., 2011; HP2020, 2010). Given the range of
social stressors identified, they can be acute or chronic in nature and can result in acute and/or
chronic stress (Rothberg et al., 2011), which may impede or complicate disease prevention or
management, including adherence to treatment plans.
A psychosocial theoretical framework focuses on biological responses to human
interactions, the role of stress in the biologic mechanisms, and on how people manage or behave
in the presence of stress (Krieger, 2001, p. 670). Psychosocial theoretical frameworks primarily
examine the relationship between (social) stressors and their effect on health and on the role of
social integration or social support and health outcomes (Krieger, 2001; Berkman, 1985; Cohen,
1988; Cohen & Syme, 1985). Social integration and support have been found to be inversely
associated with morbidity and mortality and positively associated with health maintenance,
(Berkman et al., 2014) while factors like depression and discrimination have been found to
exacerbate outcomes. Psychosocial factors including but not limited to depression and chronic
life stress have been linked with cardiovascular disease (Rozanski et al., 1999). Psychosocial
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theory in social epidemiology has emerged in part from the combination of John Cassel’s
exploration of the role of the social environment on the experience of stress and its effect on
disease (1964, 1976) and Selye and Wolf’s focus on the biological effects of stress on the body
(1973). As these concepts emerged, so did new terms for “states of being”. For instance,
“allostasis”—the body’s ability to “achieve balance” amidst a changing environment, a concept
akin to homeostasis (Cannon, 1935; 1941), and “allostatic load”—the long-term effect of
stressors on physiologic systems (Sterling & Eyer, 1988; Krieger, 2001)—were introduced.
Though the relationship between the social environment and health status is now commonly
explored across a range of disciplines including social epidemiology, the ecosocial model
(Krieger, 2001) is one unifying theory through which to explore mechanisms that may link the
social environment, including social stressors, to health outcomes (Krieger, 2001; Marmot et al.,
2006; Cohen, 1988). These models situate the individual and his/her/their behavior downstream
of social/environmental contexts and associated stressors.

3.1.2.2.Results from 2 Recent Population Surveys
Since 2007, the American Psychological Association (APA) has administered an annual national
“Stress in America” survey. The top five sources of stress (stressors) among adults in 2015 were:
1) money (67%; top source of stress since 2007); 2) work (65%; 2nd top source of stress since
2007); 3) family responsibilities (54%); 4) personal health concerns (51%); tied for 5th) health
problems affecting the family (50%); and the economy (50%) (APA, 2016). Over 51% of adults
report having at least one chronic illness, 13% report having a diagnosis of depression and 16% a
diagnosis of anxiety disorder. The 2015 survey indicated that stress is a health disparity (APA,
2016) and assessed stress associated with discrimination, where experience with discrimination
was measured as day-to-day and as major forms of discrimination across several subgroups
including by age, race/ethnicity, gender, disability, sexual orientation and gender identity (APA,

97

2016). Sixty-nine percent of respondents reported experiences of discrimination. This includes
61% who reported day-to-day discrimination such as being treated impolitely or disrespectfully,
receiving inadequate services compared to others, and/or experiencing threats or harassment
(APA, 2016). Nearly 1 in 2 (47%) of respondents reported experiencing major forms of
discrimination such as being stopped unfairly by police, being discouraged to pursue an
education, or having an unfair health care experience (APA, 2016).
In 2014, a collaboration between National Public Radio (NPR), Robert Wood Johnson
Foundation (RWJF) and the Harvard School of Public Health conducted a Burden of Stress in
America Survey (N=2,505) to examine the role of stress in people’s lives. Of the 49% who
reported having had a major stressful event or experience in the last year, health-related issues
(43%) were the primary source of stress. Among those who reported a great deal of stress in the
last month, the most commonly reported stress-related experiences were having too many
responsibilities (54%), problems with finances (53%), work problems (53%), health problems
(38%), health problems with family (37%) and problems with family members (32%) (RWJ,
2014). Among those with a chronic illness or disability and who reported a great deal of stress in
the past month, over half reported that stress exacerbated symptoms (53%) or complicated their
ability to manage their chronic illness or disability (52%) (RWJ, 2014). In summary, these two
population stress reports indicate between 49% to 67% report experiencing a major stressor and,
among those, between 43% to 51% were due to health-related issues. Among those with chronic
illness, stress impedes chronic disease management (RWJ, 2014).

3.1.3. Ecosocial/Physiologic Mechanisms
As discussed in Chapter 1, three broad areas have been hypothesized as links between social
conditions and health outcomes: 1) social/built environments; 2) health behaviors; and 3) stress
and cognitive/affective processes (Kubzansky et al., 2014, p.512). Additionally, based on a recent
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and summative review conducted by the American Heart Association, there are three primary
biologic pathways that link SDoH specifically to cardiovascular health. The pathways include: 1)
socioeconomic disadvantage leads to higher burden of risk factors; 2) on-going social and
environmental stressors lead to cumulative stress on the biologic systems or allostatic load; and 3)
lifecourse exposure to low socioeconomic position (SEP; e.g., in utero and during critical
windows of development) can have long term effects on risk for CVD in adulthood (AHA &
Havranek et al., 2015).
The brain integrates perceptions of stress and coordinates responses to stress (McEwen,
2008). The brain assesses potential stressors, whether they are acute or chronic in nature, and
determines the physiological and behavioral responses to the stressors (McEwen, 2008). As
defined earlier, stress is a physiologic response and when the stress response is to
social/environmental demands (social, family, work, neighborhood) (Selye, 1955, 1973) it has
been suggested as a mechanism by which social factors are literally incorporated (Krieger, 2001)
into the body (Kubzansky et al., 2014; Krieger, 2001a; Krieger, 2001b; Krieger, 2004). A range
of physiologic responses have been associated with the stress response, including higher heart
rate and blood pressure, (McEwen, 2008), inflammatory biomarkers, (e.g., interleukin-6 and Creactive protein), stress biomarkers (e.g. higher catecholamines and cortisol levels), and higher
blood glucose levels (Cesari et al, 2003; Kubzansky et al., 2014). When the stress response,
precipitated in the brain, is triggered by a chronic stressor rather than an acute one, the result can
be chronically higher heart rate, blood pressure, and other physiological markers of being
“stressed”. When the body is responsive to daily routine stressors, it is able to experience a
stressor, go through a stress response, but then return to normal. This process is described as
allostasis, defined as “achieving stability through change” (Sterling & Eyer 1988; McEwin,
2008). However, when the stressor is chronic, like living in poverty or experiencing social
stressors like food insecurity or low health literacy on a regular basis over the long-term, the body
has a prolonged stress response. This has been described as allostatic load and is defined as “the
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wear and tear that results from either too much stress or from inefficient management of
allostasis” (McEwen, 2008, p. 175) and this may lead to higher risk for morbidity and mortality.
Figure 1 illustrated in Chapter 1 is a conceptual framework that draws from an ecosocial
approach and from Marmot’s SDoH theoretical framework to illustrate the physiologic link via
the stress response/allostatic load of social/environmental factors to cardiometabolic disease
control.

3.1.4. Epidemiologic Evidence
Based on the current emphasis of SDoH in health care and prevention and management initiatives
like HP2020 to eliminate health disparities, social stressors can be thought of as the
social/environmental exposures that can trigger a stress response. There are several commonly
used and well known scales to measure stress. They include the Holmes and Rahe Stress Scale
(Holmes, 1967); the Perceived Stress Scale (Cohen et al.; 1983); the Depression Anxiety Stress
Scales (Lovibon et al, 1983; 1993); and the Standard Stress Scale (Gross et al., 2014). In
addition, several disease-specific stress scales are also commonly used including the HIV-Stress
Scale (Pakenham et al., 2002); the Diabetes Distress Scale (DDS) (Polonsky et al., 2005); the
Questionnaire on Stress in Patients with Diabetes (QSD-R) (Duran et al.,1995); and Problem
Areas in Diabetes Scale (PAID) (Polonsky et al., 1995). The body of research on the association
between life events, stress and chronic disease is abundant and dates back over seven decades
(Selye, 1955; Dodge et al, 1970; Holmes et al, 1974; Rahe et al., 1992). A more recent and
rapidly expanding area of this body of research is racial discrimination and health disparities
research and addresses the relationship between psychosocial stressors, life events, stress and
health outcomes (Sternthal et al., 2011; Lantz et al, 2005; Albert et al, 2011; Williams et al.,
2012; Krieger, 2014; 2012; 2005).
Within the context of the Affordable Care Act and the emergence of regulatory
requirements for primary health care providers (e.g., Federally Qualified Community Health
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Centers) to become Patient-Centered Medical Homes and to meet population health quality
improvement benchmarks (NCQA; AHRQ), efforts to embed the assessment of social stressors
and specifically SDoH within the clinical primary care setting emerged. However, research to
examine the association between clinically-assessed social stressors/SDoH and health outcomes,
particularly among community health center patients, is still in its infancy.
In response to the common but challenging observation among health care providers that
many of the barriers to chronic disease prevention and management occur outside of the clinical
visit, a clinical research team from Baystate Medical Center in Springfield, Massachusetts,
developed a scale—the Tool for Assessing Patient Stressors (TAPS) (Rothberg, 2011; Welch et
al., 2015). The aim of this tool was to facilitate provider care teams to be able to quickly assess
social/environmental barriers to self-management within the clinical visit and use the information
to identify opportunities for linking patients with community resources that mitigate the identified
barriers (e.g., if the TAPS identifies a patient does not have sufficient food, then linking to her to
a food panty may improve her insulin adherence and overall diabetes control). Given the scope of
this study, the following is an epidemiologic review of studies that have used the TAPS5. A
detailed description of the TAPS including the number and content of questions, types of
stressors assessed, and scoring is described in detail in the Exposure Assessment section and in
Table 13.
A cross-sectional study using the newly developed social stress scale (TAPS) enrolled
250 patients with diabetes were surveyed by telephone. The social stressor scale was found to
have acceptable internal consistency Social Stressor: Chronbach1 s 2 0.8 (Rothberg et al.,
2011). Of the 20 items, the top five sources of stress were: 1) depression or anxiety; 2) sickness,

5

Given the focus of the current study and the timing of the research, the TAPS was included in
the RxHL study (see Study Method) to assess SDoH and associated stress in the study population.
The instrument development phase of RxHL pre-dated the PRAPARE tool (NACHC, 2016), an
emerging SDoH measurement tool coming into wider use in FQHC and other primary care
settings in the U.S.
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disability, or death in the family; 3) affording food, housing or clothes; 4) family’s needs and
problems; and 5) affording to send money back home (Rothberg et al., 2011). There was a
positive association between social stressors and depression (assessed using the Patient Health
Questionnaire (PHQ-9 )(Pearson’s r=0.60, p<0.0001) (Rothberg et al., 2011).
A case-control study was conducted by the same research group to assess the effect of
social distress on diabetes control among 246 patients with a diagnosis of diabetes for at least one
year. Cases were defined as those patients with HbA1c>9% and controls were those patients with
HbA1c<7%. In addition to social stressors, diabetes self-care and knowledge, depression and
clinical measures were also assessed. Social stressor scores were higher among those with
uncontrolled diabetes (6.9 vs. 5.7, P=0.03) (DuVal et al., 2011). After adjusting for age,
employment status, and BMI, every one-unit increase in social stress was associated with a 33%
higher odds of having uncontrolled HbA1c (DuVal et al., 2011). Self-care, depression and
diabetes knowledge were all examined as possible mediators but did not change the association
(DuVal et al., 2011). The HbA1c differed significantly among patients on the stress scale on two
items: 1) difficulty paying for medications, doctor’s visits or medical equipment (HbA1c<7 %:
34%, HbA1C>9%: 50%, p=0.015); and 2) lack of affordable local transportation (HbA1c<7%:
24%, HbA1C>9%: 43%, p=0.001) (DuVal et al., 2011). The median number of stressors also
differed by glycemic control status (HbA1c<7% median stressors=5, HbA1C>9% median
stressors=7, p=.002) (DuVal et al., 2011). There was a positive association between stress score
and HbA1c such that for every one-unit increase in stress score there was a statistically
significant 0.08% higher HbA1c (p=0.04) after controlling for age, employment status and BMI
(Duval et al., 2011).
Since its development, several other cross-sectional studies have utilized the 20-item
TAPS social stressor scale to examine the relationship between social stressors and chronic
disease control. The first was a study to examine social stressors over the past month (in contrast
to over the past week as the scale was originally designed) and medication adherence among 192
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English- and Spanish-speaking low-income patients with diabetes. A mean of 4.8 stressors were
reported by the sample. Only 13% reported no stressors while nearly 50% reported between 1-5
stressors and 30% reported 6-10 stressors. The five most common stressors reported were: 1)
sickness or disability in the family or self (57.3%); 2) not having enough money for food,
rent/mortgage, or clothes (56.3%); 3) problems with depression or anxiety (48.7%); 4) difficulty
paying for medications, doctor’s visits or medical equipment (48.2%); and 5) taking care of
family’s different needs and problems (45.3%). A higher number of stressors reported was
associated with a higher number of depressive symptoms using the PHQ-9 (rho=0.54, p<0.001).
Additionally, higher number of stressors was also associated with lower medication adherence
(6 = −0.36, < < 0.001). After adjusting for depression symptoms, social stressors remain
independently associated with lower medication adherence; however, this association remained
only among those with the highest medication adherence scores (Osborn et al., 2014).
In another cross-sectional study using the same sample of patients, social support was
examined to determine if it buffered or exacerbated the association between social stressors and
depressive symptoms and medication nonadherence (e.g., social support as a possible effect
modifier) (Mayberry et al., 2015). Independent associations between social stressors and
medication nonadherence, and between depressive symptoms and medication nonadherence, were
stronger at higher levels of obstructive family behaviors. The investigators found no evidence of
the buffering hypothesis for social support. Unexpectedly, they found that stronger depressive
symptoms were associated with medication nonadherence among those with higher family
support (Mayberry et al., 2015). The investigators suspect this unexpected finding may either be
attributed to the cross-sectional study design or how social support was measured (Mayberry et
al., 2015).
Lastly, a recent randomized controlled trial was conducted to examine the effect of a
patient-centered, comprehensive diabetes team care model on social distress (another term used to
describe social stressors) among Latino patients with T2D from two community health centers in
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Western Massachusetts (Allen et al., 2017). The 6-month intervention included five individually
and culturally-tailored diabetes education sessions delivered one-on-one with either a diabetes
nurse or diabetes dietician. Social distress (referred to this way in the article but is the same as
social stressors) was assessed using the 20-item TAPS. Over 90% of participants reported at least
one stressor in the prior week and the top three stressors reported were: 1) problems with
depression or anxiety in my family or myself (65.6%); 2) taking care of my family’s different
needs and problems (57.0%); and 3) difficulty affording the cost of travel to visit friends and
family (52.0%). Both the control (6.8 to 6.2) and intervention groups (7.2 to 5.6) experienced a
decline in the number of stressors reported from baseline to 6-months follow-up, and the
difference between control and intervention groups from baseline to 6-months differed
significantly (p=0.01). Based on the stressors identified, the intervention team provided clinicalcommunity linkages to connect patients to local resources and social services—a primary aim of
patient-centered, coordinated care. This program appears to have been successful in reducing
social stressors within 6-months compared to usual care (Allen et al., 2017).

3.1.4.1 Summary
In summary, several cross-sectional studies, a case-control study and a randomized controlled
trial have been conducted to examine social stressors and chronic disease outcomes. All have
used the TAPS to measure social stressors. Having more than one stressor in the last week or last
month is common, with a mean of 4.8 to 6 stressors reported (Osborn et al., 2014; Rothberg et al.,
2011) and with between 50% to 90% of respondents having at least one stressor (Osborn et al.,
2014; Allen et al, 2015). Several studies with participants of similar socioeconomic status being
served in community health centers have identified the following stressors as the most commonly
reported: 1) taking care of my family’s needs and problems; 2) not having enough money for
food, housing or clothes; 3) sickness, disability or death in the family; 4) problems with
depression or anxiety (Rothberg et al., 2011; Osborn et al., 2014; N. Allen et al., 2015). Higher
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number of social stressors was associated with poorer glycemic control (Duval et al., 2011), with
higher number of depressive symptoms (Rothberg et al., 2011; Osborn et al., 2014) and with
lower medication adherence as measured by the adherence to refills and medications scale for
diabetes (ARMS-D) (Osborn et al. 2014). Patient-centered, care coordination that identifies social
stressors and then links individuals with corresponding social resources may reduce social
stressors over time (Allen et al., 2015).

3.1.5. Hypotheses and Specific Aims
Preliminary findings using this sub-set of data from the RxHL study have identified statistically
significant associations between social stressors and inadequate medication adherence, as
assessed by self-report (Huebner Torres et al., 2015). This study expanded those analyses to
assess social stressors, medication adherence (as a possible mediator) and cardiometabolic disease
control, and to assess two possible effect modifiers (depression and social support).
Specific Aims
1: To examine the relationship between social stressors and cardiometabolic disease control. We
hypothesized that patients with higher social stressor scores would have:
1a) poorer cardiometabolic disease control as measured by their respective clinical
marker of disease control (HbA1c, SBP, non-HDL/LDL);
2. To examine if medication adherence mediates the association between social stress and
cardiometabolic disease control. Based on Marmot’s model of SDoH, we hypothesized social
stress would be:
2a) negatively associated with medication adherence (higher social stress would be
associated with lower medication adherence);
And, that lower medication adherence would be:
2b) positively associated with poorer cardiometabolic disease control.
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3. To evaluate whether the association between social stressors and cardiometabolic disease
control varies by: a) depression status; and b) social support. Based on Marmot’s model of SDoH,
we hypothesized that the association between social stressors and cardiometabolic disease control
would:
3a) be stronger among those with depression or higher levels of depressive symptoms,
compared to ….; and
3b) be weaker among those with higher levels of social support, compared to those with
low levels of social support.

3.2. Methods
3.2.1. Study Design and Population
The proposed study assessed the association between social stressors and cardiometabolic disease
control using a subset of the cross-sectional data from the Medication Adherence, Health Literacy
and Cultural Health Beliefs mixed-methods study (RxHL) study as described in Chapter 1 (Figure
1, Chapter 1).

3.2.2. Exposure Assessment
Social stress was measured using the 20-item Tool for Assessing Patients’ Stressors (TAPS;
Table 1) (Rothberg, DuVal, Luciano, Frederici & Welch, 2011). The TAPS was developed by a
team of medical providers and investigators at Baystate Medical Center in Springfield,
Massachusetts. They conducted focus groups with physicians, nurses and diabetes educators who
work with patients at an academic urban health center that serves a similar patient population—
high percentage of low income and racially/ethnically diverse—as for this study. They created a
20-item measure of social stressors in English and Spanish. The stressors identified for the scale
were commonly reported by the patient population served—specifically, low income, ethnically
diverse and urban dwelling. After pilot testing with target subjects, the scale was modified for
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clarity. For each item, the interviewer asks the participant: “In the past week, have any of the
following family issues been stressful to you?” Examples of the stressors include, “Not enough
money for food, rent or mortgage, or clothes for my family or myself,” and “Problems with
depression or anxiety in family or myself,” and “Family members experiencing discrimination or
racism at work or in public”. The scale includes a family focus because it was developed in an
area that serves a large Puerto Rican population and other patient populations known to interdepend on family and social networks for resources and support and a process of collective
caregiving (Evans et al., 2017; Ino et al., 2002). Therefore, family issues and or stressors become
stressors for the individual and vice versa.
Response options were 1=yes and 0=no. The TAPS is scored by summing all “yes”
responses resulting in a social stressor score ranging from 0 to 20, which represents the number of
stressors identified as stressful in the past week. The score ranged from 0-20. The originators of
the scale suggested expanding the scale from including a dichotomous yes/no (e.g., 0/1) response
option to include a categorical response option. Therefore, we added a 3-point Likert expanded
response option for those who reply 1=yes. They are then asked “How stressful was it?” and the
response options include: “a little stressful, somewhat stressful, a lot stressful, and refused”. As a
continuous measure, the score ranged from 0-60 wherein the latter range represents a weighted
score to include the level of stress (little, somewhat, a lot).
The TAPS was translated by a professional translation company into Russian and
Vietnamese. The professional translations were reviewed by health center staff who are native
speakers of the languages to address any additional revisions needed. Bilingual/bicultural, trained
interviewers administered surveys containing the 20-item TAPS to assess the exposure.
Participants were interviewed in the language of their choice (Russian, Vietnamese, Spanish, or
English) either at the health center or in their home depending on their preference. The measure
was designed to assess the number of social stressors and degree of stress experienced by the
participant in the past week.
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3.2.2.1. Validity of exposure assessment
The 20-item TAPS has been demonstrated to be have sound reliability (KD-20=0.8)6 among
English- and Spanish-speaking community health center patients (Rothberg et al., 2011; Welch et
al., 2011). The most commonly reported stressors have been very similar across multiple studies
with similar patient populations (Mayberry et al., 2015). Addition of the likert scale has not been
assessed for validity.

3.2.3. Outcome Assessment and Validity
The outcomes of interest are cardiometabolic disease control (dichotomous) and level of control
(continuous) in patients with diabetes, hypertension and/or dyslipidemia and are described in
detail in Chapter 2. Briefly, we defined control using dichotomous cut-points for each disease.
They are defined for diabetes as: HbA1c <7.0%; for hypertension as: SBP<140 mmHg; and for
dyslipidemia as: non-HDL-C <130 gm/dL; LDL-C <100 mg/dL. The cardiometabolic disease
outcomes were modeled as both dichotomous and continuous measures.

3.2.4. Covariate Assessment
Sociodemographic and clinical variables known to be associated with social stressors and
cardiometabolic disease control were included. Measurement and categorization were discussed
in detail in Chapter 2. They include age, gender, race/ethnicity, educational level, monthly
household income, language spoken at home, employment status, health literacy level and
depressive symptoms. Sociocultural factors included primary language spoken at home, partner
status, and social support. Clinical data including diagnosis of diabetes, hypertension,
dyslipidemia and depression, oral medications, insulin use, tobacco and alcohol use, BMI, and

6

Kudar-Richardson Formula 20: Same as Cronbach’s alpha but interpreted as KD-20 for
dichotomous response options.
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health insurance were collected from the electronic medical record (EMR). Prior studies
demonstrating a significant association between social stressors as measured by the TAPS
(Rothberg et al. 2011) and poor cardiometabolic disease control have included these covariates as
well in their analyses (Rothberg et al., 2011; DuVal et al., 2011; Osborn et al., 2014; Mayberry et
al., 2015).
Medication adherence was assessed as a possible mediator of the association between
social stressors and cardiometabolic disease control using the same method described in Chapter
2. Depression and social support were assessed as possible moderators of the association between
social stressors and cardiometabolic disease control as described in Chapter 2.
3.2.5. Statistical Analysis
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas).
Two-sided P values of less than 0.05 were considered to be statistically significant.
Descriptive analyses indicated the social stress score using both the 0-20 dichotomous
version and the weighted 0-60 expanded Likert version of the scale were positively skewed and
had similar response distributions. As such, we chose to focus the analyses on the 0-20 version
only. To address the skewed distribution, two categorical versions of the variable were created.
First, based on the frequency distribution of the 20-item social stress score, the variable was
categorized into four groups: Low=0 to1 stressors; Some=2 to 4 stressors; Moderate=5 to 7
stressors; and High = 8 or more stressors (Table 11). Additionally, because the distribution of
social stress scores differed significantly by racial/ethnic group and given that self-reported social
stress is a subjective measure, we also created a relative stress variable using ethnicity-specific
cut points. We created the ethnic-specific cut-points to address 1) how the scale items may be
culturally perceived/understood differently in the different racial/ethnic groups; and 2) that
“objective” stressors may be more or less present in each of the cultural groups. To do so, within
each cultural group, we used the frequency distributions of the 20-item social stress to define
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approximate tertiles of social stress (Figure 10). Participants were thus classified as having low,
medium and high social stress based on the distribution of score in their specific cultural group
(Table 12. Ethnic-group specific social stress scores).
We followed the same univariate and bivariate analyses as presented in Chapter 2. In
summary, we calculated the number and percent or mean and standard deviation of categorical
and continuous variables, respectively. Categorical covariates were cross-tabulated with both the
exposure and the outcome variables using chi-square or Fisher’s Exact tests accordingly and
corresponding P-values were reported. For continuous variables, T-tests and analysis of variance
(ANOVA) were calculated and mean and standard deviations were presented for both the
exposure and outcome variables. Based on the literature, covariates known to be associated with
social stressors and cardiometabolic disease control were identified a priori and included as
potential confounders on this basis. To assess covariates as potential confounders, T-tests,
ANOVA, chi-square or Fisher’s Exact Tests were used to assess continuous and categorical
covariates, respectively. We assessed a priori identified and other covariates as potential
confounders following the same procedure as presented in Chapter 2.
Separate unadjusted logistic regression models were built to examine the cross-sectional
independent relationship between social stressors and cardiometabolic disease control. Separate
unadjusted linear regression models were also built to examine the independent cross-sectional
relationship between social stressors and the cardiometabolic disease outcomes as continuous
measures.
Two adjusted models were built for each exposure-outcome relationship. First, we built a
saturated model (Model A) and adjusted for variables identified a priori in the literature as
associated with the exposure and outcome (age, gender, race/ethnicity, education, income,
employment, health insurance, comorbidities/number of diseases, and depression, BMI, social
support, tobacco use). In this model, we also included additional confounders identified as
associated with the exposure or outcome based on having a p-value of p<0.25 (alcohol use,
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homelessness, cost barriers to care and medications, transportation barriers to care and pharmacy,
and social stress). Second, we then built a parsimonious model (Model B) and adjusted for only
those covariates whose inclusion in the model resulted in more than 10% change in estimate or
had a likelihood ratio test or F-partial test with a p-value of <0.05 for logistic and linear
regression models, respectively.
Possible effect modification by depression was assessed by stratifying the multivariate
logistic regression model of social stressors and cardiometabolic disease control by depression
(depressed, not depressed). If the odds ratios of each stratum differ significantly from one another
and from the overall odds ratio as measured by Mantel-Haenszel test of homogeneity, we
included a multiplicative interaction term (depression X social stressors) in our multivariate
models and used likelihood ratio or F-partial tests to determine if the interaction term was
statistically significant in the logistic or linear regression model, respectively. If it was, we
presented stratum-specific odds ratios to describe the association between social stressors and
cardiometabolic disease control.
We followed the same procedure to assess the relationship between social support (e.g.,
low social support/high social support) as a possible effect modifier in the association of social
stressors and cardiometabolic disease control.

3.3. Results
Participant characteristics for the study sample of 361 community health center patients are
described in Chapter 2 and shown in Table 1a.

3.3.1. Social Stressors
A mean (SD) of 4.6 (4.1) and a median of 4.0 stressors were reported by the sample. Only 15.5%
of the sample reported no stressors, while 31% reported 2-4 stressors, 19.7% reported 5-7
stressors, and 22.7% report 8 or more stressors (Table 11). Of the twenty items, the top four
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reported stressors were: 1) taking care of my family’s different needs and problems (50.6%); 2)
problems with depression or anxiety in my family or myself (48.3%); sickness or disability in
myself or my family, or death in the family (43.3%); and not enough money for food, rent or
mortgage, or clothes for my family or myself (42.9%) (Table 13).
Social stress differed significantly by racial/ethnic group (p<0.001) with higher levels of
social stress reported by Latino and African American participants (moderate/high stress 73.7%
and 56.5%, respectively; row totals) and lower levels of social stress reported by Vietnamese and
Russian-speaking participants (moderate/high stress 19.6% and 20.6%, respectively; row totals).
Compared to those with low or some stress, those with moderate or high stress had higher levels
of education (p=0.03), lived alone (p=0.02), reported being homeless (p<0.001), and spoke
English or Spanish at home (<0.001). Those reporting high stress also reported transportation
barriers to care and to medication (p<0.001) and cost barriers to medication (p<0.001). Smoking
was highest among those who reported high stress (p=0.002). Those reporting high stress had the
highest mean depression score of 9.2 (9.5) as measured by PHQ-9 (<0.001) and the highest
proportion with a medical diagnosis of depression (41.5%) (p<0.001) (Table 14).
Univariate disease prevalence and control as well as bivariate association with covariates
were discussed in detail in Chapter 2 (Table 1a & 3, respectively).

3.3.2. Dyslipidemia Control
3.3.2.1. Social Stress & non-HDL-C
Social stress (categorical: 0/1 stressor=low stress; 2-4 stressors=medium stress; 5-7
stressors=moderate stress; 8+ stressors = high stress)) and non-HDL-C (continuous) were
independently associated (p=0.0498). There was a significant positive association between high
social stress (8+ stressors) and non-HDL-C though the confidence intervals were wide
(MD=16.8; 95% CI= 0.38, 33.25). After adjusting for age, gender, race/ethnicity, education,
income, employment, gaps in insurance coverage, multimorbidity, depression, BMI, social
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support, and smoking status (Model A-Saturated), this association was attenuated and, while the
point estimate remains substantial from a clinical perspective, the confidence interval became
wider and included the null (MD=14.1; 95% CI -6.6, 34.7) (Table 15a). In the trim model (Model
B), the point estimate increased but the confidence interval remained wide and included the null
(MD=19.7, 95% CI= -0.08, 39.5).
Using the same exposure categorization and non-HDL-C dichotomized (controlled vs.
not controlled), no association was observed at any level in the unadjusted or adjusted
(parsimonious model) logistic regression models (Tables 5c).

3.3.2.2. Social Stress & LDL-C
Social stress (categorical) and LDL-C (continuous) were also independently associated
(p=0.046). A significant positive association was observed between moderate stress (5-7
stressors) and LDL-C (MD=17.6; 95% CI 2.3, 32.9). The positive association remained
significant for LDL-C in both the saturated model (MD=18.1; 95% CI 0.68, 35.6) and the
parsimonious model (MD=23.2; 95% CI= 7.1, 39.4). After adjusting for race/ethnicity, BMI,
depression and smoking status, participants reporting moderate social stressor (5-7 stressors) had
LDL-C levels 23.2 points units higher than those reporting 0 or one social stressor. In addition,
there was a significant positive association between high social stress and LDL-C in the
parsimonious model (MD=20.6; 95% CI= 2.2, 39.0) (Table 16a). Those reporting high social
stress (8+ stressors) had LDL-C levels 20.6 units higher than those reporting no or one social
stressor.
For analyses of LDL control, there was no association at any level in the unadjusted
(OR=1.49; 95% CI 0.67, 3.34) or adjusted (parsimonious model) logistic regression models (High
Social Stress: OR=2.42; 95% CI 0.88, 6.64) (Tables 16c).
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3.3.2.3. Ethnic-specific Social Stress & Non-HDL-C
Using the ethnic-specific social stressor variable categorized to reflect absolute low, medium and
high stress in pooled analyses and relative stress in ethnic-specific analyses, there were no
associations with continuous non-HDL-C observed at any level in the pooled unadjusted and
pooled adjusted (saturated model) linear regression analyses (Table 15b). There were also no
associations observed in each of the ethnic-specific unadjusted and adjusted models.
Using the same ethnic-specific social stressor variable and dichotomous non-HDL-C,
there were no associations observed at any level in unadjusted and adjusted logistic regression
models (Table 15d). There were also no associations observed in each ethnic-specific model.
Using the ethnic-specific social stressor variable and continuous LDL-C, there was no
observed association at any level in the pooled unadjusted model. There was, however, a
significant positive association in the pooled adjusted (saturated model) linear regression analyses
(High Stress compared to Low Stress: MD= 14.7% CI 1.6, 27.7) (Table 16b). In pooled adjusted
logistic regression analysis (parsimonious model) the confidence interval crossed the null but was
slightly (High Stress compared to Low Stress: OR 2.03; 95% CI 0.98, 4.2) (Table 16d). Due to
the wide confidence interval, these results are difficult to interpret. There were no observed
associations among the other ethnic-specific models.

3.3.3. Diabetes Control
3.3.3.1. Social Stress & A1c
We did not observe an independent association between social stress (categorical) and A1c
(continuous) (p=0.30) and no association was observed at any level in unadjusted or adjusted
models (Table 17a).
Using the same exposure categorization and dichotomous A1c, no association was
observed at any level in the unadjusted or adjusted logistic regression models (Table 17c).
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Though we did not find statistically significant associations of social stress with level of A1c, we
did observe a positive linear trend in higher A1c with higher levels of social stress.

3.3.3.2. Ethnic-specific Social Stress & A1c
Using the ethnic-specific social stressor variable, there were no associations with continuous A1c
observed at any level in the pooled unadjusted and pooled adjusted linear regression analyses
(Table 17b). In the African-American ethnic-specific adjusted model (Model D-results not
shown), a significant positive association was observed (MD=2.16; 95% CI=0.17, 4.16). Among
African Americans, after adjusting for BMI, depression and smoking status, those who report
high social stress (8+ stressors) compared to those who report low social stress (0-2 stressors)
have a significant 2.16 unit higher A1c. Using the same ethnic-specific social stressor variable
and dichotomous A1c, there were no associations observed at any level in unadjusted and
adjusted logistic regression analyses (Table 17d). There were no associations observed in each
ethnic-specific model.

3.3.4. Hypertension Control
3.3.4.1. Social Stress & SBP
We did not observe an independent association between social stress (categorical) and SBP
(continuous) (p=0.16) and no association was observed at any level in unadjusted or adjusted
models (Table 18a). Using the same exposure categorization and dichotomous SBP, there was no
association at any level in the unadjusted or adjusted logistic regression analyses (Table 18c).

3.3.4.2. Ethnic-specific Social Stress & SBP
Using the ethnic-specific social stressor variable, there were no associations with continuous SBP
observed at any level in the pooled unadjusted and pooled adjusted linear regression analyses
(Table 18b). There were no associations observed in each of the ethnic-specific model. Using the
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same ethnic-specific social stressor variable and dichotomous SBP, there were no associations
observed at any level in unadjusted and adjusted logistic regression analyses (Table 18d). There
were also no associations observed in each ethnic-specific model.

3.3.5. Evaluation of Potential Mediation by Medication Adherence
We observed an independent association between social stress and dyslipidemia control (nonHDL-C: MD=16.81, 95% CI=0.38, 33.25; LDL-C: MD=17.6, 95% CI=2.3, 32.9). The
unmediated model (Step 1) is illustrated in Figures 13. We found that social stress was
independently associated with self-reported medication adherence (Step 2; Figures 14-15) such
that those with high stress compared to those with low or no stress have a 2.25 lower medication
adherence score (MD= -2.25, 95% CI= -2.7, -1.8). There was not, however, a similar independent
association between social stress and medication adherence as measured by pill count. Lastly, we
determined there was an independent association between self-reported medication adherence and
dyslipidemia control (non-HDL-C: MD -21.6, 95% CI -33.77, -9.41; LDL-C: MD = -17.61, 95%
CI -29.3, -6.0) (Step 3; Figures 14-15). Compared to those with inadequate medication adherence,
those with adequate medication adherence had a 21.6 lower non-HDL-C and a 21.6 lower LDLC.
The final mediation analysis examined the association between social stress, self-reported
medication adherence (i.e., the Morisky method) and dyslipidemia control using both non-HDL-C
and LDL-C, as illustrated in Figures 14 and 15. After including medication adherence in our
regression model and controlling for race/ethnicity, depression, BMI and smoking status, there
was no longer an independent association between social stress and dyslipidemia control as
measured by non-HDL-C (MD= 14.07, 95% CI=-4.3, 32.4) suggesting the association is partially
mediated—though only minimally—by medication adherence (Figure 14). We observed a
slightly attenuated independent association between social stress and dyslipidemia control as
measured by LDL-C once medication self-reported adherence was added to the model and
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adjusted for race/ethnicity, depression, BMI and smoking status (MD = 18.7, 95% CI = 2.6, 34.7)
suggesting self-reported medication adherence was a partial mediator of this association as well
(Figure 15).

3.3.6. Potential Effect Modification
3.3.6.1. Depression
We assessed whether the association between social stress and each of the cardiometabolic
outcomes was modified by prevalent depression (not depressed vs. depressed) or social support
(low social support vs. high social support (Tables 19a-b). After identifying differing stratumspecific estimates from linear regression models for social stress and dyslipidemia control among
those with no diagnosis of depression, we tested a social stress X depression interaction term and
found no evidence of effect modification of the social stress-dyslipidemia control relationships by
depression.

3.3.6.2. Social Support
After identifying differing stratum-specific estimates from linear regression models for social
support and dyslipidemia control as measured by non-HDL-C, we tested a social stress X social
support interaction term and found no evidence of effect modification of the social stressdyslipidemia control relationships by social support (Table 20).

3.4. Discussion
The relationship between stress and chronic disease is well documented (Selye, 1956; Dodge et
al, 1970; Homes et al, 1974; Rahe et al., 1992; Sternthal et al., 2011; Lantz et al, 2005; Albert et
al, 2011; Williams et al., 2012; Krieger, 2014; 2012; 2005). In the current context of health care
reform, examining the role of social determinants on health outcomes (and other factors like
health care utilization and cost) has emerged as a priority focus area in the fields of public health,
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implementation science, and medicine. However, to date, research examining the association
between social stressors—or the perceived stress associated with social determinants of health—
and chronic disease have been limited (Allen et al., 2015; Mayberry et al., 2015; Osborn et al.,
2014; Rothberg et al., 2009; DuVal et al., 2009). In this analysis of a culturally diverse population
of community health center patients with chronic disease, we aimed to examine the association
between social stressors and uncontrolled cardiometabolic disease using Marmot’s social
determinant of health theoretical framework.
We found a significant positive association of social stress with risk of uncontrolled
dyslipidemia as measured by LDL-C. Those patients reporting moderate- or high-levels of social
stress compared to those with no/low social stress had significantly higher LDL-C levels in in
adjusted models. Using this categorization of social stress, we did not find significant associations
between social stressors and diabetes or hypertension control. This is in contrast to prior research
that has identified lower glycemic control among those reporting higher levels of social stressors
(Duval et al., 2011). Similar to other prior studies, we also found higher social stress associated
with depression (Rothberg et al., 2011; Osborn et al., 2014) and with lower medication adherence
(Osborn et al., 2014). Though we did not find statistically significant associations of social stress
with level of A1c, we did observe a similar positive linear trend in higher A1c with higher levels
of social stress as demonstrated in the literature. This may be due to limited sample size.
Prior research has referred to the burdensome nature of the stressors in the TAPS and that
having multiple may indicate a substantial level of social/environmental life stress (Osborn et al.,
2014). Similar to prior research (Osborn et al., 2014; Rothberg et al., 2011), participants reported
a mean of 4.6 (SD=4.1) social stressors, reflecting the high prevalence of barriers often reported
among patients of federally qualified community health centers. We found the number of social
stressors reported differed significantly by cultural group with higher mean social stressors
reported among African Americans and Latinos compared to Vietnamese and Russian-speaking
patients. This finding contributes to fill a gap in the literature regarding how social stress is
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perceived and reported across diverse patient populations. It is possible the difference in number
of social stressors reported by African Americans and Latinos compared to Vietnamese and
Russian-speakers may reflect objective differences in the level of burden from social stressors
experienced between groups or it may reflect cultural differences in the perception/interpretation
of social stressors as measured with TAPS. In an effort to assess the latter, we created an ethnicspecific social stressor variable (Table 12) to assess cultural differences in the relationship social
stressors and chronic disease control. We identified the threshold for high stress was substantially
higher among African Americans (>8 stressors) as compared to white (>6 stressors) or
Vietnamese and Russian-speakers (>4 stressors). Among African Americans with diabetes, we
identified a significant 2.2% higher A1c (95% CI 0.17, 4.16) among those with high social stress
(8+ stressors) compared to those with low social stress (0-2 stressors). Among Russian-speaking
patients with dyslipidemia, we identified significantly higher LDL-C levels among those with
high stress (4+ stressors) compared to those with low stress (0-1 stressor).
We did not identify any significant associations between relative or absolute ethnicspecific social stress and hypertension control.
We also identified self-reported medication adherence as measured by the 8-item
Morisky scale as a fairly small partial mediator of the association between social stress and
uncontrolled dyslipidemia as measured by LDL-C. These findings, though modest, may help to
inform the development of targeted clinical interventions among patient populations with
uncontrolled dyslipidemia tailored to address the role of social stressors.
We did not find depression or social support to act as effect modifiers of the association
between social stress and dyslipidemia control.

3.4.1. Strengths and Limitations
In addition to the strengths described in Chapter 1, this study broadened the existing literature on
social stressors allowing examination of social stress across five diverse cultural groups and
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identified culturally variable levels of social stress. This is timely given the current changes in
health care and attention to the role of SDoH on health outcomes, health care utilization and
health care costs. With improved awareness of the distribution of stress associated with
social/environmental factors as captured in the TAPS, culturally tailored interventions and
resources can be developed and implemented.
The present analysis of social stress has similar limitations as those described in detail in
Chapter 1, including the cross-sectional design and associated lack of temporality, small sample
size, and possible measurement error associated with a self-reported exposure and with laboratory
disease control measures. Additionally, the TAPS is a newer instrument (Rothberg, 2009) and
few studies have used it. The TAPS does not measure all sources of stress, it may be more or less
culturally relevant for different people or groups, different people or groups may be more or less
likely to report presence and/or severity of social stressors. It is possible that some of the meaning
was lost in translation into Vietnamese and/or Russian as this was the first time it was used in
these groups. The time frame measured was only the past week, which may not be best for
chronic conditions and cumulative measures such as our outcomes. The scale only asks for a
“yes” if the social stressor was experienced as stressful rather than just having been experienced.
Within the context of SDoH and stress research, an important debate has emerged in research on
racial discrimination and health about whether racial discrimination should be asked/reported
explicitly versus implicitly (Krieger et al., 2011; Shariff-Marco et al., 2011; Krieger et al., 2013).
Lastly, the wording and possible overlap between certain items may warrant additional
assessment. For instance, items 2) Not enough money for food, rent…, and 3)Sickness or
disability in myself or my family; may be difficult for the participant to disentangle from item 1)
Taking care of my family’s different needs and problems. And, item 6) Family members
experiencing discrimination or racism at work or in public; does not include the participant’s
account of experiencing discrimination or racism. Based on the APA (2016) finding that 61% of
the adult study sample reported experiences stress associated with discrimination, the wording in
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the TAPS may have impacted the low reports of discrimination across all groups. and wording of
some questions (e.g., discrimination question); and experienced in last week???-verify
Keeping these possible limitations in mind, prior studies that used the TAPS were
similarly set in a FQHC serving low income, African American and Latino patients with chronic
disease and, using the past month as the time frame, identified a similar set of top-reported social
stressors (Mayberry et al., 2015). Furthermore, the reported validity and reliability in English and
Spanish is sound (Rothberg 2011; Welch, 2011).
The outcome variables were all collected from the electronic medical record (EMR).
While documentation in the EMR is a standard practice, quality improvement initiatives at the
research site indicate that EMR data can be flawed. This can be related to either human error in
measurement as is possible with blood pressure measurement. Or, this can be related to
documentation errors such that information is either improperly entered or documented in
incorrect fields and therefore may appear to be missing. While this could lead to nondifferential
misclassification of outcome, we addressed these potential limitations by ensuring that members
of the care team responsible for collecting blood pressure are properly trained, by conducting a
rigorous and comprehensive cleaning of the data to identify potential errors or outliers, and by
verifying that missingness was less than 10% in any variable.
An important question that has emerged from these findings is why we observed
associations between social stressors and dyslipidemia (LDL-C and non-HDL-C) but not with the
diabetes (A1cs) or hypertension (SBP)? It is possible that effect size for hypertension and
diabetes is smaller than for dyslipidemia and therefore more difficult to detect particularly with
smaller sample sizes. A known limitation of the study, the relatively small overall and diseasespecific model sample sizes, may have resulted in Type 2 errors—effects that were undetected—
due to lack of power. Or, it is possible that social stressors—or these specific types of stress
measured by the TAPS—affects cholesterol differently than A1cs and SBP.
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There are several other possible limitations to the study. The wide confidence intervals
are due to small sample sizes and warrant careful consideration when interpreting the results.
Though it is most likely that the imprecision is due to the small sample size, we took many steps
to ensure it was not due to other factors. We conducted a thorough data cleaning procedure to
ensure that the variability observed was not related to possible outliers or missingness. We
considered alternative hypotheses and conducted a range of sensitivity analyses to eliminate this
possibility. We considered the non-normal distribution of social stress and created a categorical
variable based on these assessments. However, it is possible that the cut points may not be at
optimal places to detect an association between the exposure and outcome. After each of these
steps, the variability remained. Given the cultural diversity of the groups, it is possible that the
level of variation as evidenced by the very wide confidence intervals may indicate the actual level
of variability in this particular study sample, which due to the small sample size, was unable to be
further parsed out through stratification. However, we also created an ethnic-specific social stress
variable to get at the absolute and relative reports of social stress per cultural group (Table X).
This step resulted in the identification of an independent association between social stress and
level of A1c among African Americans with diabetes and level of LDL-C among Russianspeakers with dyslipidemia. These findings indicate that it is possible thresholds for stress per
cultural group vary and should be taken into consideration when addressing social determinants
of health as they relate to cardiometabolic disease control. There appears to be variability across
groups with more social stressors reported among African Americans and Latinos as well as
possibly a higher threshold for social stressors among these groups as compared to Vietnamese
and Russian-speakers. However, additional research is warranted to determine whether these
differences are due to differences between groups’ perception of stressors, objective experience
of stressors, or are more an artifact of limited power and sample size.

122

3.4.2. Confounding
We evaluated potential confounders known to be associated with social stressors and
cardiometabolic disease control as identified in the literature. These included age, gender
race/ethnicity, educational level, employment status, household income, partner status, language
spoken at home, insurance, social support, medication adherence, depression (symptoms or
diagnosis), body mass index, comorbid conditions, smoking status, alcohol status, medications
prescribed for diabetes (including oral and insulin), hypertension, dyslipidemia. There were
several possible confounders recognized in the literature that were not available in our dataset.
They were household size (with which to assess poverty), duration of diagnoses, length of stay in
the U.S., acculturation, and exercise. Potential confounders not measured in the study could lead
to residual confounding and could bias the results in either direction. It is also possible that we
have inadequately measured one or more of our other confounders. If this were to have occurred,
the residual confounding could lead to either an over- or under-estimate of the effect estimate and
bias the results toward or away from the null.
We have considered the possible role of unmeasured, residual confounding and took
several steps to reduce this possibility. First, though household size was not collected, we created
an income equivalence variable to account for reported single/partnered status and divided
household income by the square root of 2 for those reporting partnered status. Additionally, we
conducted model building procedures (both saturated to trim and trim to saturated) using
likelihood ratio testing to select the appropriate covariates to include in each model.

3.5. Significance
We identified a significant positive association between X amount of social stress and elevated
LDL-C level. We detected self-reported medication adherence as a partial mediator of this
association. We identified a non-significant positive linear trend between the level of social stress
and A1c. Finally, we identified some evidence of cultural variability in the perception, reporting

123

and possibly the experience of social stressors. From an ecosocial approach, this study lends some
important evidence toward the role of social stressors in cholesterol control among federally
qualified health center patients and suggest efforts to address SDoH in the prevention and
management of chronic disease is warranted, especially among groups disproportionately
burdened by health disparities.
Patient-centered care coordination that identifies social stressors and then links
individuals with corresponding social resources may reduce social stressors over time (Allen et
al., 2015). The recent roll-out of Medicaid ACOs, including at the research site, has included a
wide-spread, health system integration of SDoH screening and on-going payment reform
assessments to address SDoH. Existing initiatives at the research site are currently being spread
to other health centers within the ACO, including the integration of community health workers
into primary care and clinical-community linkage to social services and navigational resources.
The integration of these innovative initiatives indicate practice transformation steps aimed at
addressing SDoH to improve health outcomes from an ecosocial approach. Future research aims
to continue to examine the association between social determinants of health, stress, and chronic
disease prevention and management.
Based on the findings from this study and the current health systems reforms, next
research steps aim to examine self-reported SDoH screening data, stress and inflammation
biomarker data, and chronic disease management among a larger, culturally diverse Medicaid
population. Replication is needed to determine that these findings and trends are robust across
different and/or larger samples of patients from similar settings. Future research needs to also
examine whether in fact there are ethnic differences in the objective and perceived experience of
social stressors or SDoH-related barriers as well as differences across disease endpoints.
Additionally, future research should examine similar questions in a wider study including patients
without prevalent cardiometabolic disease. Once replicated, if these findings are found to be
robust, the cultural variability and the suggestion of independent association between social stress
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and lipid levels but not A1c or SBP warrant continued and thoughtful consideration by
interdisciplinary investigators and practitioners of possible methodologic, statistical, clinical, and
theoretical reasons for the findings and the associated implications.

3.5.1. Generalizability
The results of this study may be generalized to other similar populations of low-income
individuals with cardiometabolic diseases, particularly those served in community health center
environments. However, it is possible that the ecosocial mechanism through which social
stressors may impact disease control can vary by region or cultural group. It is possible that
among groups with higher or lower support or access to resources, cultural perceptions and
objective reports of social stressors may vary.
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Table 11. Univariate distribution of social stressors (Tool for Assessing Patient Stressors
(TAPS))

Social Stressors
Categorical
Social Stress
Yes
No
Social Stress
0-1 stressor
2-4 stressors
5-7 stressors
8 or more stressors
Ethnic-specific Social Stress
Low
Medium
High
Continuous
20-item scale (0-20)
20-item weighted scale (0-60)

N=361
n(%)
305(84.5)
56(15.5)
95(26.3)
113(31.3)
71(19.7)
82(22.7)
131(36.3)
114(31.6)
116(32.1)
Mean(SD)
4.6(4.1)
9.1(9.5)
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Median
4.0
6.0

Range
0-20
0-54

Table 12. Ethnic-group specific stress scores

Relative
Stress
(tertile)

White

Low
Medium
High

0-2
3-5
6+

African Vietnamese Russian- Latino
American
speaking
Absolute Stress (Range)
0-2
0-1
0-1
0-5
3-7
2-3
2-3
6-8
8+
4+
4+
9+
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Table 13. Distribution of responses to individual social stress items on TAPS 20-item scale
Stressor Item

Stressful in last
week?
Yes

If yes, how stressful?
A little

Somewhat

A lot

n(%)

n(%)

n(%)

n(%)

1

Taking care of my family’s different needs and problems.

182 (50.6)

71(39.0)

61(33.5)

48(26.4)

2

Not enough money for food, rent or mortgage, or clothes for my family or myself.

154 (42.9)

51(31.8)

49(31.8)

56(36.4)

3

Problems with alcohol or drug abuse in my family or myself.

44 (12.2)

15(34.1)

12(27.3)

17(38.6)

4

Problems with violence or physical abuse in my family or myself.

24 (6.7)

14(58.3)

1(4.2)

9(37.5)

5

Sickness or disability in myself or my family, or death in the family.

155 (43.3)

43(27.7)

48(31.0)

64(41.3)

6

Family members experiencing discrimination or racism at work or in public.

32 (8.9)

13(40.6)

9(28.1)

9(28.1)

7

Problems with depression or anxiety in my family or myself.

174 (48.3)

58(33.3)

56(32.2)

58(33.3)

8

Problems reading or understanding written information (newspapers, bills, official forms, letters).

111 (30.8)

52(46.9)

32(28.8)

27(24.3)

9

Difficulty paying for medications, doctor’s visits, or medical equipment for my family or myself.

70 (19.4)

28(40.0)

20(28.6)

22(31.4)

10 Lack of affordable local transport for my family or myself (car, bus, taxi,).

89 (24.7)

29(32.6)

26(29.2)

34(38.2)

11 Having conflict or arguments among family members.

84 (23.3)

35(41.7)

27(32.1)

22(26.2)

12 Overcrowding or lack of privacy in the house.

49 (13.7)

17(34.7)

15(30.6)

16(32.7)

13 Family members working in unsafe, low paying, or stressful jobs, or being unemployed.

75 (20.8)

31(41.3)

22(29.3)

22(29.3)

14 Legal problems for my family or myself (fines, arrest, court appearances, immigration problems, detention or prison).

38 (10.6)

11(29.0)

11(29.0)

16(42.1)

15 Living in an unsafe neighborhood (crime, violence, conflict).

58 (16.1)

22(37.9)

14(24.1)

22(37.9)

16 Our neighborhood looks run down and neglected.

52 (14.4)

18(34.6)

14(26.9)

19(36.5)

17 Problems at school for your children or teens (poor conduct, grades, or attendance).

17 (4.7)

7(41.2)

3(17.7)

5(29.4)

18 Difficulty affording to send money or gifts back home to friends and family.

80 (22.2)

33(41.3)

20(25.0)

27(33.8)

19 Difficulties adjusting to American culture or language.

61 (17.0)

25(41.0)

13(21.3)

23(37.7)

107 (29.6)

30(28.0)

27(25.2)

49(45.8)

20 Difficulty affording the cost of travel back home to visit friends and family.
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Figure 11. Frequency distribution of social stressors by race/ethnicity
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Table 14. Distribution of covariates by social stress (categorical) (N=361)
Social Stress
Low Stress

Some Stress

Moderate Stress

High Stress

(0-1 stressor)

(2-4 stressors)

(5-7 stressors)

(8+ stressors)

62.3(10.5)

62.3(11.2)

57.1(10.1)

51.6(11.0)

p value*

mean(SD)
Age
Income (Equialence Scale)

<.001

969.5(397.1)

992.4(600.3)

1166.2(753.7)

906.6(462.9)

0.03

Social Support

3.9(1.1)

3.5(1.1)

3.0(1.1)

3.1(1.7)

<.001

PHQ_Score

0.76(2.1)

2.7(4.7)

5.1(6.2)

9.2(8.5)

<.001

Morisky Medication Adherence
Score

2.3(0.6)

2.0(0.7)

1.7(0.7)

1.5(0.6)

<.001

BMI Score

30.9(6.5)

32.0(7.6)

32.6(8.1)

33.5(9.6)

0.18

Male

45(47.4)

49(43.4)

26(36.6)

32(39.0)

0.50

Female

50(52.6)

64(56.6)

45(63.4)

50(61.0)

9(9.5)

14(12.4)

10(14.1)

7(8.5)

African American

19(20.0)

18(15.9)

15(21.1)

33(40.2)

Vietnamese

38(40.0)

40(35.4)

14(19.7)

5(6.1)

Russian-speaking

24(25.3)

26(23.0)

7(9.9)

6(7.3)

5(5.2)

15(13.3)

25(35.2)

31(37.8)

Not employed

78(82.1)

95(84.1)

59(83.1)

71(86.6)

Part/full-time employed

16(16.8)

18(15.9)

12(16.9)

11(13.4)

1(1.1)

0(0)

0(0)

0(0)

<High School

42(44.2)

48(42.5)

22(31.0)

28(34.2)

High School Degree (or GED)

37(39.0)

33(29.2)

21(29.6)

22(26.8)

Some college+

15(15.8)

32(28.3)

28(39.4)

32(39.0)

1(1.0)

0(0)

0(0)

0(0)

Adequate Health Litearcy

56(59.0)

66(58.4)

51(71.8)

54(68.9)

Low Health Literacy

39(41.0)

47(41.6)

20(28.2)

28(34.1)

Living single/not partnernered

50(52.6)

64(56.6)

51(71.8)

58(70.7)

Living with partner/family

45(47.4)

49(43.4)

20(28.2)

24(29.3)

87(91.6)

110(97.4)

68(95.8)

66(80.5)

8(8.4)

3(2.6)

3(4.2)

16(19.5)

n(%)
Gender

Ethnicity
White

Latino

<.001

Employment

missing

0.77

Educational Level

Missing

0.03

Health Literacy
0.23

Partner/Household Status
0.02

Homeless
Not homeless
Homeless
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<.001

Table 14. Distribution of covariates by social stress (categorical) (N=361) (continued)
Social Stress (Categorical)
Low Stress

Some Stress

Moderate Stress

High Stress

(0-1 stressor)

(2-4 stressors)

(5-7 stressors)

(8+ stressors)

30(31.6)

39(34.5)

33(46.5)

50(61.0)

3(3.2)

10(8.9)

17(23.9)

22(26.8)

Vietnamese

38(40.)

39(34.5)

14(19.7)

5(6.1)

Russian

24(25.2)

25(22.1)

7(9.9)

5(6.1)

High

64(67.4)

64(56.6)

25(40.2)

33(40.2)

Low

31(32.6)

49(43.4)

46(64.8)

49(59.8)

No

87(91.6)

104(92.0)

65(91.6)

66(80.5)

Yes

8(8.4)

9(8.0)

5(7.0)

15(18.3)

0(0)

0(0)

1(1.4)

1(1.2)

No

92(96.8)

100(88.5)

66(93.0)

72(87.8)

Yes

3(3.2)

13(11.5)

5(7.0)

9(11.0)

0(0)

0(0)

0(0)

1(1.2)

No

91(95.8)

101(89.4)

48(67.6)

47(57.3)

Yes

4(4.2)

10(8.9)

23(32.4)

35(42.7)

0(0)

2(1.8)

0(0)

0(0)

No

87(91.6)

91(80.5)

49(69.0)

42(51.2)

Yes

8(8.4)

22(19.5)

21(29.6)

40(48.8)

0(0)

0(0)

1(1.4)

0(0)

No

91(95.8)

107(94.7)

60(84.5)

53(64.6)

Yes

4(4.2)

5(4.4)

11(15.5)

29(35.4)

0(0)

1(0.9)

0(0)

0(0)

No Depression

84(88.4)

87(77.0)

46(64.8)

48(58.4)

Depression

11(11.6)

26(23.0)

25(35.2)

34(41.5)

89(93.7)

94(83.2)

46(64.8)

40(48.8)

6(6.3)

19(16.8)

25(35.2)

41(50.0)

0(0)

0(0)

0(0)

1(1.2)

No insulin

39(41.1)

43(38.1)

25(35.2)

20(24.4)

Insulin

11(11.6)

13(11.5)

10(14.1)

10(12.2)

missing

45(47.3)

57(50.4)

36(50.7)

52(63.4)

<30 (not obese)

43(45.3)

45(39.8)

27(38.0)

30(36.6)

>30 (obese)

49(51.6)

59(52.2)

41(57.8)

42(51.2)

3(3.1)

9(8.0)

3(4.2)

10(12.2)

No

62(65.3)

74(65.5)

35(49.3)

31(37.8)

Yes

32(33.7)

38(33.6)

36(50.7)

50(61.0)

1(1.0)

1(0.9)

0(0)

1(1.2)

No

79(83.2)

90(79.7)

55(77.5)

56(68.3)

Yes

13(13.7)

23(20.3)

14(19.7)

23(28.1)

3(3.1)

0(0)

2(2.8)

3(3.6)

p value*

n(%)
Language Spoken at Home
English
Spanish

<.001

Social support
<.001

Gap in Health Insurance Coverage

missing

0.11

Barriers to Care-Cost

missing

0.16

Barriers to Care-Transportation

missing

<.001

Barriers to Medication-Cost

missing

<.001

Barriers to MedicationTransportation

missing

<.001

Depression (Dx)
<.001

Depression Screen (PHQ-9)
No Depression
Depression
Missing

<.001

Insulin (among those with diabetes)
0.35

BMI

missing

0.28

Smoking Status

missing

0.00

Alcohol Use

missing
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0.14

Tables 15a-d. Social stress and dyslipidemia (non-HDL-C; N=224)
Table 15a. Unadjusted and adjusted mean differences (95% CI) of Non-HDL-C and social stress (categorical) (n=224)
N(%)

Unadjusted

Model A

Model B

MD

95% CI

MD

95% CI

MD

95% CI

0.00

Referent

0.00

Referent

0.00

Referent

Social Stress Level
Low (0-1 stressor)

65(29.02)

Some (2-4 stressors)

80(35.71)

-1.23

-14.67, 12.22

-2.86

-17.0, 11.3

-1.20

-14.98, 12.56

Moderate (5-7 stressors) 41(18.30)

13.87

-2.18, 29.92

14.37

-3.96, 32.71

16.28

-1.02, 33.58

High (8+ stressors)

16.81

0.38, 33.25

14.07

-6.6, 34.7

19.71

-0.08, 39.49

38(16.96)

Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps,
number of diseases, depression, BMI, social support and smoking status.
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 15b.
Unadjusted and adjusted mean differences (95% CI) of Non-HDL-C and social stress (ethnic-specific) (n=224)
N(%)

Unadjusted
MD

Model B
95% CI

MD

95% CI

Social Stress Level
Low

91(40.62)

0.00

Referent

0.00

Referent

Medium

67(29.91)

-4.97

-18.0, 8.06

-5.14

-19.06, 8.78

High

66(29.46)

9.52

-3.57, 22.61

12.74

-1.27, 26.75

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 15c. Unadjusted and adjusted odds ratios (95% CI) of non-HDL-C and social stress (categorical) (n=224)
Cases
Unadjusted
Model A
Model B
(n=118)

N(%)

OR

95% CI

OR

95% CI

OR

95% CI

Low (0-1 stressor)

30(25.4)

1.00

Referent

1.00

Referent

1.00

Referent

Some (2-4 stressors)

39(33.1)

1.11

0.58, 2.14

0.89

0.42, 1.89

1.13

0.56, 2.28

Moderate (5-7 stressors)

24(20.3)

1.65

0.75, 3.63

1.48

0.54, 4.03

1.85

0.76, 4.50

High (8+ stressors)

25(21.2)

2.24

0.98, 5.14

1.28

0.42, 3.96

2.11

0.77, 5.81

Social Stress Level

Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps,
number of diseases, depression, BMI, social support and smoking status.
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Table 15d. Unadjusted and adjusted odds ratios (95% CI) of non-HDL-C and social stress (ethnic-specific) (n=224)

Cases
(n=118)
N(%)

Unadjusted

Model B

OR

95% CI

OR

95% CI

Low

46 (39.0)

1.00

Referent

1.00

Referent

Medium

32 (27.1)

0.89

0.48, 1.68

0.94

0.46, 1..90

High

40 (33.9)

1.51

0.79, 2.86

1.68

0.82, 3.45

Social Stress Level

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Table 16a-d: Social stress and dyslipidemia (LDL-C; N=224)
Table 16a. Unadjusted and adjusted mean differences (95% CI) of LDL-C and social stress (categorical) (n=224)
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N(%)

Unadjusted

Model A

Model B

MD

95% CI

MD

95% CI

MD

95% CI

Social Stress Level
Low (0-1 stressor)

64 (28.70)

0.00

Referent

0.00

Referent

0.00

Referent

Some (2-4 stressors)

80 (35.87)

-1.00

-13.82, 11.81

-1.18

-14.3, 11.9

-0.03

-12.90, 12.83

Moderate (5-7 stressors) 41 (18.39)

17.58

2.30, 32.87

21.30

4.3, 38.3

23.23

7.09, 39.37

High (8+ stressors)

10.78

-4.86, 26.43

15.15

-4.0, 34.3

20.60

2.16, 39.04

38 (17.04)

Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number
of diseases, depression, BMI, social support and smoking status.
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 16b. Unadjusted and adjusted mean differences (95% CI) of LDL-C and social stress (ethnic-specific) (n=224)
N(%)
Unadjusted
Model B
MD

95% CI

MD

95% CI

Social Stress Level
Low

90 (40.36)

0.00

Referent

0.00

Referent

Medium

67 (30.04)

-6.11

-18.49, 6.26

-7.57

-20.60, 5.44

High

66(29.60)

9.27

-3.16, 21.71

14.65

1.57, 27.73

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 16c. Unadjusted and adjusted odds ratios (95% CI) of LDL-C and social stress (categorical) (n=224)
Cases
(n=114)

Unadjusted

Model A

Model B

N(%)

OR

95% CI

OR

95% CI

OR

95% CI

Low (0-1 stressor)

29(25.44)

1.00

Referent

1.00

Referent

1.00

Referent

Some (2-4 stressors)

40(35.09)

1.21

0.62, 2.33

1.23

0.6, 2.7

1.39

0.68, 2.83

Moderate (5-7 stressors) 24(21.05)

1.7

0.77, 3.76

1.95

0.7, 5.1

2.3

0.94, 5.67

High (8+ stressors)

1.49

0.67, 3.34

1.9

0.6, 5.7

2.42

0.88, 6.64

Social Stress Level

21(18.42)

Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps, number
of diseases, depression, BMI, social support and smoking status.
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 16d. Unadjusted and adjusted odds ratios (95% CI) of LDL-C and social stress (ethnic-specific) (n=224)
Cases
(n=114)
N(%)

Unadjusted

Model B

OR

95% CI

OR

95% CI

Low

45(39.47)

1.00

Referent

1.00

Referent

Medium

30(26.32)

0.81

0.43, 1.53

0.83

0.40, 1.70

High

39(34.21)

1.44

0.76, 2.74

2.03

0.98, 4.21

Social Stress Level

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 17a-d: Social stress and diabetes (HbA1c; N=162)
Table 17a. Unadjusted and adjusted mean differences (95% CI) of A1c and social stress (categorical) (n=162)
N(%)
Unadjusted
Model A
Model B
MD
95% CI
MD
95% CI
MD
95% CI
Social Stress Level
Low (0-1 stressor)
49 (30.25)
0.00
Referent
0.00
Referent
0.00
Referent
Some (2-4 stressors)
52 (32.10)
-0.17
-0.88, 0.54
-0.19
-0.95, 0.58
-0.16
-0.92, 0.60
Moderate (5-7 stressors) 32 (19.75)
0.37
-0.44, 1.19
0.41
-0.54, 1.37
0.15
-0.74, 1.03
High (8+ stressors)
29 (17.90)
0.54
-0.30, 1.38
-0.02
-1.16, 1.13
0.33
-0.72, 1.39
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps,
number of diseases, depression, BMI, social support and smoking status.

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Table 17b. Unadjusted and adjusted mean differences (95% CI) of A1c and social stress (ethnic-specific) (n=162)
N(%)
Unadjusted
Model B
MD
95% CI
MD
95% CI
Social Stress Level
Low
70 (43.21)
0.00
Referent
0.00
Referent
Medium
44(27.16)
-0.14
-0.84, 0.55
-0.23
-0.99, 0.53
High
48 (29.63)
0.12
-0.55, 0.80
0.15
-0.56, 0.85
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 17c. Unadjusted and adjusted odds ratios (95% CI) of A1c and social stress (categorical) (n=162)

Cases (n=79) Unadjusted
N(%)
OR

Model A
OR

Model B
OR

95% CI
95% CI
95% CI
Social Stress Level
Low (0-1 stressor)
26 (32.91)
1.00
Referent
1.00
Referent
1.00
Referent
Some (2-4 stressors)
23 (29.11)
0.7
0.32, 1.54
0.87
0.34, 2.21
0.92
0.38, 2.20
Moderate (5-7 stressors) 17 (21.52)
1
0.41, 2.45
2.1
0.64, 6.90
1.26
0.45, 3.51
High (8+ stressors)
13 (16.46)
1.13
0.65, 1.98
0.96
0.23, 3.94
1.06
0.31, 3.59
Model A-Saturated: Adjusted for age, gender, race/ethnciity, education, income (equivalence scale), employment, insurance gaps,
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
Table 17d. Unadjusted and adjusted odds ratios (95% CI) of A1c and social stress (ethnic-specific) (n=162)

Cases (n=79) Unadjusted
(n=162)
N(%)
OR

Model B
(n=151)
OR

95% CI
95% CI
Social Stress Level
Low
36 (45.57)
1.00
Referent
1.00
Referent
Medium
19 (24.05)
0.72
0.34, 1.53
0.87
0.36, 2.10
High
24 (30.38)
0.94
0.45, 1.97
1.15
0.51, 2.59
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 18a-d: Social stress and hypertension (SBP; N=309)
Table 18a. Unadjusted and adjusted mean differences (95% CI) of SBP and social stress (categorical) (n=309)
N(%)
Unadjusted
Model A
Model B
MD
95% CI
MD
95% CI
MD
95% CI
Social Stress Level
Low (0-1 stressor)
81(26.21)
0.00
Referent
0.00
Referent
0.00
Referent
Some (2-4 stressors)
101(32.69)
1.01
-3.78, 5.81
1.83
-3.31, 6.98
1.25
-3.74, 6.25
Moderate (5-7 stressors) 60(19.42)
-4.58
-10.06, 0.89
0.39
-5.98, 6.75
-2.23
-8.11, 3.65
High (8+ stressors)
67(21.68)
1.03
-4.27, 6.35
5.27
-1.60, 12.14
3.04
-3.18, 9.27
Model A-Saturated: Adjusted for age, gender, race/ethnicity, education, income (equivalence scale), employment, insurance
gaps, number of diseases, depression, BMI, social support and smoking status.

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 18b. Unadjusted and adjusted mean differences (95% CI) of SBP and social stress (ethnic-specific) (n=309)
N(%)
Unadjusted
Model B
MD
95% CI
MD
95% CI
Social Stress Level
Low
112(36.25)
0.00
Referent
0.00
Referent
Medium
97(31.39)
-0.56
-5.05, 3.93
0.001
-4.83, 4.83
High
100(32.36)
-0.51
-4.97, 3.94
0.01
-4.74, 4.76
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 18c. Unadjusted and adjusted odds ratios (95% CI) of SBP and social stress (categorical) (n=309)
Cases
(n=90)

Unadjusted

Model A

Model B

N(%)
OR
95% CI
OR
95% CI
OR
95% CI
Social Stress Level
Low (0-1 stressor)
22 (24.44)
1.00
Referent
1.00
Referent
1.00
Referent
Some (2-4 stressors)
32 (35.56)
1.24
0.65, 2.37
1.32
0.64, 2.72
1.22
0.62, 2.41
Moderate (5-7 stressors) 14 (15.56)
0.82
0.38, 1.77
1.2
0.48, 3.01
0.92
0.40, 2.09
High (8+ stressors)
22 (24.44)
1.31
0.65, 2.66
1.67
0.64,4.32
1.46
0.64, 3.35
Model A-Saturated: Adjusted for age, gender, race/ethnicity, education, income (equivalence scale), employment, insurance
gaps, number of diseases, depression, BMI, social support and smoking status.
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 18d. Unadjusted and adjusted odds ratios (95% CI) of SBP and social stress (ethnic-specific) (n=309)
Cases
(n=90)
N(%)

Unadjusted
OR

Model B
95% CI

OR

95% CI

Social Stress Level
Low
31 (34.44)
1.00
Referent
1.00
Referent
Medium
28 (31.11)
1.06
0.58, 1.94
1.04
0.54, 2.00
High
31 (34.44)
1.17
0.65, 2.12
1.21
0.64, 2.29
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 19a: Effect modification of social stress and dyslipidemia (LDL-C) by depression
Dyslipidemia (LDL-C)
No Depression (N=174)

Depression
(N=49)

Model B

Model B

N(%)

Beta

95% CI

N(%)

Beta

95% CI

Low (0-1 stressor)

59(33.91)

1.00

Referent

5(10.20)

1.00

Referent

Some (2-4 stressors)

65(71.26)

0.06

-13.84, 13.96

15(30.61)

14.42

-36.74, 65.58

Moderate (5-7 stressors)

27(15.52)

25.44

6.67, 44.22

14(28.57)

30.70

-26.20, 87.59

High (8+ stressors)

23(13.22)

7.73

-14.14, 29.60

15(30.61)

42.27

-17.48, 102.03

Social Stress Level

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status

Table 19b: Effect modification of social stress and dyslipidemia (non-HDL-C) by depression
Dyslipidemia (non-HDL-C)
No Depression (N=174)

Depression
(N=49)

Model B

Model B

N(%)

Beta

95% CI

N(%)

Beta

95% CI

Low (0-1 stressor)

60(34.29)

1.00

Referent

5(10.20)

1.00

Referent

Some (2-4 stressors)

65(37.14)

-3.22

-17.64, 11.21

15(30.61

32.39

-23.66, 88.45

Moderate (5-7 stressors)

27(15.43)

17.72

-1.78, 37.22

14(28.57

43.05

-19.29, 105.39

High (8+ stressors)

23(13.14)

10.52

-12.41, 33.45

15(30.61)

57.95

-7.52, 123.43

Social Stress Level

Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Table 20: Effect modification of social stress and dyslipidemia (non-HDL-C) by social support
Dyslipidemia (non-HDL-C)
Low Social Support (N=116)

High Social Support (N=108)

Model B

Model B

N(%)

Beta

95% CI

N(%)

Beta

95% CI

Low (0-1 stressor)

27(23.28)

1.00

Referent

38(35.19)

1.00

Referent

Some (2-4 stressors)

39(33.62)

-1.50

-22.29, 19.29

41(37.96)

-2.84

-21.48, 15.80

Moderate (5-7 stressors)

28(24.14)

10.23

-13.09, 33.55

13(12.04)

12.37

-15.04, 39.78

-5.79

-35.85, 24.27

Social Stress Level

High (8+ stressors)

22(18.97)
25.53
-1.51, 52.56
16(14.81)
Model B-Parsimonious model: Adjusted for race/ethnicity, BMI, depression, smoking status
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Figure 12. Mean difference and 95% CI in disease outcome by social stress (categorical)
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Figure 13. Unmediated Model: Social stress and cardiometabolic disease control
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Figure 14. Mediated Model: Social stress, self-reported medication adherence, and NonHDL-C control
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Note: Final mediated model included all a priori covariates. Solid arrows indicate statistically significant associations.
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Figure 15. Mediated Model: Social stress, self-reported medication adherence, and LDL-C
control
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CHAPTER 4
RACIAL/ETHNIC DIFFERENCES IN SOCIAL DETERMINANTS OF HEALTH,
MEDICATION ADHERENCE AND CARDIOMETABOLIC DISEASE
CONTROL:AN ECOSOCIAL APPROACH

4.1. Introduction
Cardiovascular disease (CVD) is the leading cause of death in the United States (CDC, 2016).
Three cardiometabolic diseases—diabetes mellitus, high blood pressure (hypertension) and high
blood cholesterol (hyperlipidemia) –have been identified as modifiable risk factors for CVD
(AHA, 2016). As discussed in detail in Chapters 1 to 3, effective management of each of these
cardiometabolic diseases, including medication adherence, is fundamental to preventing
morbidity and mortality associated with disease progression and to reduce the risk of CVD events
(e.g., heart attack and stoke). Social determinants of health—defined in detail in the Introduction
Chapter—include socioeconomic status (education and income), food security, housing,
transportation and other social and environmental factors that are upstream of individual
behaviors—have been associated with downstream health outcomes (Marmot et al., 2006).
Health disparities research has well established racial/ethnic differences in health
outcomes in diabetes (CDC, 2016; Kaplan et al., 2013; Egede et al., 2011; Egede et al., 2010),
hypertension (Fryar et al., 2017; Ferdinand et al., 2017), and dyslipidemia (CDC, 2017; Frank et
al., 2014; ). Research to examine the role of social determinants in health disparities and,
specifically, on cardiometabolic disease outcomes is expanding (Walker et al., 2014; Walker et
al., 2016; Williams et al., 2002; Adler et al., 2008; Marmot et al., 2014; ) and examine possible
mechanisms of these relationships.
However, fewer studies have examined racial/ethnical ethnic differences among
community health center populations where SDoH-related barriers and cardiometabolic diseases
are both prevalent (Shaw et al., 2018) and are a primary focus of current health care reform
initiatives. This is important for two primary reasons. First, community health centers are
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charged with two often competing goals of providing tailored, patient-centered care while also
meeting population health quality benchmarks. Better understanding how these factors differ by
race/ethnicity can help to target policy and practice efforts in both patient-centered and
population health-focused care. Second, most health disparities research is framed as comparing
all populations to the white population. However, based on the findings presented in Chapters 2
and 3, we have observed differences by race/ethnicity that may indicate opportunities to both
target resources and tailored service delivery to better address unmet needs and capture and learn
from the strengths of populations not commonly included in health disparities research.
Fifteen years after the Institute of Medicine’s seminal reported racial/ethnic health
disparities (Smedley et al., 2003) and nearly ten years after Healthy People 2010 (CDC, 2018)
first identified eliminating racial/ethnic disparities, racial/ethnic disparities in the prevalence and
management of cardiometabolic diseases persist and remain a public health priority (NCHS,
2018). Racial/ethnic differences in medication adherence to treat cardiometabolic diseases have
also been identified (Ferdinand et al., 2017; Kaplan et al., 2013). Much less is known about
cardiometabolic disease control among racially/ethnically diverse populations with multimorbid
cardiometabolic disease.
As is common in most national studies in the United States, non-Hispanic white
participants are used as the reference group to whom each other racial/ethnic group is compared.
Often, the racial/ethnic categorizations are based on census categories. From an epidemiologic
and statistical perspective, the referent group is usually selected based on being either the largest
group in the study or the group with the highest prevalence to optimize power to detect effects.
Tracking racial/ethnic disparities in this manner has identified groups that are disproportionately
burdened by disease, morbidity and mortality and these data are used to inform the development
of policies and distribution of resources aimed at eliminating disparities. Furthermore, this
method of comparison is warranted to illustrate the lifecourse effects of historical, political,
economic and social injustice embedded into the social structures and institutions of education,
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health care, and housing, to name a few, on racial/ethnic minority populations’ health and life
expectancy in the United States as compared to whites independent of socioeconomic status.
As a result of this common practice that is both statistically and historically warranted,
less is known about how racial/ethnic minority groups differ from each other particularly in
environments where census-based racial categorizations may result in overly heterogeneous
groups and where socioeconomic status is relatively homogeneous. One important situation in
which this occurs is in community health centers that serve a diverse U.S- and foreign-born
immigrant and refugee patient population.
4.1.1. Hypotheses and Specific Aims
This study aims to examine racial/ethnic differences in social determinants of health,
medication adherence and cardiometabolic disease outcomes among community health center
patients with cardiometabolic disease.

Specific Aims
1: To examine the relationship between race/ethnicity and social determinants, specifically food
insecurity and social stressors. We hypothesized that there are differences between groups in
these SDoH.

2. To examine the relationship between race/ethnicity and medication adherence as measured by
self-report (8-item Morisky Medication Adherence Scale (MMAS)) and by pill count. We
hypothesized that there are differences between groups in both medication adherence
measurement approaches.

3. To examine the relationship between race/ethnicity and cardiometabolic control including
diabetes (A1c), hypertension (SBP), and dyslipidemia (non-HDL-C and LDL-C). We
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hypothesized that there are differences between groups in all four cardiometabolic disease
control.
An ultimate goal of research in this area is to evaluate how findings from these three aims
are interconnected. However due to sample size constraints, conclusions about interrelationships
in this study will be qualitative rather than quantitative. Future research aims to examine possible
mediators to assess the interrelationships.

4.2. Methods
4.2.1. Study Design and Population
The study assessed the association between race/ethnicity, SDoH, medication adherence, and
cardiometabolic disease control using a subset of the cross-sectional data from the Medication
Adherence, Health Literacy and Cultural Health Beliefs mixed-methods study (RxHL) study as
described in Chapter 1 (Figure 1, Chapter 1).

4.2.2. Exposure Assessment
4.2.2.1. Self-reported race/ethnicity
The exposure in this study was self-reported race/ethnicity. Participants in the study selfidentified as non-Hispanic U.S.-born white, non-Hispanic U.S.-born African American, Latino,
Russian-speaking or Vietnamese. Because the larger RxHL study is in large part examining the
effect of cultural health beliefs and practices on medication adherence and disease management,
an effort was made to decrease the heterogeneity of culture represented by each racial/ethnic
group. Therefore, the RxHL study defines white as U.S. born. In this way, white is distinguished
from Russian-speaking based on the difference in culture and language. Similarly, African
American was also defined as U.S. born. Therefore, this group does not include individuals who
self-identify as Black African or Black Caribbean. Again, this was done in an effort to limit the
heterogeneity of culture and language among the self-identified African American group. Based
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on the location of the study, Latinos are primarily U.S.-born Puerto Rican. The research team is
aware that these study groups do not reflect the usual Census-derived racial/ethnic categories.

4.2.3. Outcome Assessment and Validity
The outcomes of interest are two social determinants of health measured in the RxHL Study (PI
Shaw) including food insecurity and social stressors, self-reported and pill count medication
adherence, and cardiometabolic disease control (dichotomous) and level of control (continuous)
in patients with diabetes, hypertension and/or dyslipidemia. Each of these measures was
described in detail in Chapters 1 and 2.

4.2.4. Covariate Assessment
Sociodemographic and other self-reported variables (e.g., educational level, income, depression
symptoms (PHQ-9)) were collected by a bicultural/bilingual interviewer administered survey in
the participant’s preferred language. Clinical variables (e.g., diagnoses, lab results, body mass
index) were abstracted from the electronic medical record.
4.2.5. Statistical Analysis
We conducted statistical analyses using Stata 12.1 (STATA Corporation, College Station, Texas).
Two-sided P values of less than 0.05 were considered to be statistically significant.
We presented univariate distributions of all factors in Chapters 1 and 2. Categorical
covariates were cross-tabulated with both the exposure and the outcome variables using chisquare tests or Fisher’s Exact Test as appropriate. Corresponding p-values were reported. For
continuous variables, mean and standard deviations were presented for both the exposure and
outcome variables using Student T test and ANOVA. Based on the literature, covariates known
to be associated with race/ethnicity, SDoH, medication adherence, and cardiometabolic disease
control were identified a priori. To assess covariates as potential confounders, T-tests, ANOVA,
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and chi-square or Fisher’s Exact tests were used to assess continuous and categorical covariates,
respectively. P-values were reported for both.
Separate unadjusted linear regression models and logit regression models were built to
examine the cross-sectional independent relationship between race/ethnicity, SDoH, medication
adherence and cardiometabolic disease control.
Parsimonious adjusted linear and logit regression models were built for each exposureoutcome relationship. First, we built an unadjusted model. Then we tested each of the variables
identified a priori in the literature as potentially associated with the exposure and outcome (age,
income equivalence, education, depression, gender, employment, comorbidities/number of
diseases, and BMI). Age, income equivalence, education, and depression were included in the
final adjusted model regardless of the outcome of the likelihood ratio test (logit regression
models) or F Partial Test (linear regression models) based on the literature. For the remaining
covariates, those that resulted in more than 10% change to the relative risk or beta coefficient or
for which the model test produced a p-value of <0.05 were retained in the final adjusted model.
To be aligned with the majority of health disparities research, we chose to use white
participants as the reference group, though the small sample size of this group would limit
statistical power. However, the primary aim of this study was to examine differences in outcomes
variables between each group rather than in comparison to white participants. Thus, we also
evaluated specific differences between groups by plotting adjusted differences and 95%
confidence intervals and conducting pairwise comparisons, with ten pairwise comparisons per
model. We used the Sidak correction to correct for multiple comparisons among unbalanced
groups.
We followed the same procedure for the logit regression models to examine the adjusted
predictive probabilities (predicted prevalence) of each dichotomous outcome.
For the model examining race/ethnicity and social stressors—an ordinal outcome—we
conducted a proportional odds model to examine predicted prevalence of self-reported higher

152

social stress. We examined the association of race/ethnicity with the ordinal social stressor
outcome variable ((1) no/low social stress, (2) 2-4 social stressors; (3) 5-6 social stressors; (4) 8+
social stressors) and adjusted for covariates. We tested the proportional odds assumption—“that
the relationship between each pair of outcome groups is the same” (IDRE, 2018, p. 10)—using
the two recommended methods of a likelihood ratio test and the Brant Test. We then conducted a
margins plot and ten pairwise comparisons with the Sidak correction for multiple comparisons to
examine the adjusted predicted prevalence of self-reporting a higher level of social stress by
race/ethnicity. Given the proportional odds assumption, the predicted probability results of the
pairwise comparisons test for Social Stressor Level 1 apply to each of the four levels of the
ordinal social stressor outcome variable.

4.3. Results
Participant characteristics for the study sample of 361 community health center patients are
described in Chapter 1 (Chapter 1, Table 1). Associations of disease prevalence and control with
covariates were discussed in detail in Chapter 1 (Table 1a & 3, respectively).

4.3.1. Race/Ethnicity
Among the 361 study participants, 26.9% were Vietnamese, 23.6% were African American,
21.1% were Latino, 17.5% were Russian-speaking and 11.1% were white (Table 1).

4.3.2. Bivariate Analysis
4.3.2.1. Uncontrolled Cardiometabolic Disease
Uncontrolled cardiometabolic disease was prevalent in all five groups. Mean A1c, SBP and lipids
as well as the proportion of uncontrolled cardiometabolic disease differed significantly by
race/ethnicity (Table 2a).
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Among those with clinically diagnosed diabetes, Vietnamese participants had a clinically
and statistically significant lower mean A1c compared to the other four groups; wherein clinical
significance is indicated by a minimum 0.5% difference (Campbell et al., 2012). Uncontrolled
A1c was higher among white and Russian-speaking participants and lower among Latino
participants. Among those with clinically diagnosed hypertension, mean SBP levels differed
significantly by group and was highest among Russian-speakers and African Americans and
lowest among white participants. African Americans had the highest rate of uncontrolled
hypertension while white participants had the lowest. Russian-speakers, followed by Latino
participants, had substantially higher mean non-HDL-C. Russian-speakers also had substantially
higher LDL-C levels while the other four groups were fairly comparable.

4.3.2.2. Medication Adherence: Self-reported Morisky (MMAS) and Pill Count
Self-reported low medication adherence was highest among Latino and African Americans
participants and lowest among Russian-speakers and Vietnamese participants. In contrast, based
on pill count, low medication adherence (<80%) was highest among Russian-speakers, Latinos
and African Americans and lowest among White participants. African Americans (44.7% vs.
40%) and Latinos (48.7% vs. 42.1%) had similarly low medication adherence rates based on the
two methods of adherence measurement. In contrast, pill count adherence revealed an
approximate 3-fold lower adherence rate compared to self-report among Vietnamese (selfreported 12.4% vs. pill count 37.1%) and Russian-speakers (self-reported 15.1% vs. pill count
42.9%) (Table 1b). White participants’ self-reported and pill count low medication adherence
were more similar (self-reported 25% vs. pill count 30%), however, self-reported adherence was
also an underestimate.
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4.3.2.3. Social Determinants: Food Insecurity and Social Stress
Food insecurity was substantially higher than the 12% national average among all but the
Russian-speaking participants. Food insecurity was highest among Latinos, at five times the
national average, followed by African Americans and white participants. Food insecurity was
lower—though still nearly double the national rate—among Vietnamese participants and lowest
among Russian-speakers. In contrast, while SNAP also differed significantly by ethnicity
(p=0.03), unlike food insecurity, it was highest among Vietnamese participants (30.4%) followed
by African American (25.6%), Latinos (17.6%), Russian-speaking (16.0%) and white (10.4%)
participants. The proportion of participants who self-reported high levels of social stressors (8+
stressors in the past week) was at least 4-times higher among Latinos and African Americans
compared to Russian-speakers and Vietnamese participants (Table 2c).

4.3.2.4. Factors of Socioeconomic Status (SES): Income and Education
Russian-speakers had the highest reported monthly income from all sources ($1469.97, SD
817.44) and Vietnamese participants reported the lowest ($864.13, SD 296.13). Using the
equivalence income measure7, highest mean income from all sources was reported among white
participants ($1130.94, SD 672.66) and the lowest among Vietnamese participants ($753.20, SD
299.28). Having less than a high school education was highest among Vietnamese participants
(50%) and lowest among white participants (4%). Vietnamese and Russian-speaking participants
had significantly higher levels of low health literacy compared to the other groups (Table 2d).

4.3.3. Multivariable Model Results:
4.3.3.1. Race/Ethnicity and Cardiometabolic Disease Outcomes

7

Equivalence income measure: The monthly income from all sources divided by the square root
of 2 for those participants who report living with a partner.
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4.3.3.1.2. Diabetes
Among those with clinical diagnosis of diabetes, Vietnamese participants had a significantly and
clinically lower mean A1c compared to whites and African Americans (Table 3a). In contrast,
Russian-speakers had a significantly and clinically higher A1c compared to Vietnamese
participants (Table 3a).
White participants had the highest predicted prevalence of uncontrolled diabetes and
Vietnamese participants had the lowest (Table 3b). There were no significant pairwise
comparisons of the predicted prevalence of uncontrolled diabetes (Table 3b).

4.3.3.1.3. Hypertension
Russian-speakers and African Americans had a significantly higher mean SBP compared to white
and Vietnamese participants (Table 4a).
African Americans had the highest predicted prevalence of uncontrolled SBP and white
participants had the lowest but differences were not significant (Table 4b).

4.3.3.1.4. Dyslipidemia Non-HDL-c
Russian-speakers had a substantially higher non-HDL-C compared to white, Vietnamese and
African American participants (Table 5a).
Russian-speakers also had the highest predicted prevalence of uncontrolled non-HDL-C
while Vietnamese participants had the lowest and this difference was significant (Table 5b).

4.3.3.1.5. Dyslipidemia LDL-c
Russian-speaking participants had a significantly higher LDL-C compared to white participants
and Vietnamese participants (Table 6a).
Russian-speakers had the highest predicted prevalence of uncontrolled LDL-C and
Vietnamese participants had the lowest. African American, white and Latino participants had
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similar predicted prevalence of uncontrolled LDL-C. Russian-speakers’ predicted prevalence of
uncontrolled LDL-C was significantly higher compared to Vietnamese participants (Table 6b).

4.3.3.4. Race/Ethnicity and Medication Adherence
4.3.3.4.1. Morisky Adherence (self-report)
African Americans and Latinos had a significantly lower self-reported mean medication
adherence score compared to white participants. Additionally, Russian-speakers and Vietnamese
participants had a significantly higher self-reported adherence compared to African Americans
(Table 7a).
The predicted prevalence of adequate self-reported medication adherence was highest
among Russian-speakers and Vietnamese participants and lowest among African Americans and
this difference was significant between Russian-speakers compared to African American
participants (Table 7b).

4.3.3.4.2. Pill Count Adherence
Russian-speakers and African Americans had a significantly lower mean medication adherence
by pill count percent compared to white participants. Pairwise comparisons indicated no
additional statistically significant differences between racial/ethnic groups (Table 8a).
Latinos had the highest predicted prevalence of low adherence by pill count followed by
Russian-speakers. Vietnamese participants and African American participants had similar
predicted prevalence and White participants had the lowest. However, predicted prevalence of
low adherence by pill count did not significantly between any of the racial/ethnic groups (Table
8b).
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4.3.3.5. Race/Ethnicity and Social Determinants of Health
4.3.3.5.1. Food Insecurity
Latino participants had a significantly higher mean food insecurity score compared to white
participants while Vietnamese participants had significantly lower food insecurity score
compared to white participants. Russian-speakers had a significantly lower food insecurity score
compared to both Latinos and African Americans (Table 9a).
The predicted prevalence of food insecurity was highest among Latinos and African
Americans followed by Vietnamese and white participants. Russian-speakers had the lowest
predicted prevalence of food insecurity. Latino participants’ predicted prevalence of food
insecurity was significantly higher compared to Russian-speakers (Table 9b).

4.3.3.5.2. Social Stressors
Latinos and African Americans had significantly higher mean social stressors compared to whites
and Latinos had higher mean social stressor scores compared to Vietnamese and Russianspeakers. Vietnamese and Russian-speakers had significantly lower mean social stressor scores
compared to white and African American participants (Table 10a).
Using a proportional odds model, both the likelihood ratio test (c2(2)=0.56, p=0.76) and
the Brant Test (c2(2)=0.54, p=0.76) were not significant indicating the proportional odds
assumption was not violated. We found that Latinos had a significantly higher odds of reporting a
higher level of social stressors compared to whites and a significantly higher predicted prevalence
of higher stressors compared to Russian-speakers and Vietnamese participants. Russian-speakers
and Vietnamese participants reported substantially higher predicted prevalence of low social
stressors compared to African Americans (Table 10b).
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4.4. Discussion
The aim of this study was to address a gap in health disparities research in the United States to
better understand differences in SDoH, medication adherence and cardiometabolic disease
outcomes among racially/ethnically diverse community health center patients. Understanding
differences compared to non-Hispanic whites as well as compared to each other is important
because standard racial/ethnic categorizations may result in overly heterogeneous groups. For
example, based on traditional categorization, Russian-speakers would likely be categorized as
non-Hispanic white. As a health care environment charged with providing culturally and
linguistically appropriate services (CLAS; MADPH, 2018) and in the midst of implementing a
Medicaid Accountable Care Organization (ACO), capturing the cultural and ethnic differences
between groups plays a central role in the delivery of efficient and comprehensive quality care.
This study provides insights into the current state of SDoH, medication adherence and
cardiometabolic disease control among an ethnically diverse community health center population
and includes two groups less frequently included in health disparities research—Vietnamese and
Russian-speakers. Several important patterns of racial/ethnic differences emerged. First,
race/ethnicity was independently associated with each of the cardiometabolic control measures
(continuous A1c for Diabetes), medication adherence, and SDoH outcomes adjusting for age,
education, income, and depression and in some cases additional variables such as BMI and
number of comorbid chronic conditions (Tables 3-10).
Second, we also identified that for all factors excluding pill count medication adherence,
there were additional significant differences between the racial/ethnic minority groups detected
with the pairwise comparisons. Russian-speakers fared significantly worse on all clinical
outcomes compared to Vietnamese and on non-HDL-C compared to African Americans.
Vietnamese had significantly lower A1c compared to African Americans.
In contrast to the clinical outcomes, Russian-speakers reported the lowest SDoH-related
factors. Latinos and African Americans had substantially higher food insecurity and social
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stressors. Vietnamese and white participants were in the middle on both SDoH factors. Possible
explanations of lower SDoH factors among the two foreign-born groups have been initially
explored using qualitative data in the larger mixed-methods RxHL study (PI Shaw). Participants
have reported strict requirements for newly arriving refugees to have documented family
sponsors. These requirements may result in Russian-speaking and Vietnamese participants having
well-developed community, family and social support networks (Shaw et al., 2018). Though we
do not have measure of length of stay in the U.S., it appears long-standing social networks may
mitigate gaps in food resources and manage social stressors.
Third, medication adherence rates were relatively low across all groups and differed
significantly by group, however, the two methods of medication adherence measurement had
substantially different results. The differences in low medication adherence as measured by selfreport versus pill count (Table 2) suggest that Russian-speakers and Vietnamese participants were
not accurately captured by the self-report. In contrast, African Americans and Latinos had fairly
comparable adherence rates captured by both methods of measurement (Table 2). There is
currently no gold standard for medication adherence. Pill count is, however, considered an
objective measure of medication adherence and, based on these findings, may be an overall more
accurate capture of medication adherence for all participants. Multimeasure approach is
recommended and, depending on the feasibility of conducting pill counts, this study provides
insights as to the comparability between measures and the differences between the two methods
among diverse patient populations (Korchmaros et al., 2018).
White participants in this study comprised the smallest group (n=40) which presents a
potential challenge to their use as the referent group. White participants in this study were also
patients of the community health center, low-income and most were managing multiple chronic
diseases. Though it is likely that the white participants benefit over the lifecourse from white
privilege, based on their membership in a low-income urban environment, it is also possible that
they are negatively impacted by policies that have historically benefited whites (Malat et al.,
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2018). While we identified significant differences among the racial/ethnic minority group
participants compared to the non-Hispanic white participants in the linear and logit regression
models, the differences indicated both worse and better outcomes compared to whites.
Furthermore, the pairwise comparisons helped to highlighted additional differences by explicitly
making the comparison between each group; differences that would have been still true if
comparing to whites but may not have been as readily recognizable by an interdisciplinary public
health audience. The differences identified in this study underscore the need for more granular
breakout of racial/ethnic groups beyond the more standard categorizations that ignore the role of
cultural and ethnic identity and assume homogeneity among racial groupings. From a
community-responsive research and implementation science perspective, these differences may
help to inform the translation of research into historically/politically relevant, culturallymeaningful interventions that build on the strengths, assets, or other important factors identified
among racial/ethnic minority groups.
In related research, social epidemiologists have developed the subjective social status
(SSS). SSS was developed toward a goal of “more fully captur[ing] the cumulative influences of
social hierarchy on health by taking into account people’s earlier life circumstances, group
experiences, family history and perceived future trajectories” (Wolff et al., 2009, p.561). The SSS
is a new measure in health disparities research and, while it is newer and validity studies are still
needed, findings have indicated that perception of social status differs across groups and that
selection of the referent group does matter (Wolf et al., 2009). This further highlights the
importance of using self-reported racial/ethnic categories based on culture, language, and country
of origin. In this way, groupings were more homogeneous regarding their historical/political,
social and economic context compared to if we had used census-based race/ethnicity
categorizations. Additional community responsive research strategies for conducting research
with racially/ethnically and culturally diverse groups have been reported by the investigator team
(Shaw et al., 2018).
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The findings in this study are also responsive to a health equity call to action that public
health and health care policy, messaging, and systems not inadvertently reify social biases.
Though statistical procedures are not in and of themselves biased, they can represent human
biases when they incorporate socially-determined risk factors, when they prescribe what or who
we “ought” to be like as a standard, or when data are presented without social, historical, political
and economic context. In a recent National Public Radio and TED Talk segment, Cathy O’Neil, a
mathematician and data scientist, warned that algorithms and analytics used in “big data”
reproduce inequality by embedding social bias in analytic code—a process she argued can
“codify bias and bigotry” (O’Neil, 2017). Some state- and regional public health entities have
taken action to develop health equity statements to be included when presenting racial/ethnic
health disparities data. The health equity statements contextualize racial/ethnic health disparities
data as being rooted in the historical, social, political and economic injustices that are upstream of
the group-based disparities and that are independent of individual behaviors (Colorado DPH,
2018; PHIWMA, 2018; Phelan et al., 2004; Phelan et al., 2010). As public health scientists and
educators, we are positioned and charged with a responsibility to translate research findings into
actionable opportunities for improvements in the community. Therefore, framing health
disparities research to better detect possible strengths and assets among racial/ethnic minorities is
an important contribution to this process.

4.4.1. Strengths and Limitations
In addition to the strengths described in Chapter 1, this study broadened the existing literature on
racial/ethnic differences in SDoH, medication adherence and cardiometabolic outcomes by
examining patterns of health disparities between each racial/ethnic group among a diverse
community health center patient population. The findings are timely given the current efforts in
health care reform to identify opportunities for applied intervention that are responsive to SDoH-
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related barriers to care and self-management among racially/ethnically diverse low-income
patients.
This study has similar limitations as described in detail in Chapter 1 including those
related to cross-sectional design, small sample size, and measurement error associated with selfreport, electronic medical record data abstraction, and pill count. Beyond these potential
limitations, in this study it is also possible that perceptions of food insecurity, social stress, and
medication adherence as captured in the instruments may differ across the groups and translation,
particularly into Vietnamese and Russian, may not fully capture the intended meaning of the
concepts being measured based. We reduced the likelihood of this by using professional
translators and then having native bicultural/bilingual staff including the research interviewers at
the health center review the translations to provide additional feedback to ensure the translations
were accurate and representative of the regional dialects represented in the patient population.
The investigator team is examining a similar question as it relates to the health literacy measure
(Shaw et al., 2018) and will continue to consider cultural, educational, language, and other related
factors and qualitative themes that impact conducting research with U.S.-born, immigrant and
refugee patient populations.

4.4.2. Confounding
We evaluated potential confounders known to be associated with race/ethnicity and each of the
outcome variables as identified in the literature. Potential confounders not measured in the
study—exercise, length of time in U.S., household size, date of disease onset—could lead to
residual confounding and could bias the results in either direction. It is also possible that we have
inadequately measured one or more of our other confounders. For instance, if there was
measurement with BMI it may be limited in its ability to control for adiposity. If this were to have
occurred, the residual confounding could lead to either an over- or under-estimate of the effect
estimate and bias the results toward or away from the null. Given the relatively minimal
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confounding detected overall (including in Chapters 2 and 3), additional consideration as to the
role and impact of confounding (measured and unmeasured) within the social determinants of
health theoretical (and causal) framework merits additional consideration.
We have considered the possible role of unmeasured, residual confounding and took
several steps to reduce this possibility. First, though household size was not collected, we created
an income equivalence variable to account for reported single/partnered status and divided
household income by the square root of 2 for those reporting partnered status. Additionally, we
conducted model building procedures (both saturated to trim and trim to saturated) using
likelihood ratio testing and F Partial Tests to select the appropriate covariates to include in each
model.

4.5. Significance & Next Steps
While limited by small sample size to examine the interrelationship between SDoH, medication
adherence and cardiometabolic disease outcomes through mediation and effect modification
analyses, several important qualitative patterns have been identified that raise additional questions
for future research. First, African American and Latino participants’ high levels of SDoH,
relatively low medication adherence, and relatively poor cardiometabolic disease control may
indicate a pattern illustrated in Marmot’s SDoH theoretical framework (Marmot et al., 2006)—the
guiding theoretical framework in Chapters 1 and 2. In contrast, Russian-speakers’ lower levels of
SDoH, low medication adherence, and uncontrolled disease suggest a need to further explore
factors upstream of medication adherence that are culturally, historically/politically relevant to
this group. Vietnamese participants’ low social stress and moderate food insecurity, low
medication adherence, and relatively better disease control suggest there may be other upstream
factors that should be further explored that are influencing individual-level behaviors beyond
medication adherence (e.g., exercise, ethnic density) that are positively impacting
cardiometabolic disease outcomes. These may be social, cultural, or other environmental factors
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and may serve as important protective factors that could be further explored and possibly tailored
to expand to other racial/ethnic groups. The emerging patterns highlight possible differences
between U.S.-born racial/ethnic groups and immigrant/refugee groups as well as differences
between the immigrant/refugee groups. Based on the emerging patterns, factors such as
racism/discrimination, historical/political contexts and experiences, patient/provider
communication, trust, social support, ethnic density and neighborhood factors, cultural health
beliefs and related protective factors may be important to consider in future research.
Continued identification of qualitative themes are needed to further explain the findings.
Additional research in similarly diverse community health center patient populations where
SDoH-related barriers and unmanaged cardiometabolic disease is prevalent is also needed. Use of
pairwise comparisons across all groups in addition to using non-Hispanic white as the referent
group can facilitate identifying differences that may otherwise go unidentified. Identification of
possibly protective features or strengths among racial/ethnic minority groups can be used to
develop historically/politically and culturally relevant interventions, practice improvements, and
policy.

4.5.1. Generalizability
The results of this study may be generalized to other similar populations of low-income
individuals with cardiometabolic diseases, particularly those served in community health center
environments. Though there is low likelihood of finding this specific grouping of community
health center patients in other geographic regions, it is likely that racial/ethnic differences and
patterns will emerge among other ethnically diverse low-income patient populations. This may be
particularly true in environments that include culturally/linguistically diverse populations
including U.S.-born (e.g., African American and Puerto Rican populations) and foreign-born
immigrant and refugee groups and where there is less variability in socioeconomic status.
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4.6. Overall SDoH and Cardiometabolic Disease Project Summary
We had unexpected null findings in the relationship between SDoH and glycemic control among
those with a clinical diagnosis of diabetes and SBP control among those with a clinical diagnosis
of hypertension. Food insecure participants had significantly higher lipid levels. Those with
moderate/high social stressors had significantly higher lipid levels. Self-reported medication
adherence partially mediates the association of SDoH and lipid levels. There is a higher
correspondence between self-reported and pill count medication adherence among African
Americans and Latinos, and a lower correspondence between the two measures among Russianspeakers and Vietnamese participants.
SDoH factors—food insecurity and social stressors—are significantly higher among
Latinos and African Americans compared to white, Vietnamese and Russian-speakers. Russianspeakers had the poorest disease outcomes and African Americans had significantly higher SBP
despite being patients in an environment where they have similar access to care and medications
compared to whites and other racial/ethnic groups. Significant differences between racial/ethnic
minority groups and between U.S.-born/foreign-born may indicate opportunity to examine
strengths/assets among cultural groups to inform policy, practice interventions/improvements.
All of the conditions in this study – HTN, DM and Dyslipidemia – are affected by diet
and therefore, by extension, we expected would also be impacted by food insecurity. Our null
findings with diabetes and hypertension and our independent association with dyslipidemia
control may indicate that dyslipidemia is potentially more sensitive to diet or to the actual dietary
content of this sample versus the other conditions. Fatty foods (e.g., fast foods and high density,
low nutrient foods) could affect dyslipidemia more than HTN or DM and therefore may provide
insight to the patterns we detected.
In addition to combining all medications to calculate a mean percent medication
adherence, we established disease-specific pill-count medication adherence and found those with
dyslipidemia had slightly higher adequate adherence (63.2%) compared to those with diabetes
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(57.9%) and those with hypertension (60.2%). For each disease control model, we adjusted for
number of comorbid diseases. However, it is possible that in the disease-specific modeling and
adherence analyses, there may have been individuals with comorbid disease for which they were
not prescribed or not taking medications. Next steps include consideration of multimorbidity and
multimorbid disease-specific medication adherence.
Given the public health programming and initiatives focused specifically on diabetes and
hypertension prevention and management at the community health center research site and
throughout the region, it is also possible that 1) people were more aware of their diabetes and
hypertension; 2) understood the self-management requirements for diabetes and hypertension
better than dyslipidemia; and/or 3) consider hypertension and diabetes to be more important.
There were several limitations in this study. This was a cross-sectional design and
therefore we are unable to assess temporality among the observed relationships or capture timevarying/cyclic variables. We had relatively small sample size and wide confidence intervals
which may have limited our ability to assess mediation and effect modification. It is possible that
measurement error was an issue based on using self-reported variables and EMR lab data. There
may be possible residual confounding from certain factors not measured such as exercise, onset
of disease, household size, and length of time in U.S. Additionally, there may be unknown
social/cultural factors, unknown cultural differences in meaning, interpretation, social
desirability. These factors may impact translation and scale validity—an issue we are examining
closely in the larger RxHL study as it relates to health literacy.
There were several strengths of the study as well. Our study includes a unique US- and
foreign-born racially/ethnically diverse patient population. It includes immigrant/refugee groups
that are less frequently included in SDoH and health disparities research. It includes a community
health center population where cardiometabolic disease and SDoH are prevalent and are the focus
of applied efforts in health care reform.
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The research is conducted based on a community-responsive research approach with an
interdisciplinary, interprofessional research team and with a strong commitment to translation of
findings inform applied, sustainable interventions and to spearhead next-steps in research.
According to Carter-Pokras et al. Jay Kaufman (2012), our research approach contributes to the
need and call for “epidemiologists to encompass the complexity of health disparities and address
contextual social determinants that contribute to disease, and the foundation of successful health
equity strategies that can reduce and/or eliminate health disparities”.
In future community-responsive research, we aim to analyze the current data using the
revised AHA/ACA hypertension control guideline of 130/80 mmHg. Also in response to the
ACC/AHA guidelines, we aim to consider ASCVD risk and statin use (with statin intensity)
among those at risk, for instance among the food insecure; and among those with high social
stress.
From a method perspective, we aim to assess and implement culturally acceptable
methods to measure biomarkers of stress and inflammation and to examine stress using selfreported and biomarker as possible mediators of SDoH and cardiometabolic disease control.
Ideally, a prospective research design would allow us to address temporality and the time varying
factors. Additionally, we aim to use multilevel modeling for cluster analysis of neighborhoodlevel factors like ethnic density.
We aim to increase our sample size and associated power to detect effects. Two goals to
achieve this are to possibly collaborate on research initiatives with the newly formed ACO
Medicaid patient population and to establish a multi-site and/or multi-community health center
research collaborative or network.
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Table 21. Number and percent of racial/ethnic groups
Race/Ethnicity

N (%)

African American

85( 23.6)

Latino

76 (21.1)

Vietnamese

97 (26.9)

Russian-speaking

63 (17.5)

White

40 (11.1)
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Table 22.Cllinical outcome variables by race/ethnicity

Diabetes
Uncontrolled (N, %)
A1c (Mean, SD)
Hypertension
Uncontrolled (N, %)
SBP (Mean,SD)
Dyslipidemia
Uncontrolled (N, %)
non-HDL-C (Mean,SD)
Dyslipidemia
Uncontrolled (N, %)
LDL-C (Mean,SD)

African American

Latino

Study Group
Vietnamese

17 (48.6)
7.9 (2.4)

18 (40.9)
7.8 (2.0)

22 (41.5)
6.9 (1.0)

14 (56.0)
7.8 (2.0)

8 (57.1)
8.0 (2.2)

0.1
0.04

29 (37.7)
133.0 (14.4)

14 (23.7)
127.5 (16.8)

23 (25.6)
129.7 (17.1)

18 (31.6)
137.0 (14.8)

6 (16.2)
125.1 (17.7)

0.03
0.002

24 (49.0)
133.0 (36.6)

22 (57.9)
145.9 (47.6)

34 (38.6)
125.6 (37.6)

24 (66.7)
159.8 (42.0)

14 (50.0)
136.9 (38.0)

0.03
0.001

24 (49.0)
108.1 (35.8)

18 (47.37)
109.8 (42.7)

35 (39.8)
98.0 (35.3)

23 (63.9)
129.2 (47.1)

14 (50.0)
100.7 (31.9)

0.06
0.003

Russian-speaking

white

p-value

Table 23. Medication adherence outcome variables by race/ethnicity

Medication Adherence
Low Adherence (N, %)
Morisky score (Mean,SD)
Medication Adhernece
Low Adherence (<80%)(N, %)
Pill Count (Mean,SD)

African American

Latino

Study Group
Vietnamese

Russian-speaking

white

p-value

38 (44.7)
5.3 (2.1)

37 (48.7)
5.3 (1.8)

12 (12.4)
6.7 (1.2)

10 (15.9)
6.5 (1.3)

10 (25.0)
6.2 (1.5)

<0.001
<0.001

34 (40.0)
67.4 (28.8)

32 (42.1)
67.6 (27.5)

36 (37.1)
80.2 (14.9)

27 (42.9)
68.6 (23.7)

12 (30.0)
78.3 (20.0)

0.004
0.001
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Table 24. SDoH outcome variables by race/ethnicity

Food Security
Food Insecure (N, %)
Food Security score (Mean, SD)
Social Stress (N, %)
0-1 Stressors
2-4 Stressors
5-7 Stressors
8+Stressors
Social Stressor Score (Mean, SD)
Health Literacy
Low Health Literacy (N, %)
Health Litearcy score (Mean,

African American

Latino

Study Group
Vietnamese

36(42.3)
1.8(2.2)

50(65.8)
2.7(2.1)

22(22.7)
0.92(1.3)

9(14.3)
0.52(1.0)

14(35.0)
1.6(2.2)

<0.001
<0.001

19(22.35)
18(21.18)
15(17.65)
33(38.82)
6.2(5.2)

5(6.58)
15(19.74)
25(32.89)
31(40.79)
6.8(3.6)

38(39.18)
40(41.24)
14(14.43)
5(5.15)
2.7(2.6)

24(38.10)
26(41.27)
7(11.11)
6(9.52)
2.78(2.9)

9(22.5)
14(35.00)
10(25.00)
7(17.50)
4.3(3.1)

<0.001

23(27.1)
14.8(4.0)

21(27.6)
14.6(4.8)

54(55.7)
11.1(6.1)

30(47.6)
13.9(3.1)

6(15.0)
16.1(3.4)

<0.001
<0.001
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Russian-speaking

white

p-value

<0.001

Table 25. Covariates by race/ethnicity
Gender
Male
Female
Partner/living status
Living w partner/family
Homeless
Yes
Language
English
Spanish
Vietnamese
Russian
PHQ
PHQ score (Mean, SD)
Depression symptoms (N, %)
BMI
BMI score (Mean, SD)
Obese (BMI>=30) (N, %)
Smoke
Yes
Alcohol
Yes
Insulin
Yes
Gap in Insurance (N, %)
Yes
Cost barrier to care
Yes
Transportation barrier to care
Yes
Cost barrier to medication
Yes
Trans. barrier to medication
Yes

African American

Latino

Study Group
Vietnamese

Russian-speaking

white

p-value

35 (41.2)
50 (58.8)

38 (50.0)
38 (50.0)

34 (35.1)
63 (64.9)

19 (30.2)
44 (69.8)

26 (65.0)
14 (35.0)

<0.003

19 (22.4)

24 (31.6)

44 (45.4)

42 (66.7)

9 (22.5)

<0.001

13 (15.3)

11 (14.5)

4 (4.1)

1 (1.6)

1 (2.5)

0.02

85 (100)

24 (31.6)
52 (68.4)

1 (1.0)

2 (3.2)

40 (100)

<0.001

96 (99.0)
61 (96.8)
4.8 (6.6)
27 (31.8)

7.8 (8.2)
34 (44.7)

1.6 (3.5)
9 (9.3)

3.1 (4.8)
14 (22.2)

3.6 (6.6)
7 (17.5)

<0.001
<0.001

34.5 (9.1)
58 (68.2)

33.1 (8.0)
45 (59.2)

26.3 (4.0)
16 (16.5)

35.2 (6.3)
44 (69.8)

34.3 (7.5)
28 (70.0)

<0.001
<0.001

56 (65.9)

49 (64.5)

15 (15.5)

5 (7.9)

31 (77.5)

<0.001

39 (45.9)

14 (18.4)

9 (9.3)

1 (1.6)

10 (25.0)

<0.001

12 (34.3)

14 (31.8)

10 (18.9)

2 (8.0)

6 (42.9)

0.04

13 (15.3)

10 (13.2)

4 (2.1)

8 (12.7)

10 (13.2)

0.09

9 (10.6)

6 (7.9)

3 (3.1)

9 (14.3)

3 (7.5)

0.12

30 (35.3)

21 (27.6)

10 (10.3)

2 (3.2)

9 (22.5)

<0.001

36 (42.4)

32 (42.1)

6 (6.2)

7 (11.1)

10 (25.0)

<0.001

24 (28.2)

19 (25.0)

1 (1.0)

2 (3.2)

3 (7.5)

<0.001
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Table 26a. Adjusted mean difference (95% CI) of A1c%, Adjusted Predicted A1c% (95% CI) and Adjusted Pairwise Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted A1c

Adjusted Pairwise Comparisons

Mean Difference

95% CI

A1c

95% CI

p<0.05

12 (7.4)

1

Referent

8.13

7.12, 9.15

~

African American

35 (21.6)

-0.04

-1.21, 1.13

8.10

7.47, 8.72

~

Vietnamese

52(32.1)

-1.50

-2.71, -0.30

6.63

6.06, 7.20

vs. African American

Russian-speaking

22(13.6)

-0.10

-1.35, 1.15

8.03

7.28, 8.78

vs. Vietnamese

Latino

41 (25.3)

-0.37

-1.55, 0.81

7.76

7.18, 8.34

~

Race Ethnicity
white

Adjusted Mean Difference-Parsimonious model: Adjusted for age, education, income (equivalence),
depression.

Table 26b. Adjusted odds of uncontrolled DM (95% CI), Adjusted Predicted Prevalence Uncontrolled
DM (95% CI) and Adjusted Pairwise Comparisons

Cases n=79

Adjusted Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Uncontrolled DM

95% CI

p<0.05

8 (10.1)

1.0

Referent

0.72

0.48, 0.97

~

African American

17 (21.5)

0.41

0.10, 1.71

0.53

0.35, 0.71

~

Vietnamese

22 (27.9)

0.22

0.05, 1.07

0.38

0.22, 0.55

~

Russian-speaking

14 (17.7)

0.72

0.15, 3.35

0.66

0.46, 0.89

~

Latino

18 (22.8)

0.29

0.07, 1.28

0.45

0.28, 0.61

~

Race Ethnicity
white

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
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Figure 16. Adjusted mean difference and 95 % CI in A1c by race/ethnicity
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Figure 17. Adjusted Predicted A1c and Pairwise Comparisons by Race/Ethnicity
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Table 27a. Adjusted mean difference (95% CI) of SBP mmHg, Adjusted Predicted SBP mmHg (95% CI) and Adjusted Pairwise
Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted SBP

Adjusted Pairwise Comparisons

Mean Difference

95% CI

SBP

95% CI

p<0.05

Race Ethnicity
white

37 (12.0)

1

Referent

125.70

120.34, 131.02

~

African American

77 (24.9)

8.52

2.12, 14.92

134.21

130.44, 137.99

vs. white

Vietnamese

79 (25.6)

2.23

-4.98, 9.42

127.91

123.66, 132.17

~

Russian-speaking

57 (18.4)

10.97

4.12, 17.81

136.66

132.34, 140.99

vs. white; vs. Vietnamese

Latino

59 (19.1)

2.77

-4.00, 9.55

128.47

124.12, 132.82

~

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.

Table 27b. Adjusted odds of uncontrolled HTN (95% CI), Adjusted Predicted Prevalence Uncontrolled HTN (95% CI) and Adjusted
Pairwise Comparisons
Cases (n=90)
Adjusted Odds
Adjusted Predicted Prevalence
Adjusted Pairwise Comparisons
N(%)

OR

95% CI

Uncontrolled HTN

95% CI

p<0.05

6 (6.7)

1.0

Referent

0.16

0.04, 0.28

~

African American

29 (32.2)

3.19

1.17, 8.70

0.38

0.26, 0.49

vs. white

Vietnamese

23 (25.6)

2.16

0.71, 6.60

0.29

0.17, 0.41

~

Russian-speaking

18 (20.0)

2.42

0.84, 7.01

0.32

0.19, 0.44

~

Latino

14 (15.5)

1.6

0.53, 4.79

0.23

0.12, 0.35

~

Race Ethnicity
white

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
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Figure 18. Mean Difference and 95% CI in SBP by Race/Ethnicity
Hypertension: SBP
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Figure 19. Adjusted Predicted SBP and Pairwise Comparisons by Race/Ethnicity
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Table 28a. Adjusted mean difference (95% CI) of non-HDL-C mm/dL, Adjusted Predicted non-HDL-C mm/dL (95% CI) and Adjusted
Pairwise Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted Non-HDL-C

Adjusted Pairwise Comparisons

Mean Difference

95% CI

non-HDL-C

95% CI

p<0.05

Race Ethnicity
white

27 (12.1)

1

Referent

137.06

121.53, 152.58

~

African American

43 (19.2)

-4.28

-23.58, 15.02

132.77

120.39, 145.16

~

Vietnamese

85 (37.9)

-11.73

-31.37, 7.92

125.33

115.51, 135.15

~

Russian-speaking

33 (14.7)

24.55

4.01, 45.08

161.60

147.38, 175.82

vs. white; vs. African American; vs.
Vietnamese

Latino

36 (16.1)

7.99

-12.40, 28.38

145.05

131.55, 158.55

~

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of
comorbid chronic diseases.

Table 28b. Adjusted odds of uncontrolled DYS (95% CI), Adjusted Predicted Prevalence Uncontrolled DYS (95% CI) and Adjusted
Pairwise Comparisons
Cases (n=118)
Adjusted Odds
Adjusted Predicted Prevalence
Adjusted Pairwise Comparisons
N(%)

OR

95% CI

Uncontrolled DYS

95% CI

p<0.05

white

14 (11.9)

1.0

Referent

0.52

0.32, 0.72

~

African American

24 (20.3)

1.33

0.48, 3.70

0.59

0.43, 0.75

~

Vietnamese

34 (28.8)

0.63

0.21, 1.90

0.41

0.28, 0.55

~

Russian-speaking

24 (20.3)

2.58

0.83, 7.97

0.73

0.57, 0.89

vs. Vietnamese

Latino

22 (18.6)

1.6

0.53, 4.77

0.63

0.46, 0.80

~

Race Ethnicity

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI,
number of comorbid chronic diseases.
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Table 29a. Adjusted mean difference (95% CI) of LDL-C mm/dL, Adjusted Predicted LDL-C mm/dL (95% CI) and Adjusted Pairwise
Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted LDL-C

Adjusted Pairwise Comparisons

Mean Difference

95% CI

LDL-C

95% CI

p<0.05

Race Ethnicity
white

27 (12.1)

1

Referent

102.14

87.29, 116.99

~

African American

43 (19.3)

6.45

-12.01, 24.91

108.59

96.75, 120.43

~

Vietnamese

85 (38.1)

-5.47

-24.26, 13.33

96.67

87.27, 106.07

~

Russian-speaking

32 (14.3)

29.58

9.83, 49.33

131.72

117.90, 145.53

vs. white; vs. Vietnamese

Latino

36 (16.1)

6.91

-12.59, 26.42

109.05

96.14, 121.95

~

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of
comorbid chronic diseases.

Table 29b. Adjusted odds of uncontrolled DYS (95% CI), Adjusted Predicted Prevalence Uncontrolled DYS (95% CI) and Adjusted
Pairwise Comparisons
Cases (n=114)

Adjusted Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Uncontrolled DYS

95% CI

p<0.05

white

14 (12.3)

1.0

Referent

0.54

0.34, 0.73

~

African American

24 (21.1)

1.18

0.43, 3.25

0.58

0.41, 0.74

~

Vietnamese

35 (30.7)

0.59

0.20, 1.77

0.41

0.28, 0.55

~

Russian-speaking

23 (20.2)

2.66

0.85, 8.32

0.75

0.59, 0.91

vs. Vietnamese

Latino

18 (15.8)

0.91

0.31, 2.66

0.51

0.34, 0.69

~

Race Ethnicity

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
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Figure 20. Adjusted Mean Difference and 95% CI in LDL-C by Race/Ethnicity
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Figure 21. Adjusted Predicted LDL-C and Pairwise Comparisons by Race/Ethnicity
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Table 30a. Adjusted mean difference (95% CI) of self-reported medication adherence, Adjusted Predicted self-reported medication
adherence (95% CI) and Adjusted Pairwise Comparisons
N(%)
Adjusted Mean Difference
Adjusted Predicted Adherence
Adjusted Pairwise Comparisons

Mean Difference

95% CI

MMAS

95% CI

p<0.05

Race Ethnicity
white

40 (11.1)

1

Referent

6.38

5.89, 6.87

~

African American

85 (23.6)

-0.88

-1.46, -0.29

5.50

5.16, 5.84

vs. white

Vietnamese

97 (26.9)

-0.05

-0.69, 0.59

6.33

5.97, 6.69

vs. African American

Russian-speaking

63 (17.5)

-0.05

-0.67, 0.57

6.33

5.94, 6.72

vs. African American

Latino

76 (21.1)

-0.76

-1.36, -0.15

5.62

5.26, 5.98

vs. white

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression.
Table 30b. Adjusted odds of self-reported low adherence (95% CI), Adjusted Predicted Prevalence self-reported low adherence (95% CI)
and Adjusted Pairwise Comparisons

Cases (n=107)

Adjusted Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Low Adherence

95% CI

p<0.05

10 (9.4)

1.0

Referent

0.77

0.64, 0.90

~

African American

38 (35.5)

0.40

0.16, 1.00

0.60

0.49, 0.70

~

Vietnamese

12 (11.2)

1.33

0.42, 4.15

0.81

0.71, 0.92

~

10 (9.4)

1.42

0.48, 4.19

0.82

0.72, 0.93

vs. African American

37 (34.6)

0.44

0.17, 1.11

0.62

0.51, 0.72

~

Race Ethnicity
white

Russian-speaking
Latino

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
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Figure 22. Adjusted Predicted Self-Reported Medication Adherence and Pairwise Comparisons by Race/Ethnicity
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Table 31a. Adjusted mean difference (95% CI) of pill count medication adherence, Adjusted Predicted pill count medication adherence
(95% CI) and Adjusted Pairwise Comparisons

N(%)

Adjusted Mean Difference

Adjusted Predicted Adherence

Adjusted Pairwise Comparisons

Mean Difference

95% CI

Pill Count Adher.

95% CI

p<0.05

Race Ethnicity
white

29 (10.2)

1

Referent

79.30

70.38, 88.21

~

African American

69 (24.3)

-10.48

-20.92, -0.05

68.82

63.0, 74.63

vs. white

Vietnamese

87 (30.6)

-0.48

-11.72, 10.76

78.82

72.99, 84.64

~

Russian-speaking

43 (15.1)

-12.06

-23.47, -0.64

67.24

60.0, 74.48

vs. white

Latino

56 (19.7)

-10.47

-21.44, 0.51

68.83

62.37, 75.29

~

Table 31b. Adjusted odds of pill count low adherence (95% CI), Adjusted Predicted Prevalence pill count low adherence (95% CI) and
Adjusted Pairwise Comparisons
Cases (n=141)

Adjusted Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Low Adherence

95% CI

p<0.05

12 (8.5)

1.0

Referent

0.34

0.18, 0.50

~

African American

34 (24.1)

1.42

0.60, 3.36

0.42

0.30, 0.52

~

Vietnamese

36 (25.5)

1.47

0.55, 3.88

0.42

0.29, 0.55

~

Russian-speaking

27 (19.2)

2.18

0.84, 5.64

0.52

0.37, 0.67

~

Latino

32 (22.7)

2.26

0.92, 5.58

0.53

0.40, 0.66

~

Race Ethnicity
white

Model A-Parsimonious model: Adjusted for age, gender, education, income (equivalence), depression,
BMI.
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Figure 24. Adjusted Mean Difference and 95% CI in Pill Count Medication Adherence by Race/Ethnicity
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Figure 25. Adjusted Predicted Pill Count Medication Adherence and Pairwise Comparisons by Race/Ethnicity
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Table 32a. Adjusted mean difference (95% CI) of food insecurity, Adjusted Predicted food insecurity (95% CI) and Adjusted Pairwise
Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted Food Insecurity

Adjusted Pairwise Comparisons

Mean Difference

95% CI

Food Insecurity

95% CI

p<0.05

Race Ethnicity
white

40 (11.1)

1

Referent

1.45

0.91, 1.98

~

African American

85 (23.6)

0.08

-0.55, 0.72

1.53

1.16, 1.91

~

Vietnamese

97 (26.9)

0.11

-0.59, 0.81

1.56

1.16, 1.95

~

Russian-speaking

63 (17.5)

-0.76

-1.44, -0.08

0.68

0.26, 1.11

vs. white; vs. African American

Latino

76 (21.1)

0.68

0.01, 1.34

2.13

1.72, 2.53

vs. white; vs. Russian

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression,
employment.

Table 32b. Adjusted odds of food insecurity (95% CI), Adjusted Predicted Prevalence food insecurity (95% CI) and Adjusted Pairwise
Comparisons
Cases (n=131)

Adjusted Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Food Insecure

95% CI

p<0.05

white

14 (10.7)

1.0

Referent

0.32

0.18, 0.46

~

African American

36 (27.5)

1.27

0.53, 3.04

0.36

0.26, 0.46

~

Vietnamese

22 (16.8)

1.07

0.38, 2.99

0.33

0.21, 0.45

~

9 (6.9)

0.41

0.14, 1.18

0.18

0.08, 0.28

~

50 (38.2)

2.95

1.20, 7.27

0.54

0.43, 0.68

vs. white; vs. Russian

Race Ethnicity

Russian-speaking
Latino

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, BMI.
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Figure 26. Adjusted Mean Difference and 95% CI in Food Insecurity by Race/Ethnicity
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Figure 27. Adjusted Predicted Food Insecurity and Pairwise Comparisons by Race/Ethnicity
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33a. Adjusted mean difference (95% CI) of social stressors, Adjusted Predicted social stressors (95% CI) and Adjusted Pairwise
Comparisons
N(%)

Adjusted Mean Difference

Adjusted Predicted Social Stressors

Adjusted Pairwise Comparisons

Mean Difference

95% CI

Social Stressors

95% CI

p<0.05

Race Ethnicity
white

40 (11.1)

1

Referent

4.21

3.09, 5.34

~

African American

85 (23.6)

1.73

0.39, 3.08

5.95

5.17, 6.72

vs. white

Vietnamese

97 (26.9)

-0.92

-2.39, 0.55

3.29

2.47, 4.12

vs. African American

Russian-speaking

63 (17.5)

-1.22

-2.66, 0.22

2.99

2.09, 3.90

vs. African American

Latino

76 (21.1)

2.06

0.68, 3.44

6.27

5.44, 7.10

vs. white; vs. Vietnamese; vs. Russian

Model A-Parsimonious model: Adjusted for age, education, income (equivalence), depression, number of
comorbid chronic diseases.

33b. Adjusted proportional odds of social stress level (95% CI), Adjusted Predicted Prevalence social stress level (95% CI) and Adjusted
Pairwise Comparisons
Cases (n=82; 8+ Stressors)
Adjusted Proportional Odds

Adjusted Predicted Prevalence

Adjusted Pairwise Comparisons

N(%)

OR

95% CI

Low Stress

95% CI

p<0.05

7 (8.5)

1.0

Referent

0.24

0.14, 0.35

~

33 (40.2)

1.67

0.80, 3.48

0.17

0.10, 0.23

~

Vietnamese

5 (6.1)

0.58

0.25, 1.31

0.35

0.25, 0.44

vs. African American

Russian-speaking

6 (7.3)

0.52

0.24, 1.11

0.37

0.26, 0.47

vs. African American

31 (37.8)

2.51

1.20, 5.28

0.12

0.07, 0.17

vs. white; vs. Vietnamese; vs. Russian

Race Ethnicity
white
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Figure 28. Adjusted Mean Difference and 95% CI in Social Stressors by Race/Ethnicity
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Figure 29. Adjusted Predicted Social Stressors and Pairwise Comparisons by Race/Ethnicity
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